Subcellular distribution of lipid metabolising enzymes in human skeletal muscle by Clark, Juliette A.
  
 
SUBCELLULAR DISTRIBUTION OF LIPID METABOLISING ENZYMES IN HUMAN 
SKELETAL MUSCLE  
 
 
 
JULIETTE A CLARK 
 
 
 
A thesis submitted to the 
University of Birmingham 
for the degree of 
DOCTOR OF PHILOSOPHY 
 
 
 
 
School of Sport and Exercise Sciences 
The University of Birmingham,  
   April 2012 
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
i 
 
GENERAL ABSTRACT 
 
 
In obesity, lipids stored in muscle as lipid droplets (LDs) lead to accumulation of fatty acid 
(FA) metabolites and insulin resistance. This research involves development of 
immunofluorescence microscopy methods to generate novel information on the subcellular 
content and distribution of key enzymes that play a role in the underlying mechanisms. 
Chapters 3 and 4 describe visualisation of two lipid synthesising enzymes. Both are more 
abundant in type I muscle fibres. Chapter 5 reveals no differences between these enzymes in 
non obese and obese elderly women. Chapter 6 reveals that a key lipolytic enzyme (ATGL) 
has a higher content in type I fibres, but its activator does not. Chapter 7 describes 
visualisation of SNAP23 and reveals a high content at the plasma membrane and 
mitochondria and low content in LDs. Chapter 8 fails to observe a difference between obese 
and non obese elderly women in plasma membrane SNAP23, and therefore fails to confirm 
the hypothesis that LDs hijack SNAP23. However, obese women have less SNAP23 in 
mitochondria and this may limit FA oxidation. In conclusion this thesis describes several 
novel mechanisms by which obesity leads to accumulation of FA metabolites and insulin 
resistance. The developed methods will be a valuable novel tool for future diabetes research. 
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CHAPTER 1 
 
 
 
 
 
 
 
 
 
 
GENERAL INTRODUCTION 
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1.1 Obesity and Type 2 Diabetes: Rapidly Growing Global Human Health 
Threats 
In the last three decades there has been a substantial and rapid rise in the prevalence of obesity 
and its related disorders. The prevalence of obesity has now reached epidemic levels with the 
World Health Organisation reporting in 2003 that 300 million adults were clinically obese 
(BMI  ≥ 30) (World Health Organisation, 2003). Obesity can be defined as an excess 
accumulation of fat to the extent that it becomes detrimental to health. Obesity has also been 
shown to be associated with a higher risk of cardiovascular disease, a higher risk for 
functional disabilities limiting mobility and stability during old age, some forms of cancer, as 
well as chronic diseases such as type 2 diabetes, hypertension and hyperlipidaemia (NHS 
Information Centre, 2008). In fact, for every unit increase in BMI, the risk of type 2 diabetes 
is increased by 18 % (Helmrich et al., 1991). According to the Foresight Report, obesity rates 
have trebled since the 1980’s (Department for Health, 2007) and the Health Survey for 
England (2007) adds to this bleak picture, estimating that by 2050 60 % of men and 50 % of 
women would be obese (BMI ≥ 30) (NHS Information Centre, 2008). Furthermore, in 2008, 
almost a quarter of adults (24 % of men and 25 % of women) were obese, and 66 % of men 
and 57 % of women were either classified as overweight or obese (BMI ≥ 25.0). In 
comparison, only 33 % of men and 41 % of women had a BMI within the normal range (18.5 
– 24.9) (NHS Information Centre, 2008).  
 
Energy intake has not increased dramatically over the last 30 - 40 years, in fact some evidence 
has even reported a decrease in energy intake (Prentice & Jebb, 1995). However the 
population has become increasingly sedentary (Oja, 1995), with an increasing pressure to 
work long hours in sedentary jobs and with increased reliance on cars for transportation. This 
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compares to a time when many jobs were manual, either industry based or labour-intensive 
manual work in agriculture. In addition, anecdotally, although the total energy intake has 
possibly not changed, the quality of food consumed has changed from nutritious balanced 
meals to energy dense convenience foods with very poor nutritional value. These two factors 
in combination could have impacted on the increase in the prevalence of obesity.  
 
Obesity is one of the many factors that contribute to the metabolic syndrome. The metabolic 
syndrome is a clustering of risk factors to include hypertension, hypertriglyceridaemia and 
hyperglycaemia which collectively increase the risk of developing cardiovascular disease. 
Obesity is associated with a decline in the ability to control blood glucose concentrations, 
termed insulin resistance. If this condition is not controlled it can progress into type 2 
diabetes. Insulin resistance is associated with progression to cardiovascular disease and it is 
reported that the greatest risk for type 2 diabetic individuals are cardiovascular complications, 
with around half of all diabetics dying of cardiovascular disease (World Health Organisation, 
2006).  
 
As a result of the worldwide obesity epidemic there has also been a surge in the number of 
individuals diagnosed with type 2 diabetes each year. Until recently, this disease was known 
as ‘late onset diabetes’ but with the increased prevalence of obesity, in individuals of any age, 
that term is no longer applicable. Even young children are now presenting with type 2 
diabetes. According to Fact Sheet No 312 (World Health Organisation, 2008) more than 180 
million people worldwide have diabetes and this is predicted to double by 2030. In the UK, 
currently 2.25 million adults are diagnosed with diabetes, but the actual figure is likely to be 
much higher as many cases remain undiagnosed (Diabetes UK, 2010).  Many complications 
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can occur as a result of diabetes; diabetic retinopathy, diabetic neuropathy (which increase the 
chances of blindness and amputations in the extremities, respectively), kidney failure, heart 
disease and stroke. In fact, the overall risk of dying prematurely is at least doubled in 
individuals with diabetes compared to their age-matched peers without the disease.  
 
Type 2 diabetes does not just lead to a burden on health but is also an economic burden to 
national government with the NHS estimated to spend £7 billion annually on diabetes related 
illnesses. Approximately 5% of the NHS budget and 10% of NHS spend on hospital 
inpatients is the result of diabetes and its associated complications (Department for Health, 
2007). New figures reveal that over 300 heart attacks, 300 strokes, 65 foot or toe amputations 
and 38 leg amputations occur among people with diabetes each week (NHS Information 
Centre, 2009).  
 
1.2 Insulin Signaling in Skeletal Muscle 
In healthy humans, resting blood glucose levels are approximately 5 mmol/L. Glucose is 
taken up into a variety of tissues such as liver, skeletal muscle, adipose tissue and the brain. 
Skeletal muscle accounts for 40 – 50 % of total body mass in man and is responsible for more 
than 50 % of glucose disposal in the postprandial period (Ferrannini et al., 1985;Katz et al., 
1983) and this is even larger in the period after exercise. Thus skeletal muscle is of crucial 
importance when it comes to understanding the mechanisms of impaired glucose tolerance 
and insulin resistance in obesity and type 2 diabetes. When glucose is taken up into the 
muscle then it can either be used for glycolysis or be stored as glycogen. The main hormone 
responsible for the increased uptake of blood glucose in skeletal muscle and glucose 
homeostasis in the postprandial period is insulin. In the postprandial period, blood glucose 
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levels become elevated. Insulin is a hormone released by the pancreas in response to these 
glucose excursions. Insulin binds to the insulin receptor at the plasma membrane and t-tubuli 
of the skeletal muscle fibres (Wardzala & Jeanrenaud, 1981;Douen et al., 1990), and to the 
plasma membrane of adipose tissue and liver cells enabling glucose to be taken up into these 
tissues. 
 
The amount of free glucose in the blood under fasting conditions is small (~ 3.9 - 5.5 
mmol/L). Following meal ingestion, large amounts of glucose are absorbed by the gut and 
appear in the blood. However, this does not result in substantial increases in blood glucose 
concentration due to the glucose buffering mechanisms that exist, leading to increased glucose 
disposal from plasma as well as suppression of the release of endogenous glucose stores (Fery 
et al., 1990). In individuals with impaired glucose tolerance and type 2 diabetes however, 
these glucose buffering mechanisms become impaired such that, in response to a meal, plasma 
glucose concentrations become elevated and remain so for many hours. In uncontrolled 
diabetes postprandial glucose levels may be as high as 20 mmol/L. Eventually the circulating 
glucose concentration under basal conditions also becomes permanently elevated to levels ≥ 7 
mmol/L.  
 
1.2.1 Insulin Signaling Cascade 
Insulin is a potent signal regulating metabolic events in the muscle. Two distinct insulin 
signalling pathways have been suggested to have involvement in insulin stimulated GLUT4 
translocation and glucose uptake (Figure 1.1). The first pathway is the more established of the 
two; namely the IRS - phosphoinositide 3-kinase (PI3K) pathway. The second pathway 
involves the APS-CAP-Cbl complex.  This latter pathway is currently less well understood 
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and its relative contribution in muscle less well established. The PI3K pathway has been 
shown to play a crucial role in insulin stimulated GLUT4 translocation through studies in 
which the catalytic activity of PI3K has been inhibited with wortmannin or overexpression of 
a dominant interfering mutant of the p85 regulatory subunit of PI3K. Both approaches have 
been shown to reduce glucose uptake and GLUT4 translocation (Cheatham et al., 1994;Okada 
et al., 1994). 
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Figure 1.1. Insulin and contraction mediated GLUT4 translocation. IRS1, insulin receptor substrate 1; PIP2, PI 4,5-bisphosphate; PIP3, 
PI3,4,5-triphosphate; PI3K, phosphoinositide 3-kinase; PDK, phosphoinositide dependent kinase 1; PKB/Akt, protein kinase B; PKC, protein 
kinase C; AS160/TBC1D4, Akt substrate of 160 kDa; GTP, guanine triphosphate;  AMPK, AMP dependent protein kinase;  APS, adaptor 
protein containing a PH and SH2 domain; CAP, Cbl associated protein/Cbl complex;  GLUT4, Glucose transporter 4. 
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1.2.2 The IRS-PI3K Insulin Signaling Pathway 
On arrival at the muscle insulin binds to the α-subunits of the insulin receptor (IR). The IR is 
a tetrameric structure with two α and two β subunits which act allosterically. The α subunits 
cause a conformational change that triggers the activation of the β-subunits via the inhibition 
of its intrinsic tyrosine kinase activity. The IR then phosphorylates scaffold proteins such as 
the insulin receptor substrate family (IRS 1-4) and APS (adaptor protein containing a PH and 
SH2 domain) (White, 1998;Pessin & Saltiel, 2000). The tyrosine phosphorylation reveals 
‘docking sites’ for the adaptor molecules containing SH2 domain binding sites such as the 
regulatory subunit (p85) of PI3K. The PI3K is then targeted to PI4,5-bisphosphate  (PI(4,5)P2) 
which is localised at the plasma membrane (Nebl et al., 2000). This metabolite is then 
phosphorylated to form PI3,4,5-triphosphate (PI(3,4,5)P3) in the plasma membrane. The 
formation of these molecules provide recognition sites for proteins by attracting  pleckstrin 
homology (PH) domain containing proteins including phosphoinositide dependent kinase 1 
(PDK1) and protein kinase B (PKB/Akt) to the inner surface of the plasma membrane to 
generate further signals including facilitating the PKB/Akt phosphorylation by PDK1.  
 
1.2.3 The APS/CAP/Cbl Complex Pathway 
Insulin signalling can also occur via the APS/CAP (Cbl associated protein)/Cbl complex 
pathway. This pathway is centred on lipid raft microdomains of the plasma membrane as this 
is where the initial insulin stimulated Cbl tyrosine phosphorylation is induced due to the 
association of CAP. The protein flotillin is present in the lipid rafts and its interaction with 
CAP results in the CAP/Cbl complex being recruited to and incorporated into the lipid rafts. 
Upon tyrosine phosphorylation of Cbl, the adaptor protein CrkII and the guanine nucleotide 
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exchange factor C3G are also recruited into the lipid rafts activating TC10. For a more 
detailed review see Chang et al., (2004).  
1.2.4 GLUT4 Translocation 
In skeletal muscle, glucose uptake requires an insulin stimulated signalling cascade (Figure 
1.1) which ultimately results in the translocation of a glucose transporter molecule to the cell 
surface (plasma membrane or t-tubuli) allowing glucose uptake via facilitative diffusion. It 
has been demonstrated that glucose transporter 4 (GLUT4) is primarily responsible for the 
insulin mediated glucose uptake in skeletal muscle (Watson & Pessin, 2001).  
 
It has recently been demonstrated that AS160 is a substrate for PKB/Akt and plays a role in 
GLUT4 translocation, as overexpression of dominant interfering AS160 blocked GLUT4 
uptake (Zeigerer et al., 2004;Welsh et al., 2005;Stockli et al., 2008).  AS160 (also known as 
TBC1D4) contains PKB/Akt phosphorylation sites as well as a Rab GAP (GTPase activating 
protein) domain. Rab proteins make up a group of proteins involved in secretory/endocytic 
pathways (Martinez & Goud, 1998). These Rab proteins cycle continually between a GDP-
bound and a GTP-bound state and are involved in regulating several processes involved in 
membrane trafficking. Specifically Rab proteins 4, 5 and 11 (Kanzaki, 2006) and more 
recently Rab 13 (Sun et al., 2010) have been implicated in GLUT4 trafficking processes. 
Insulin also causes polymerisation of the actin cytoskeleton which forms a mesh (track-like) 
structure to the plasma membrane (and likely to t-tubuli as well) allowing the targeted 
channelling of GLUT4 to the plasma membrane (Khayat et al., 2000) by acting as a scaffold. 
The modelling of the cytoskeleton appears to be mediated via PI3K and atypical isoforms of 
PKC, namely lambda and zeta, but not Akt (Liu et al., 2006). It appears that these enzymes 
are recruited to the plasma membrane (and t-tubuli) and are activated by PDK1 dependent 
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phosphorylation in response to insulin stimulation although the exact roles of these enzymes 
in glucose transport remain an ongoing area of research.      
 
In the basal state, GLUT4 constantly recycles between intracellular storage vesicles and the 
plasma membrane with the majority localised to intracellular storage compartments as 
endocytosis exceeds exocytosis. In the basal state approximately 2 – 5 % of GLUT4 resides at 
the plasma membrane (Kanzaki, 2006). Upon insulin stimulation GLUT4 exocytosis increases 
dramatically resulting in a large proportion of GLUT4 becoming incorporated into the plasma 
membrane at the cell surface and the t-tubules thereby allowing glucose to enter the cell 
(Cushman & Wardzala, 1980;Lauritzen et al., 2006;Marette et al., 1992). The t-tubular 
network enlarges the surface area for glucose uptake as the t-tubular surface area is two to 
three fold larger than the sarcolemma (Knudson & Campbell, 1989). Recent 
immunofluorescence microscopy images in animals would suggest that the increase in surface 
area is even larger (Wang et al., 1996;Ploug et al., 1998;Lauritzen et al., 2006;Lauritzen et 
al., 2008b;Lauritzen et al., 2010). In a mouse model, GLUT4 translocation to the t-tubules has 
been suggested to be delayed compared to translocation to the plasma membrane due to a time 
lag in insulin diffusion into the lumen of t-tubuli (Lauritzen et al., 2006), however, there also 
appears to be a delay in the reinternalisation of GLUT4 following insulin stimulation in the t-
tubuli (Lauritzen et al., 2008b). Thus the GLUT4 response to insulin is compartmentalised.   
 
1.2.5 GLUT4 tethering and fusion 
Soluble N-ethylmaleimide sensitive factor (NSF) attachment protein receptor (SNARE) 
proteins play a crucial role in many docking and fusion processes in a variety of intracellular 
organelles, particularly contributing to docking and fusion processes with the plasma 
membrane. Although there are many SNARE proteins, it has been shown in vitro that 
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SNAP25, syntaxin 1A and VAMP2 alone are sufficient for docking and fusion (Weber et al., 
1998). SNARE proteins have a distinctive coiled coil structure (Figure 1.2) due to the polar 
nature of the amino acid chain which is 60 - 70 amino acids long and contains both 
hydrophobic and hydrophilic portions arranged in heptad repeats so that a stable coil structure 
forms. 
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Figure 1.2. SNARE Complex Structure. The coiled coil structure of the SNARE complex is shown. Each individual SNARE protein has a 
coiled structure due to the polar nature of the amino acid sequence which is then intertwined with three other SNARE proteins
stable complex structure. Image adapted from Jahn and Scheller (2006). 
 
 
 
 to form this 
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SNARE proteins can be subdivided into two categories; target SNARE (tSNARE) and vesicle 
SNARE (vSNARE). tSNAREs are present on the target membrane and the vSNAREs are 
localised to the opposing vesicle membrane. As the SNARE proteins interact, the two 
membranes are drawn together; thus the SNARE proteins are crucial in many docking and 
fusion processes including GLUT4 translocation and lipid droplet fusion. This process 
however does not occur in isolation; NSF is also required and is found both on membranes 
and intracellularly. In order for NSF to interact and bind to a membrane it requires the 
interaction of alpha SNAP (soluble NSF associated protein). NSF is involved in providing the 
energy which is necessary for the SNARE proteins to change their conformational shape and 
thus become activated. However, once formed, the SNARE complex cannot disassemble 
without energy provided by NSF and alpha SNAP (Sollner et al., 1993), thus NSF and alpha 
SNAP are involved in maintaining a supply of free SNARE proteins and ensuring they are 
activated.  
 
The activation of TC10 (see section 1.2.3) results in the activation of Exo70 which also 
translocates to the lipid rafts binding to Snapin. It has been suggested that Exo70 arriving at 
the lipid rafts and interacting with Snapin may activate the SNARE protein SNAP23 
(synaptosomal associated protein 23) (Bao et al., 2008) which is required for the tethering of 
GLUT4 to the plasma membrane. SNAP23 has been shown to be involved in insulin mediated 
GLUT4 translocation and glucose uptake in vitro. SNAP23 was first identified in the 
membrane fraction of mouse adipocytes (Rea et al., 1998) and microinjection of SNAP23 
antibody directed towards the c-terminus of SNAP23 inhibited GLUT4 incorporation into the 
plasma membrane (Foster et al., 1999) and reduced glucose uptake by ~ 40 % (Rea et al., 
1998). Further, in adipocytes transfected with an inactive mutant SNAP23, insulin induced 
translocation of GLUT4 was reduced (Kawanishi et al., 2000a) .  
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Animal studies have demonstrated a role for syntaxin 4 in insulin stimulated GLUT4 
translocation, as syntaxin 4 null mice had an impaired insulin stimulated GLUT4 
translocation and impaired glucose tolerance compared to their wild type counterparts (Yang 
et al., 2001). VAMP2 has also been implicated in insulin stimulated GLUT4 translocation in 
vitro as insulin infusion resulted in an increased VAMP2 translocation to the plasma 
membrane (Martin et al., 1996). However this was less than the increase in GLUT4 
translocation suggesting that VAMP2 is not a limiting factor in the GLUT4 translocation 
process in response to insulin. The location of VAMP2 in adipocytes has also been proposed 
to differ from that of SNAP23 and syntaxin 4, both of which are proposed to reside on lipid 
rafts at the plasma membrane. VAMP2 resided in intracellular lipid rafts (Chamberlain & 
Gould, 2002). 
 
1.2.6 Insulin Signaling in Endothelium  
Insulin signalling is also known to occur at the level of the microvascular endothelium in 
muscle. It is thought that insulin regulates its own delivery to the muscle fibres via the 
activation of an insulin dependent pathway at the level of the endothelium (for a review see: 
(Barrett et al., 2009)). Binding of insulin to the insulin receptor on endothelial cells in 
terminal arterioles in skeletal muscle eventually leads to the synthesis of the vasodilator nitric 
oxide, allowing relaxation of the vascular smooth muscle layer, dilation of terminal arterioles 
and increased blood flow and nutrient delivery to the muscle. This mechanism is clearly of 
importance in the delivery of insulin and glucose to the muscle fibres and therefore in the 
regulation of insulin action and therefore plasma glucose concentrations and muscle glucose 
uptake. However, this thesis will focus on factors influencing insulin signal transduction and 
glucose uptake in skeletal muscle fibres.  
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1.3 Insulin Resistance of Skeletal Muscle Fibres 
In some individuals skeletal muscle fibres show an impaired signalling response after binding 
of insulin to the IR leading to a reduced glucose uptake and higher circulating levels of blood 
glucose (hyperglycaemia). This condition is termed insulin resistance. Skeletal muscle is a 
highly plastic tissue that adapts relatively rapidly to anabolic stimuli such as exercise (and 
catabolic stimuli such as disuse). This, taken together with its quantitative role in glucose 
uptake after meal ingestion, make skeletal muscle into an important target for understanding 
the mechanisms of insulin resistance as well as a potential therapeutic target for interventions 
designed for the treatment of type 2 diabetes. If insulin resistance is not treated successfully 
with lifestyle interventions such as a calorie controlled diet, exercise, the combination of the 
two or with antidiabetic drugs then type 2 diabetes will develop.  
 
1.3.1 Lipid Induced Insulin Resistance 
Acute increases in the concentration of plasma fatty acids (FA) achieved via intravenous 
intralipid-heparin infusions lead to impairments in glucose uptake in both rats (Nolte et al., 
1994;Jucker et al., 1997), healthy human controls (Boden et al., 1991;Kelley et al., 
1993;Boden et al., 1994;Roden et al., 1996;Roden et al., 1999) and patients with type 2 
diabetes (Boden, 1999). It has been proposed that these impairments in insulin signalling may 
be due to deleterious changes in the insulin signalling cascade and may be mediated via 
activation of protein kinase C (PKC) θ (Griffin et al., 1999). 
 
These lipid and heparin infusions, usually lasting approximately 5 hours, cause an elevation in 
plasma FA levels. It is mainly through these studies that PKC isoforms have been implicated 
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in the development of insulin resistance. It has been reported that 5 hour intravenous infusions 
of intralipid with heparin leads to increases in skeletal muscle of the FA metabolites: long 
chain fatty acyl coenzyme A (LCFACoA) (Griffin et al., 1999;Yu et al., 2002;Chalkley et al., 
1998) and diacylglycerol (DAG) (Itani et al., 2002). These increases were associated with the 
activation and translocation of PKCθ to the plasma membrane leading to serine 
phosphorylation of IRS-1 (De & Roth, 1997;Yu et al., 2002) and insulin resistance (Griffin et 
al., 1999;Yu et al., 2002;Chalkley et al., 1998). Serine phosphorylation of IRS-1 has been 
suggested to lead to down regulation of the tyrosine phosphorylation and prevent downstream 
activation of the insulin signalling cascade (Yu et al., 2002). Direct evidence of the role of 
PKCθ in lipid-induced insulin resistance in mice was illustrated through the use of PKCθ 
knock out mice which were protected against insulin resistance and serine phosphorylation of 
IRS-1 during a 5 hour intralipid-heparin infusion (Kim et al., 2004b).  In healthy humans a 6 
hour intralipid-heparin infusion substantially reduced glucose clearance during a 
hyperinsulinaemic euglycaemic clamp and increased the protein content of PKCβ 
(specifically the βII isoform) eightfold in the membrane fraction of skeletal muscle (Itani et 
al., 2002).  
 
Similar deleterious effects have also been observed in response to dietary manipulations. 
Consumption of a high fat diet for three weeks has been shown to lead to skeletal muscle 
insulin resistance in rats and showed a positive correlation with the skeletal muscle 
LCFACoA (Oakes et al., 1997a;Oakes et al., 1997b;Ellis et al., 2000) and DAG content 
(Oakes et al., 1994;Schmitz-Peiffer et al., 1997). Further, in human participants it was shown 
that the skeletal muscle LCFACoA content was inversely related to whole body insulin action 
(Ellis et al., 2000). 
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1.3.2 Lipid Overflow Hypothesis 
Adipose tissue is not simply a metabolically inert store of fat. It is metabolically flexible and 
plays a key role in regulating circulating levels of FA and TAG. In the postprandial period 
insulin inhibits the action of hormone sensitive lipase (HSL), a lipolytic hormone which 
breaks down TAG resulting in FA release into the circulation. The majority of the ingested fat 
is directed towards chylomicron-TAG synthesis in the gut. Lipoprotein lipase (LPL) which is 
present on the luminal site of endothelial cells in adipose tissue capillaries hydrolyses 
chylomicron-TAG and the FAs released are taken up by the adipocytes and re-esterified to 
form TAG. This process is mediated by the lipid synthesising enzymes glycerol-3-phosphate 
acyltransferase (GPAT) and diacylglycerol acyltransferase (DGAT). The postprandial 
clearance of chylomicron-TAG into the adipose tissue stores acts as a protective mechanism 
(Frayn, 2002), protecting the vascular wall, the liver and other tissues, including skeletal 
muscle, from increased FA and TAG exposure and deposition, which would impair 
endothelial function and increase the risk of atherosclerotic plaques (vasculature), steatosis 
and non alcoholic fatty liver disease (liver) and insulin resistance and type 2 diabetes (skeletal 
muscle). 
 
In obesity, in the postprandial state, there is a large overspill of FA from the adipose tissue 
into the circulation (Opie & Walfish, 1963;Frayn, 2002;Mittendorfer et al., 2009) and the 
clearance of chylomicron-TAG by adipose tissue has been suggested to be reduced (McQuaid 
et al., 2011). This leads to increased concentrations of circulating FA (only marginally higher 
in insulin resistant obese individuals) and especially TAG (Potts et al., 1995;Ruge et al., 
2009), which presents an increased risk for development of cardiovascular disease (Patsch et 
al., 1992;Hokanson & Austin, 1996;Bansal et al., 2007), and due to excessive deposition of 
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FA and lipids into skeletal muscle has been suggested to contribute to insulin resistance 
(Lewis et al., 2002).  
 
The intramuscular triglyceride (IMTG) pool in muscle has a limited storage capacity 
especially in sedentary and obese individuals and patients with type 2 diabetes. In obesity and 
type 2 diabetes, there is an imbalance between the uptake of FA and their use for oxidation 
and TAG synthesis in the muscle. This results in the accumulation of FA metabolites such as 
LCFACoA, DAG and ceramide which are thought to inhibit insulin signalling, thus leading to 
obesity induced insulin resistance (Figure 1.3). Trained individuals are able to maintain a low 
concentration of FA metabolites and high insulin sensitivity in spite of the fact that they have 
the largest IMTG stores (Goodpaster et al., 2001;van Loon et al., 2004).  
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Figure 1.3. Fatty Acid Spillover Hypothesis. GPAT, glycerol-3-phosphate acyltransferase; LPA, lysophosphatidic acid; AGPAT, 1-acyl-
glycerol-3-phosphate acyltransferase; PA, phosphatidic acid; DAG, diacylglycerol; DGAT, diacylglycerol acyltransferase; IMTG, 
intramuscular triglyceride; PKC, protein kinase C; PP2A protein phosphatase 2; IRS1, insulin receptor substrate-1; PIP2, PI 4,5-
bisphosphate; PIP3, PI3,4,5-triphosphate; PI3K, phosphoinositide 3-kinase; PDK, phosphoinositide dependent kinase-1; PKB/Akt, protein 
kinase B; PKC, protein kinase C; AS160/TBC1D4, Akt substrate of 160 kDa; GTP, guanine triphosphate; GLUT4, glucose transporter-4.  
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Many years ago, the Randle cycle (Randle et al., 1963) was proposed as an explanation for 
the impairment in glucose oxidation that occurs in the presence of elevated FA 
concentrations. It was thought that a series of negative feedback events led to the glucose 
concentration gradient between the circulation and the muscle being lost, thereby reducing the 
uptake of blood glucose into skeletal muscle. Randle et al., (1963) suggested that high rates of 
FA oxidation led to an increase in the mitochondrial ratio of acetyl-CoA/CoA and 
NADH/NAD+ which inhibit pyruvate dehydrogenase (PDH) and reduce pyruvate and 
therefore glucose oxidation. The high FA oxidation rate via the high acetyl-CoA/CoA ratio 
also results in citrate accumulation which inhibits phosphofructokinase (PFK). This in turn 
was assumed to lead to an accumulation of glucose-6-phosphate which then inhibits 
hexokinase II and results in an accumulation of intracellular glucose. Loss of the glucose 
gradient between the microvascular circulation and the cytosol of muscle fibres would then 
reduce glucose uptake via facilitated diffusion via GLUT4. This theory has however since 
been questioned as subsequent studies observed a decrease rather than an increase in glucose-
6-phosphate concentrations (pointing at glucose transport as the limiting step) and also failed 
to observe an increase in citrate concentration when glucose metabolism was inhibited 
through the use of an intralipid-heparin infusion as a means to elevate plasma FA levels 
(Boden et al., 1994;Boden, 1999;Roden et al., 1999).  
 
Metabolic flexibility is a term used to describe the ability of an individual to transiently 
switch fuel use from a fasted to fed state and from a fed to fasted state also (Storlien et al., 
2004;Corpeleijn et al., 2009). It is likely that in obese, insulin resistant individuals this 
metabolic flexibility is compromised and the buffering capacity of FA/TAG in plasma is 
disrupted. Plasma FA can accumulate in obese individuals as the ability of insulin to suppress 
FA release from adipose tissue is blunted in the postprandial period (Groop et al., 
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1989;Campbell et al., 1994). Further, in obese individuals there is an impairment in insulin’s 
ability to up-regulate the activity of LPL in adipose tissue (and therefore TAG clearance into 
adipose tissue) leading to increased circulating TAG (Sadur et al., 1984;Ong & Kern, 
1989;Richelsen et al., 1993;Frayn, 2002). In obesity, FA release from the adipocytes is 
increased as the adipocyte becomes insulin resistant and HSL activity is not down-regulated 
in response to insulin, thus lipolysis continues in the postprandial period (Frayn, 2002;Lewis 
et al., 2002;Corpeleijn et al., 2009). Obesity is also associated with increased VLDL-TAG as 
the increased FA released from adipose are directed to the liver where VLDL-TAG synthesis 
is increased. Conversion of plasma FA into VLDL-TAG does explain why some studies fail 
to observe increased plasma FA levels but observe large increases in VLDL-TAG in obese 
insulin resistant individuals (Bickerton et al., 2008). A high concentration of VLDL-TAG is a 
major risk factor for cardiovascular disease. In order to ’manage’ the increase in circulating 
FA there may also be increased uptake of FA into other tissues such as liver, heart and muscle 
where they are either oxidised (Hodson et al., 2010) or re-esterified into TAG. This ectopic 
fat accumulation has been associated with insulin resistance and is termed the lipid ‘overflow’ 
or ‘spillover’ hypothesis (Bays et al 2004; Lewis et al 2002).  
 
1.4 Lipid Droplets 
Lipid droplets are found in skeletal muscle and may act as a readily available fuel source in 
trained individuals during exercise. However, excessive storage of these lipid droplets is 
pivotal to the development of many metabolic diseases such as obesity, insulin resistance  and 
type 2 diabetes (Guo et al., 2009). For many years, lipid droplets were simply considered to 
be inert storage depots but more recently they have been demonstrated to be dynamic 
organelles with a direct role in the pathogenesis of metabolic disease.  
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1.4.1 Lipid Droplet Structure 
Lipid droplets consist of a core of neutral lipids (mainly TAG), surrounded by a monolayer of 
phospholipids (Bartz et al., 2007b). A large number of proteins have been identified in 
isolated lipid droplet fractions (Brown, 2001;Bartz et al., 2007a). Most of these proteins are 
assumed to be functionally associated with or even embedded in the surrounding phospholipid 
monolayer. The proteins assumed to be functional include the PAT proteins, (perilipin, 
adipophilin/adipocyte differentiation related protein (ADRP), tail interacting protein of 47 
kDa (TIP-47), muscle lipid droplet storage protein (MLDSP)/OXPAT), lipid synthetic 
enzymes such as acetyl-CoA carboxylase 1 (synthesising malonylCoA for de novo 
lipogenesis) and DGAT2 (Stone et al., 2009), lipolytic proteins such as ATGL and membrane 
trafficking proteins such as Rabs. The proteins embedded in the phospholipid layer may have 
important regulatory functions. The PAT proteins for instance have been suggested to regulate 
the access of lipolytic enzymes to the TAG core (Brasaemle et al., 2000b). Unfortunately, the 
majority of knowledge regarding lipid droplets has been discovered in vitro or in adipocytes 
and thus currently this information must be extrapolated to skeletal muscle. The core of the 
lipid droplets surprisingly has been shown to also contain proteins (Robenek et al., 2005). 
However, further research is needed into how these proteins are transported into and out of 
the lipid core and whether they indeed are functional or artefacts. 
 
1.4.2 Lipid Droplet Formation 
Lipid droplets are thought to be formed in the vicinity of or within the endoplasmic reticulum 
(ER) although the exact mechanisms by which this occurs are unknown, particularly for 
skeletal muscle. Therefore, information must again be extrapolated from in vitro cell studies 
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or other tissues. Newly formed lipid droplets are known as ‘primordial’ and are approximately 
0.1 - 0.4 µm in diameter (Marchesan et al., 2003), however they have the capacity to greatly 
increase in size by up to 50 times in the majority of cell types (and even more in adipocytes).  
Primordial lipid droplets form from microsomes, having a diameter of approximately 0.1µm 
and contain ADRP, vimentin, caveolin and GRP78 (Marchesan et al., 2003). Lipid droplets 
are formed of a core of neutral lipids and cholesterol esters encased by a phospholipid 
monolayer (Ohsaki et al., 2009). Lipid droplets can increase in size via the process of TAG 
synthesis however it has been shown that lipid droplets can also form complexes as they fuse 
and thus their size can increase independent of this process. For example, in vitro inhibition of 
TAG biosynthesis using Triacsin C resulted in no increase in oil red O staining in response to 
7 hours oleic acid incubation (Bostrom et al., 2005). Lipid droplet size however did increase 
with an increase in number of the largest droplets (> 3µm in diameter). 
 
There has been much controversy regarding the mechanisms of lipid droplet biogenesis. Until 
recently, the popular hypothesis was that lipid esters gradually accumulate between two 
leaflets of the ER membrane. The gradual accumulation of lipid esters allows the familiar 
globular shape to form until, on reaching a critical size, they are pinched off (Murphy & 
Vance, 1999). Recently however, unequivocal evidence has come to light using freeze 
fracture electron microscopy in macrophages suggesting that it is in fact ADRP enriched 
domains of the ER membrane that allow for the formation of lipid droplets which fit into the 
membrane (like an egg in an egg cup) (Robenek et al., 2006). The lipid does not accumulate 
within the ER membrane as first hypothesised, instead it seems that both membranes lie 
external to, and follow the contour of the lipid droplet. ADRP has previously been implicated 
in lipid droplet biogenesis. ADRP co-exists with Rab18 in lipid droplets however 
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immunofluorescence microscopy shows a reciprocal relationship. That is, when the signal for 
Rab18 is strong, the signal for ADRP is weak (Ozeki et al., 2005). Rab18 is found at the lipid 
droplet monolayer and this association is increased following stimulation of lipolysis in 
adipocytes (Martin et al., 2005). 
 
The microtubule network has also been implicated as playing a crucial role in the formation of 
lipid droplets. Incubation of adipocytes with the microtubule destroyer nocodazole decreased 
lipid droplet complex formation by 88 % as well as blunting the growth of existing lipid 
droplets (Bostrom et al., 2005). The motor protein dynein co-immunoprecipitated with ADRP 
suggesting that it is the ADRP containing droplets that can be transported along the 
microtubule network leading to the formation of lipid droplet complexes. Dynein is thought to 
be phosphorylated by ERK2 (Andersson et al., 2006) implicating ERK2 in the process of lipid 
droplet assembly. This has been clarified through its inhibition with Ste-Mek113 (Kelemen et 
al., 2002) which resulted in a significant decrease in the rate of lipid droplet formation. This 
effect was independent of incubation in oleic acid. Using this inhibitor with insulin 
simulation, it was found that the insulin induced stimulation of lipid droplet formation was 
also reduced.  
 
1.5 IMTG Metabolism 
Throughout this thesis lipid droplets and IMTG are investigated. Whilst these terms are often 
used interchangeably, the difference for the purpose of this thesis is that the term lipid droplet 
describes the individual intracellular structure containing IMTG, surrounded by a 
phospholipid monolayer and a number of proteins such as perilipins. IMTG is used to 
describe the fuel source that these lipid droplets can collectively provide and is also used 
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when describing reactions of synthesis and lipolysis as these reactions work specifically to 
produce IMTG that fills the lipid droplet or to hydrolyse the IMTG stored within the lipid 
droplet. 
 
The lipid levels within the muscle are tightly regulated by the balance of lipid synthesis and 
lipolysis. If this process becomes unbalanced, or FA uptake is not matched by FA oxidation, 
lipid metabolites can accumulate in the muscle, leading to insulin resistance. When FAs first 
enter the muscle they are diverted towards IMTG synthesis via the lipid synthetic pathway 
involving the lipid synthetic enzymes GPAT and DGAT and, when energy is required, the 
lipolytic pathway involving adipose triglyceride lipase (ATGL) and HSL allows for the 
release of FA from the IMTG stores to undergo mitochondrial β-oxidation (Figure 1.4). 
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Figure 1.4. Lipid Turnover in Skeletal Muscle. G-3-P, glycerol-3-phosphate; GPAT, glycerol-3-phosphate acyltransferase; LPA, 
lysophosphatidic acid; AGPAT, 1-acyl-glycerol-3-phosphate-O-acyltransferase; PA, phosphatidic acid; DAG, diacylglycerol; DGAT, 
diacylglycerol acyltransferase; ATGL, adipose triglyceride lipase; CGI-58, comparative gene identification-58; HSL, hormone sensitive 
lipase; MGL, monoglyceride lipase. 
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1.5.1 IMTG Synthesis 
The synthesis of IMTG in human skeletal muscle is an important process as it utilises the FA 
metabolites (LCFACoA and DAG) in the synthetic process thus reducing their levels and 
potentially protecting against insulin resistance. The process involves a series of sequential 
acylation reactions in which the ultimate product is TAG. The first committed step of TAG 
synthesis is the acylation of glycerol-3-phosphate with LCFACoA to form lysophosphatidic 
acid (LPA). This reaction is catalysed by GPAT (Figure. 1.3). The LPA product of this 
reaction is acylated to phosphatidic acid (PA) by 1-acyl-glycerol-3-phosphate-O-
acyltransferase (AGPAT). A phosphate group is then removed from the PA to form DAG. 
The final step of TAG synthesis is the acylation of DAG to TAG which is catalysed by 
DGAT.  Two of the enzymes involved in this process are investigated in further detail in this 
thesis, namely, GPAT1 and DGAT1.  
 
1.5.1.1 Glycerol-3-Phosphate Acyltransferase 
GPAT is responsible for catalyzing the first step of IMTG synthesis; the acylation of glycerol-
3-phosphate with LCFACoA to form LPA. Currently four isoforms of GPAT are known to 
exist; two mitochondrial isoforms namely GPAT1 and GPAT2,  (Monroy et al., 1973;Shin et 
al., 1991;Lewin et al., 2004) were first described in mouse liver and were named 
mitochondrial isoforms as each was found to be present in a high concentration in liver 
mitochondria (Monroy et al., 1973). Two microsomal isoforms also exist; GPAT3 and 
GPAT4 which were first measured in rat liver microsomes (Yamashita & Numa, 
1972;Yamashita et al., 1972) and have since been cloned (Cao et al., 2006;Chen et al., 2008). 
GPAT1 makes up less than 10% of total GPAT activity in adipocytes as well as hepatocytes 
and baby hamster kidney cells (Stern & Pullman, 1978;Bell & Coleman, 1980), however its 
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contribution in skeletal muscle is currently unknown. GPAT1 also shows a preference for 
saturated acyl-CoAs (Coleman & Lee, 2004). The enzymes involved in the latter stages of 
IMTG synthesis are present at the ER along with microsomal GPAT, thus the LPA produced 
must be transported from the mitochondria to the ER most probably via liver-fatty acid 
binding protein (Gonzalez-Baro et al., 2007), however it is currently unknown how this 
process occurs in skeletal muscle.  
 
The putative role of GPAT1 has previously been investigated in GPAT1 knockout mice. 
These mice demonstrated a reduced body mass, lower hepatic TAG content, lower plasma 
TAG and VLDL-TAG and decreased liver TAG secretion (Hammond et al., 2002), 
suggesting that GPAT1 is important for liver VLDL-TAG production but that its role can at 
least in part be taken over by GPAT 2 - 4 as these mice are not totally devoid of TAG. In 
hepatocytes overexpressing GPAT1, TAG content has been shown to increase in response to 
oleate incubation (Lewin et al., 2005). This response has also been shown in mice (Linden et 
al., 2006) and Chinese hamster ovary cell (Igal et al., 2001) models.  
 
To date, few studies have measured the protein abundance of GPAT1 or 2 by Western 
blotting in human skeletal muscle. GPAT1 content was found to be increased the day 
following a bout of endurance exercise (45 min treadmill exercise and 45 min cycle ergometer 
exercise at 65% VO2peak) (Schenk & Horowitz, 2007). The increase in GPAT1 was found to 
be concurrent with an increase in DGAT1 and was found to protect against insulin resistance 
induced by lipid-heparin infusion in non obese women. In a further study, using a similar 
exercise protocol, an increase in GPAT1 activity was observed, but there was no increase in 
GPAT protein content (Newsom et al., 2010). Regardless of this, a 30 % increase in IMTG 
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content was seen following an overnight lipid-heparin infusion and the exercise again resulted 
in protection against lipid induced insulin resistance.   
 
The location of GPAT1 at the outer mitochondrial membrane has recently come under 
scrutiny as a recent publication has demonstrated two storage sites for GPAT1 in rat liver 
(Pellon-Maison et al., 2007). One storage site appears to be present in a vesicular membrane 
fraction associated with the mitochondria (MAV) however the GPAT specific activity in this 
fraction appeared low. The second store of GPAT1 appeared to be found at the mitochondrial 
outer membrane (OMM) and this was where the greatest specific GPAT activity was found. 
Therefore, it is possible that GPAT1 in rat liver translocates from the MAV to the OMM upon 
activation e.g. by insulin, where it is involved in synthesising IMTG in close proximity to the 
mitochondria. A more recent study in NIH 3T3 fibroblasts has shown that mitochondria may 
be coupled to lipid droplets in a process regulated by the SNARE protein SNAP23 
(Jagerstrom et al., 2009) and it is possible that GPAT1 is involved in the tightly regulated 
formation of lipid droplets in close proximity to the mitochondria which are then coupled to 
lipid droplets via SNAP23. There was no information on the spatial localisation of the 
GPAT1-4 isomers in skeletal muscle when beginning the research described in this thesis.  
 
1.5.1.2 Diacylglycerol Acyltransferase  
DGAT is the enzyme responsible for the final step of IMTG synthesis (Choi et al., 2007), 
catalysing the acylation of DAG with LCFACoA resulting in TAG formation.  In this role, 
DGAT can both increase the IMTG content and reduce the DAG content. As DAG, apart 
from being implicated in the mechanisms leading to insulin resistance, also exerts a variety of 
signalling roles, the latter role may be of equal or even greater importance. Two DGAT 
30 
 
isoforms are known to exist, DGAT1 and DGAT2 (Cases et al., 1998;Cases et al., 2001). 
Current evidence perhaps suggests that these two isoforms play differing roles in lipid 
metabolism as DGAT1 knockout mice have 50% less TAG in tissues and are protected from 
diet induced obesity and insulin resistance through a mechanism seemingly related to 
increased energy expenditure (Chen et al., 2002). Overexpression of DGAT1 also has been 
suggested to have a protective effect against insulin resistance. Overexpression of myocellular 
DGAT1 by recombinant adenovirus in C2C12 myotubes resulted in a three - fold increase in 
DGAT activity and led to a six - fold increase in intracellular TAG and reduced DAG by 50 
% (Liu et al., 2007) . Further, it has recently been reported that an increase in the content of 
DGAT1 (and GPAT1) occurred the day following a single bout of endurance exercise and 
prevented insulin resistance induced by lipid-heparin infusion in healthy humans by reducing 
the content of DAG and ceramides, FA metabolites which are known to lead to insulin 
resistance (Schenk & Horowitz, 2007). However, in a follow up study of the same group no 
increase in DGAT1 activity and protein content was found, but an acute bout of exercise prior 
to an overnight lipid-heparin infusion still protected against lipid induced insulin resistance 
(Newsom et al., 2010). These studies suggest that high levels of GPAT1 and DGAT1 may 
protect against the development of insulin resistance.  
 
1.5.2 Lipolysis 
Just as a high rate of triglyceride synthesis may protect against insulin resistance by reducing 
levels of FA metabolites, it is also possible that high rates of IMTG hydrolysis, not 
compensated by increased oxidation, may lead to insulin resistance, particularly if incomplete 
lipolysis to DAG and LCFACoA were to occur. Two enzymes responsible for hydrolysis of 
IMTG are ATGL and HSL.  
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1.5.2.1 Adipose Triglyceride Lipase 
In adipocytes it has been shown that, in the basal state, ATGL is present both in the cytoplasm 
and attached to lipid droplets (Zimmermann et al., 2004;Granneman et al., 2007).  Activation 
of PKA with adrenaline has been shown to lead to translocation of ATGL towards the lipid 
droplets (Granneman et al., 2007). The hydrophobic region within the C-terminal of ATGL 
seems to be important for colocalisation with lipid droplets, although the mechanism by 
which this interaction facilitates lipid droplet colocalisation is still currently unknown 
(Kobayashi et al., 2008;Schweiger et al., 2008). Translocation to the lipid droplets also 
coincides with an increase in ATGL activity, but the increase in activity is not thought to be 
the result of the increase in PKA activity (Zimmermann et al., 2004). The kinases that do 
regulate this process are currently unknown. ATGL phosphorylation leading to activation is 
thought to occur at residues Ser404 and Ser428 (Bartz et al., 2007a). Maximal activation of 
ATGL requires the interaction of comparative gene identification 58 (CGI-58) (Lass et al., 
2006), increasing its activity up to 20 fold in a cultured kidney cell line. However it is 
currently not known if, and under which conditions, it activates ATGL in human skeletal 
muscle.  
 
Rates of lipolysis are also mediated by the PAT proteins (Perilipin, ADRP and TIP-47) which 
regulate the access of the lipolytic enzymes ATGL and HSL to the TAG in the lipid core. 
Under basal conditions it is thought that CGI-58 is colocalised with the PAT protein perilipin 
on the surface of the lipid droplets. In the basal state, ATGL is proposed to be both found in 
the cytoplasm and bound to lipid droplets in adipose tissue, however upon adrenergic 
stimulation which causes phosphorylation of perilipin, CGI-58 dissociates from the lipid 
droplets into the cytoplasm (Brasaemle et al., 2004;Granneman et al., 2007;Yamaguchi et al., 
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2007) to recruit and activate ATGL on the surface of the lipid droplets lacking perilipin 
(Granneman et al., 2007;Yamaguchi et al., 2007). However, this CGI-58 mediated activation 
is unlikely to occur in skeletal muscle as skeletal muscle lacks perilipin (Greenberg et al., 
1993;Londos et al., 1995;Servetnick et al., 1995;Sztalryd et al., 2003). It may be that another 
of the PAT proteins present in skeletal muscle is involved in this process in that case.  
 
1.5.2.2 Hormone Sensitive Lipase 
Human HSL is 775 amino acids in length and is made up of three domains; a catalytic 
domain, a regulatory domain containing phosphorylation sites and an NH2-terminal domain 
involved in protein-protein and protein-lipid interactions (Watt & Spriet, 2010). In adipocytes, 
three phosphorylation sites are involved in PKA dependent increases in HSL activity (Ser563, 
Ser 659 and Ser660) (Anthonsen et al., 1998;Shen et al., 1998). However, the importance of 
Ser563 is unclear (Anthonsen et al., 1998). PKA phosphorylation leads to a 2 - 3 fold increase 
in HSL activity and promotes translocation of HSL to the lipid droplet in adipocytes (Egan et 
al., 1992) in response to β-adrenergic stimulation. ERK also increases HSL activity via 
phosphorylation at Ser660 (Greenberg et al., 2001). Ser565 is a site of negative regulation by 
AMPK in adipocytes (Garton et al., 1989;Daval et al., 2005). HSL activity is also negatively 
regulated by the action of insulin which causes its dephosphorylation in both adipose tissue 
and skeletal muscle (Enoksson et al., 1998;Narkar et al., 2008).  
 
HSL was initially thought to be responsible for the first rate limiting step of lipolysis. 
However since the discovery of ATGL it is known that HSL is primarily responsible for the 
lipolysis of DAG, with its relative hydrolase activity in vitro 11-fold greater against DAG 
than TAG (Fredrikson et al., 1981a). In intact rat adipocytes, phosphorylation of HSL has 
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been shown to take place on two residues ((Ser563 (Garton et al., 1988) and Ser565 (Garton et 
al., 1989)). Catecholamine stimulation of β-adrenergic receptors results in elevation of cAMP 
which activates PKA leading to phosphorylation of HSL (Stralfors et al., 1984). In primary 
adipocytes this activation leads to an ~50 fold increase in lipolysis, however in vitro this 
increase in PKA mediated activation only results in a two-fold increase in HSL activity 
(Fredrikson et al., 1981b). This is likely due to HSL translocation from the cytosol to the lipid 
droplets for lipolysis upon activation.  In vitro studies have revealed the translocation of HSL 
from cytosolic fractions to the fat cake fraction of isolated rat adipocytes (Hirsch & Rosen, 
1984;Egan et al., 1992). This translocation from the cytosol to the lipid droplet surface has 
also been demonstrated in response to adrenergic stimulation in adipocytes (Brasaemle et al., 
2000a) as well as in response to adrenaline incubation and electrical stimulation in single 
fibres of rat skeletal muscle (Prats et al., 2006). The exact mechanisms of the translocation are 
currently unknown however it has been shown that the translocation events do not rely on the 
cytoskeletal compartments; microfilaments or microtubules (Brasaemle et al., 2000a). 
Therefore this spatial redistribution of HSL may be of crucial importance in the regulation of 
lipolysis; however this translocation is yet to be demonstrated in human skeletal muscle. 
 
1.5.3 The Role of SNARE Proteins in IMTG Metabolism 
In obese individuals the increased lipid spillover resulting from the reduced chylomicron-
TAG clearance by adipose tissue as well as the increased VLDL-TAG production by the liver 
seems to lead to an increase in the size of IMTG stores. This may be accompanied by an 
increase in lipid droplet size. In obese and insulin resistant individuals it has been shown that 
there is a distinct increase in IMTG stores (Kelley et al., 2002). Further, the severity of insulin 
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resistance is associated and correlated with the size of IMTG stores in obese individuals; the 
IMTG concentration being inversely related to insulin sensitivity (Pan et al., 1997).  
1.5.3.1 SNAP23 and its Role in Insulin Resistance 
SNAP23 is a SNARE protein which has been identified in non neural tissues and has been 
found to be an analogue of SNAP25 sharing high sequence homology (Ravichandran et al., 
1996). In its role as a SNARE protein SNAP23 binds with VAMP1 and 2 and also Syntaxin1, 
2, 3 and 4 and is the functional equivalent to SNAP25 in non-neural cells playing a role in 
targeted exocytosis. A hypothesis of highjacking of SNAP23 away from the plasma 
membrane to the lipid droplets has been put forward by Sollner (2007). A decreased content 
of SNAP23 at the plasma membrane would lead to a decreased availability of SNAP23 for 
transport, docking and fusion of GLUT4 and therefore could be a factor leading to the 
impairments in insulin mediated GLUT4 translocation seen in obesity and type 2 diabetes 
shown in Figure 1.5. 
 
SNAP23 has also been shown to play a role in lipid droplet fusion in cardiomyocytes as 
knockdown of the genes for SNAP23, syntaxin-5 and VAMP4 or microinjection of mutant α-
SNAP resulted in a decrease in the rate of lipid droplet fusion (Bostrom et al., 2007). 
Furthermore, oleic acid incubation resulted in decreased insulin sensitivity; however this was 
overcome with transfection of SNAP23 to these cells, likely due to replenishment of the 
plasma membrane SNAP23 store. The exact mechanisms regulating the increase in insulin 
sensitivity with greater SNAP23 content had remained unclear until recently. Oleic acid 
incubation results in an increase in the volume of the lipid droplet pool in cardiomyocytes, 
leading to a decreased availability of SNAP23 at the plasma membrane and a concomitant 
decrease in insulin mediated glucose uptake. It is possible that the action of SNAP23 could 
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explain the increased lipid droplet size and the hijacking of SNAP23 by fusing lipid droplets 
could prevent GLUT4 docking with the plasma membrane resulting in decreased glucose 
uptake in response to insulin in obese and type 2 diabetic individuals. 
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Figure 1.5. SNAP23 hijacking hypothesis. In response to insulin, GLUT4 translocates to the plasma membrane, docking with the aid of 
SNAP23 residing at the plasma membrane allowing glucose entry into the cell. However, in a cell with a high lipid droplet (LD) content 
(right panel) SNAP23 is sequestered away from the plasma membrane for lipid droplet fusion, limiting GLUT4 docking at the plasma 
membrane and leading to hyperglycaemia. Image adapted from Sollner (2007). Note that additional SNARE proteins (VAMP2, VAMP4, 
Syntaxin 4 and Syntaxin 5) also play a role n GLUT4 docking but have been excluded from the scheme to highlight the role of SNAP23. 
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1.6 IMTG Metabolism in Humans 
1.6.1 High Fat Diets and IMTG Content 
Many studies have investigated the effects of high fat diets on lipid metabolism and insulin 
resistance. Dietary intervention studies in human volunteers have ranged in time from 24 h to 
7 days and the studies measuring the IMTG content via biochemical extraction methods 
observed a maximal increase by up to 90 % (Starling et al., 1997;Zderic et al., 2004). Other 
studies used 1H-MRS for the determination of IMTG content and showed that consumption of 
a high fat (60 % of energy) diet in as little as 48 h increased resting IMTG levels by 45 % 
(Starling et al., 1997;Johnson et al., 2003;Zderic et al., 2004). Further, in as little as 60 h after 
the start of the consumption of  a high saturated fat diet (45 % energy from fat of which 60 % 
was saturated fat), insulin sensitivity, as measured by hyperinsulinaemic euglycaemic clamp, 
was reduced by 25 % (Stettler et al., 2005). A consistent finding in these dietary intervention 
studies regardless of the length of the diet appears to be the increase in skeletal muscle lipids. 
In longer protocols of high fat feeding, a one week 60 % high fat diet led to a 54 % increase in 
IMTG (Schrauwen-Hinderling et al., 2005) which was comparable to increases seen in the 
shorter term high fat feeding regimes. A 2.3 fold increase in IMTG content was seen after a 5 
week high fat diet (53 % energy from fat) (Vogt et al., 2003) and following 7 weeks of high 
fat feeding (65 % energy from fat) IMTG concentration was significantly elevated by 73 % 
(Helge et al., 2001). Bachmann et al., (2001) found a significant 50 % increase in IMTG in 
soleus muscle but only a 14 % increase in tibialis anterior muscle in response to a 3 day high 
fat diet (55 - 60 % energy from fat). However the soleus muscle is an oxidative muscle and 
relies on fat for energy, whereas the tibialis anterior has a lower initial content of IMTG and a 
much lower reliance on fat oxidation (Schrauwen-Hinderling et al., 2005). It has been 
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reported that type I fibres contain approximately two fold more lipid than type II fibres 
(Malenfant et al., 2001;van Loon et al., 2004). The variation in the IMTG content in these 
studies may also, in part, be explained by the participants’ diet prior to the intervention taking 
place which may have impacted the IMTG concentrations.  
 
1.6.2 Lipid Infusion and Insulin Sensitivity in Humans 
The content of TAG in skeletal muscle has previously been shown to be correlated with 
insulin resistance in obese individuals (Pan et al., 1997). However well trained, insulin 
sensitive athletes also have high levels of TAG in skeletal muscle (van Loon & Goodpaster, 
2006) suggesting that it is not the accumulation of lipid per se which leads to insulin 
resistance. Many studies have mimicked the large lipid flux seen in obesity via lipid-heparin 
infusion in both rodents and lean humans. However when these studies have been undertaken 
in obese or type 2 diabetic individuals, the results differ from those obtained using animal 
models, with increases in different lipid metabolites, discrepancies in the time course of the 
development of insulin resistance and also the specific signalling proteins which appear to be 
involved in the development of insulin resistance.  
 
In male subjects intravenous lipid-heparin infusion (Itani et al., 2002) led to an increase in 
plasma FA, albeit to supraphysiological levels, maximally 1200 µmol/L, which led to a 3 fold 
increase in DAG mass at 6 h. PKC activity has also been shown to be increased both in the 
cytosol and at the plasma membrane (Itani et al., 2002). In similar protocols in which a 5 h 
(Dresner et al., 1999) or 7.5 h (Kruszynska et al., 2002) lipid-heparin infusion was 
administered, glucose oxidation and glycogen synthesis were 50 – 60 % lower, implying 
diminished glucose transport and reduced insulin action as a result of the lipid infusion. More 
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recently it has been shown that increasing FA levels to mimic values closer to physiological 
values (maximal increase to ~ 1 mmol/L) with an intravenous lipid-heparin infusion also led 
to a 30 % reduction in insulin sensitivity index (Schenk & Horowitz, 2007).     
 
1.6.3 Dietary Fatty Acid Composition, IMTG and Insulin Sensitivity 
It also appears that the composition of dietary fats can impact upon insulin sensitivity. 
However to date, the majority of the studies assessing FA composition have been carried out 
in cell culture with few investigating human participants. In C2C12 myotubes incubated for 
18 hours either with or without FA prior to stimulation with insulin, it was found that 
palmitate elevated ceramide concentrations two fold and inhibited insulin stimulated 
phosphorylation of glycogen synthase kinase-3 (GSK-3) and PKB. These effects, however, 
were not seen with unsaturated FA (oleate or linoleate) incubation despite inhibition of PI3K 
activity (Schmitz-Peiffer et al., 1999).  More recently, palmitate incubation of mouse 
myotubes increased DAG content, PKCθ activation and decreased IMTG content due to 
downregulation of DGAT2. Incubation with the monounsaturated FA oleate however did not 
cause these changes (Coll et al., 2008).   
 
These effects have also been investigated in animals. Under conditions of hyperinsulinaemia 
chronic high fat feeding of either high saturated or polyunsaturated fat impaired insulin signal 
transduction at the level of IRS1 Tyr612 and PKB Ser473. The findings of this study suggested 
that the amount of fat is crucial, more so than the type of fat delivered when it comes to 
insulin action (Frangioudakis et al., 2005), although these findings appear to contradict those 
of others who found contrasting effects for saturated and unsaturated fatty acids. Therefore 
this is an area in need of further research. 
40 
 
A large scale study in which 162 human participants followed a diet high in either saturated 
FA or monounsaturated FA found that insulin sensitivity was 12.4 % lower on the diet high in 
saturated FA and 8.8 % higher on the diet high in monounsaturated FA (Vessby et al., 2001). 
Whilst the animal data of Frangioudakis et al., (2005) is of interest, it is the findings in 
humans of Vessby et al., (2001) that are most relevant to this thesis. Thus it would seem that 
high fat diets do not by definition lead to increases in FA metabolites and insulin resistance 
but instead, the composition of FAs (whether saturated or unsaturated) appears to be a major 
factor in determining this effect. It would seem that diets high in saturated fat can impair 
insulin signalling through an increase in FA metabolites and decreased insulin sensitivity.  
 
1.6.4 Calorie Restriction and Insulin Sensitivity 
It is known that fasting for up to 72 hours reduced whole body glucose disposal and leads to 
insulin resistance (Mansell & Macdonald, 1990;Webber et al., 1994). A 67 h starvation 
protocol led to an increase in IMTG when compared to a mixed carbohydrate diet and also 
induced insulin resistance which was measured using an intravenous glucose tolerance test 
(Johnson et al., 2006). The similar IMTG content following short term starvation or short 
term high fat diet could perhaps be explained by the increased plasma FA in both conditions 
(during starvation there is an increase in adipose-derived FA) thereby increasing FA uptake 
into the muscle. Similar increases in IMTG have been found following a 72 h fast in non 
diabetic physically fit men which was again proposed to be due to the increase in plasma FA 
(Stannard et al., 2002). None of these studies measured the LCFACoA, DAG and ceramide 
pool, nor PKC β and θ activities and IRS-1 serine phosphorylation, implying that the medium 
by which acute fasting reduces insulin stimulated glucose uptake in skeletal muscle is not 
currently known. 
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There is however substantial evidence to suggest that alternative weight loss interventions 
involving low or reduced calorie intakes can improve insulin sensitivity and decrease IMTG 
content. It is not clear though if the decrease in IMTG content is related to the improved 
insulin sensitivity or whether reductions in fat mass reduce the lipid spillover and fat 
deposition in non-adipose tissues. Following chronic calorie restriction over 4 months in 
patients with type 2 diabetes it has been reported that a decrease in IMTG occurs (Goodpaster 
et al., 2000). However, in this study, the association between IMTG and insulin sensitivity 
was not evaluated. Bariatric surgery has also proved to be effective at improving insulin 
sensitivity from as little as 6 months follow up (when the first measurement was taken), 
although it is likely that improvements had already occurred much earlier. In a study 
comparing bariatric surgery or a 6 months hypocaloric diet, surgery resulted in significantly 
greater weight loss than calorie restriction alone and calorie restriction alone also only led to 
mild improvements in insulin sensitivity compared to insulin resistance being completely 
reversed 6 months following surgery (Greco et al., 2002). This reversal of insulin resistance 
also coincided with a decrease in the size of the IMTG pool (1.63 ± 1.06 to 0.22 ± 0.44) 
which only occurred in patients who opted for surgery. No data were provided on the 
concentrations of the FA metabolites that lead to insulin resistance (Greco et al., 2002). 
Furthermore there was a trend for GLUT4 expression to be increased following surgery. 
Significant improvements in insulin sensitivity have been seen one year following gastric 
bypass in morbidly obese patients (Houmard et al., 2002;Gray et al., 2003) along with 
decreases in BMI and fasting glucose. Bariatric surgery results in such a dramatic reduction in 
calorie intake that fat mass is reduced massively. The visceral adipose stores are often 
decreased rapidly in weight loss. Visceral fat accumulation may result in an increased flux of 
FA to the liver providing a source of FA for VLDL-TAG production and liver TAG 
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deposition (Hodson et al., 2010). The loss of visceral fat stores reduces lipid spillover and 
therefore ectopic fat accumulation in muscle, liver and the vascular wall. Taken together these 
findings suggest that the weight loss brought about by bariatric surgery results in much 
greater improvements in insulin sensitivity than the more moderate calorie restriction 
achieved without surgery. Whether this is due solely to the extreme energy restriction and 
weight loss needs to be investigated.  
 
Short term interventions involving more moderate calorie restrictions in combination with 
exercise also have been shown to improve glucose tolerance and insulin sensitivity. A two 
week diet and exercise intervention in type 2 diabetics resulted in a 19 % decrease in IMTG 
and a 57 % increase in insulin sensitivity as measured using a hyperinsulinaemic euglycaemic 
clamp (Tamura et al., 2005). Additionally, insulin sensitivity, measured using a 
hyperinsulinaemic euglycaemic clamp, was improved and IMTG content was decreased in 
individuals following 12 weeks aerobic exercise training or a reduced calorie diet (~ 33 % 
calories less than normal) (Solomon et al., 2008). However it was found that IMTG reduction 
did not have an association to insulin sensitivity but was associated with improvements in fat 
oxidation and IMTG utilisation. The increased IMTG oxidation was proposed to be the result 
of higher elevations in AMPK during exercise. AMPK is an enzyme which acts as a 
metabolic ‘fuel-gauge’ responding to changes in cellular energy. AMPK can increase FA 
oxidation in muscle through the inhibition of acetyl coenzyme A carboxylase, relieving the 
inhibition of malonylCoA on carnitine palmitoyl transferase 1, thus allowing FA to be 
shuttled efficiently into the mitochondria to undergo β-oxidation (Hardie et al., 
1998;Ruderman et al., 1999;Winder & Hardie, 1999). Further research has looked more 
specifically at the morphological changes seen in the IMTG pool (He et al., 2004). Four 
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months of weight loss via a combined caloric restriction (decrease by 500 - 1000 kcal/d) and 
exercise intervention resulted in ~ 10 % weight loss and a decrease in lipid droplet size. 
Interestingly, in this study IMTG content did not decrease. This decrease in lipid droplet size 
was correlated with an increase in insulin sensitivity and importantly the amount of physical 
activity (He et al., 2004). Thus it seems that exercise is a key component to changes in IMTG 
metabolism with an impact on glucose tolerance and muscle insulin sensitivity.  
 
A short term very low calorie diet (700 kcal/d for 6 days) in obese individuals with and 
without type 2 diabetes resulted in small but significant decreases in total body fat and BMI as 
well as a pronounced reduction in IMTG (56 % in non diabetics and 40 % in type 2 diabetics). 
Further, glucose disposal rate was increased by 9.3 % under oral glucose tolerance test 
conditions (Lara-Castro et al., 2008) suggesting that a more robust calorie restriction may be 
necessary to initiate significant reductions in IMTG, if it is not combined with exercise. An 
arguably more realistic dietary protocol of 1200 kcal/d until euglycaemia was achieved 
(between 3 - 12 weeks) showed that normal fasting glucose levels can be achieved even with 
a more moderate weight loss protocol (Petersen et al., 2005). Average weight loss was 8 kg 
and whilst fasting plasma glucose was normalised, no changes were seen in insulin stimulated 
peripheral glucose uptake, measured by hyperinsulinaemic euglycaemic clamp or IMTG.  
 
1.6.5 Gender Differences in IMTG Metabolism 
It is known that there are differences in IMTG metabolism between males and females. 
Several studies have reported a higher total IMTG content in females than in males 
(Roepstorff et al., 2002;Steffensen et al., 2002;Roepstorff et al., 2006;Tarnopolsky et al., 
2007). However, the higher IMTG content in females does not appear to impair insulin 
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signalling, in fact, with a 47 % higher IMTG content, women displayed a 22 % higher whole 
body insulin sensitivity during a hyperinsulinaemic euglycaemic clamp and 29 % higher 
insulin stimulated leg glucose uptake (Hoeg et al., 2009). An explanation for this apparently 
paradoxical result has been discussed elsewhere in this introduction (see section 1.3.2). It is 
likely that it is not the IMTG content per se that leads to the insulin resistance. Instead, the 
fractional synthesis rate of IMTG as well as the balance between lipolysis, IMTG synthesis 
and FA oxidation all impact the FA metabolite concentration (Moro et al., 2008). In respect of 
the findings of Hoeg et al., (2009), it therefore seems important that oxidative capacity is 
maintained and it was shown in non obese women that the increased IMTG was accompanied 
by a greater capillary density and a greater proportion of oxidative type I fibres than their 
male counterparts. Further, skeletal muscle HSL protein content is higher in women compared 
with men although HSL activity during 90 minutes of exercise at 60% VO2peak was not 
different (Roepstorff et al., 2006). No information is available today on differences in the 
concentration of LCFACoAs, DAGs and ceramides between the muscles of women and men. 
 
IMTG metabolism does however differ when comparisons are made between lean and obese 
sedentary individuals of the same gender. It was first proposed over 15 years ago that obese 
individuals have a lower rate of  IMTG turnover (Klein et al., 1994). Lean men with impaired 
glucose tolerance recently were shown to have lower IMTG synthesis rates than their 
normally glucose tolerant counterparts however these differences did not exist in a female 
cohort (Perreault et al., 2010). Similar to the relationship that exists in lean individuals, with 
lean women having twice as much IMTG as lean men, it has been shown that obese women 
have twice as much IMTG as obese men when matched for BMI (Haugaard et al., 
2009;Perreault et al., 2010). Further, it has also been suggested that in females obesity is also 
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associated with extramyocellular triglycerides both within and between the muscles (Weis et 
al., 2007). It is proposed that in obesity, a reduced oxidative capacity can lead to the 
accumulation of IMTG, possibly due to the position of the mitochondria in relation to the 
IMTG. In sedentary individuals the mean distance between the mitochondria and IMTG is 
large, leading to a larger diffusion distance which can lead to higher FA metabolite 
concentrations (Tarnopolsky et al., 2007) whereas in trained individuals, the IMTG and 
mitochondria are distributed in close proximity (Tarnopolsky et al., 2007;Shaw et al., 2008).  
 
Controversy exists as to the effects of weight loss on the IMTG pool between genders and 
seems to confirm that women can maintain insulin sensitivity for a higher IMTG set point. 
For example, an 11.5 % rapid (53 days) weight loss in obese women did not change the 
IMTG levels but still led to significant improvements in insulin sensitivity (Rabol et al., 
2009). A slower rate of weight loss in men (112 days vs. 53 days) resulted in a decrease in 
IMTG content and improved insulin sensitivity in a euglycaemic clamp in men (Toledo et al., 
2008). Thus it would seem that the gender differences in IMTG metabolism also exist during 
weight loss regimes. A proper evaluation of gender differences is difficult to make today as 
there is lack of information from properly controlled studies comparing the genders under 
exactly the same baseline conditions and using exactly the same intervention protocols.  
 
1.6.6 The Athletes’ Paradox 
It has been noted that the skeletal muscle of endurance trained individuals contains large 
IMTG stores (Goodpaster et al., 2001;van Loon et al., 2004) comparable with or even higher 
than those observed in obese and type 2 diabetic individuals. In trained individuals, the IMTG 
stores tend to be localised in close proximity to the mitochondria with minimal distances 
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between these organelles (Hoppeler, 1999;Tarnopolsky et al., 2007;Shaw et al., 2008) so that 
they can be readily utilised as a fuel source during exercise. A further important difference 
between the lipid pools in obese sedentary individuals and endurance trained individuals is 
the turnover of the IMTG stores. When endurance athletes are training, their IMTG stores are 
regularly depleted and then replenished in the post exercise period. This allows for a major 
proportion of the meal derived FA to enter the muscle and be channelled into IMTG 
synthesis, thus keeping FA metabolite levels within the muscle low. In obese and type 2 
diabetic individuals, the IMTG stores are not emptied during exercise (van Loon, 2004;van 
Loon et al., 2005) potentially due to the fact that the mean distance between mitochondria and 
lipid droplets is larger (Tarnopolsky et al., 2007). Thus when FA enter the muscle, they 
cannot be channelled to IMTG synthesis as these stores are already at their maximal volume. 
This then leads to increases in the concentration of FA metabolites within the muscle which 
inhibits the insulin signalling cascade (see section 1.3.1).  
 
1.7 The Importance of Immunofluorescence Microscopy as a Research Tool 
The use of different methods to investigate IMTG content and use during exercise have lead 
to equivocal findings. For example, biochemical TAG extraction of human skeletal muscle 
biopsies obtained prior to and following an acute bout of moderate intensity exercise have 
shown contradictory findings between laboratories dependant on the training status or gender 
(Roepstorff et al., 2002;Steffensen et al., 2002) of the individuals for instance. The between 
biopsy coefficient of variation (CV) for this technique is approximately 20 – 26 %, and most 
likely is too large to tease out meaningful data about TAG utilisation between genders, 
training status, exercise and diet interventions. It has been suggested that the cause of the 
large CV is the presence of a variable extra myocellular lipid pool which is part of the total 
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IMTG estimate when analysed via the biochemical TAG extraction method (Guo, 2001). This 
problem can be overcome through the use of 1HMRS. Studies using this technique have 
shown a 20 – 40 % decrease in IMTG following an acute bout of exercise in trained male and 
female participants (Boesch et al., 1997;Boesch et al., 1999;Krssak et al., 2000;Rico-Sanz et 
al., 2000;Brechtel et al., 2001;Decombaz et al., 2001;Larson-Meyer et al., 2002;van Loon et 
al., 2003b).  However, a key limitation to both of these techniques is the lack of information 
on the different fibre types present in skeletal muscle. The different fibre types have different 
metabolic characteristics with potentially a large impact on lipid content, lipid turnover, FA 
oxidative capacity, and IMTG use during exercise.  
 
Stable isotope tracers have also been used to examine IMTG utilisation when used in 
combination with indirect calorimetry. Intravenous infusions of tracer labelled FAs have been 
used to determine the rate of appearance/disappearance and oxidation of plasma FA. This 
method however cannot discriminate between plasma and muscle derived TAG, both of 
which contribute to total fat oxidation (Havel et al., 1967;Oscai et al., 1990;Helge et al., 
2001;van Loon et al., 2001;van Loon et al., 2003a).   
 
Therefore, immunofluorescence microscopy may be proposed as the most powerful analytical 
method to investigate which impairments exist in lipid metabolism of skeletal muscle with a 
potential negative impact on glucose uptake and insulin sensitivity or action. The main 
advantage of immunofluorescence microscopy is that it provides additional information 
regarding fibre type differences in lipid distribution and usage during exercise (van Loon et 
al., 2004;Koopman et al., 2001;Shaw et al., 2008). This is of importance given the differing 
metabolic characteristics that occur in type I and type II fibres for instance in terms of insulin 
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sensitivity with type I fibres being more insulin sensitive than type II fibres. As type I fibres 
utilise IMTG at a much higher rate than type II fibres (van Loon, 2004;Stellingwerff et al., 
2007), differences in fibre type distribution between individuals may also contribute to the 
large CV seen between repeated biopsies, between individuals and between the effects of 
interventions when using, for example, the biochemical extraction method to measure IMTG.  
 
Immunohistochemistry is also an invaluable research tool when investigating the morphology 
of lipid droplets and their spatial distribution, including fibre type differences. Such 
differences cannot be studied with traditional methods applied to whole muscle homogenates 
and extracts such as is the case when using Western Blots, HPLC or Mass Spectrometry. For 
instance, it has been demonstrated using immunofluorescence microscopy that overall lipid 
droplet content did not change in response to weight loss and exercise in previously sedentary 
individuals, but that the individual lipid droplets appeared to be dispersed into a larger 
number of substantially smaller droplets (He et al., 2004). This change in lipid droplet 
morphology could have crucial implications in terms of accessibility for the lipid 
metabolising enzymes and insulin resistance, for instance smaller lipid droplets may have 
greater rates of lipid turnover and, therefore, could be less subject to oxidative damage or 
result in lower levels of FA metabolites.  
 
The protein content of the lipid droplets in skeletal muscle has also been identified with 
immunofluorescence microscopy. Recently, it has been shown that ADRP colocalised with 
~60 % of the lipid droplets (Shaw et al., 2009). The PAT protein TIP47 also colocalises with 
lipid droplets (Prats et al., 2006). Immunofluorescence microscopy has also successfully 
identified that mitochondria and lipid droplets are present in a matrix structure with the lipid 
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droplets in close proximity to the mitochondria but filling only part of the spaces that are 
available between the mitochondria, which fill most of the available spaces on both sides of 
the Z-line in trained individuals (Tarnopolsky et al., 2007;Shaw et al., 2008).  
 
Immunofluorescence microscopy has also been used to demonstrate the specific redistribution 
of proteins in response to stimuli such as the translocation of HSL to the lipid droplets in 
response to adrenaline incubation or contraction (Prats et al., 2006) as well as the 
redistribution of SNAP23 and Munc18 in type 2 diabetic humans (Bostrom et al., 2010). The 
value of immunofluorescence microscopy has also been shown in an elegant series of 
experiments investigating the dynamics of GLUT4 translocation both in basal conditions and 
in response to stimulation by both insulin (Lauritzen et al., 2006;Lauritzen et al., 2008b) and 
contraction (Lauritzen et al., 2010). These studies imaged skeletal muscle from living 
GLUT4-enhanced green fluorescent protein–transfected mice. In these studies the dynamic 
nature of the GLUT4 vesicles can be visualised as well as clearly demonstrating the 
compartmentalised distribution of GLUT4 to the plasma membrane, t-tubules and the 
perinuclear regions. The fact that this technique can be used both for in vitro and in vivo work, 
is obviously of importance in order to investigate the pathogenic mechanisms.  
 
Immunofluorescence microscopy is a valuable and powerful research technique that can 
provide (semi)quantitative data as well as producing informative images showing spatial 
distribution of specific proteins of interest. Therefore, this thesis shows the development of a 
number of new immunohistochemical methods which could be used in the future to address a 
number of research questions and hypotheses that might play a role in understanding the 
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mechanism by which impairment in lipid metabolism in obesity lead to insulin resistance in 
skeletal muscle. 
 
1.8 Scope and Outline of the thesis 
In order to develop therapies that may help to prevent obesity induced insulin resistance and 
the related pathologies, it is important to identify the main mechanisms that lead to impaired 
glucose tolerance in obese individuals. This thesis aims to generate novel methods by which 
obesity induced insulin resistance in skeletal muscle may be investigated in the future. In 
particular, this thesis aims to investigate the distribution of the enzymes that play a role in the 
regulation of lipid turnover (TAG synthesis and lipolysis) in skeletal muscle, that also 
determine the concentration of FA metabolites that previously have been suggested to lead to 
obesity induced insulin resistance (explained in section 1.3.1). In the final two chapters the 
role of a protein (SNAP23) with a potentially parallel function in glucose uptake (GLUT4 
docking) and fusion of lipid droplets in skeletal muscle as a limitation in glucose uptake in 
obesity and type 2 diabetes is explored. It is of key importance to know the subcellular 
localisation of these enzymes including colocalisation with organelles and membrane 
structures as this could provide crucial information on the regulation of lipid synthesis, 
hydrolysis and oxidation.  
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1.8.1 General Overview 
Chapter 2 details the general methodology common to each of the experimental chapters and 
includes information on sample collection, sample treatment and detailed protocols for 
immunofluorescence microscopy and Western blotting.  
 
The spatial distribution of the enzymes that control IMTG synthesis is investigated in Chapter 
3 and Chapter 4 through immunofluorescence staining of GPAT1, GPAT4 and DGAT1 
respectively in six lean, moderately active men. The difference between fibre types and the 
potential colocalisation of these enzymes with lipid droplets and mitochondria is also 
investigated. Chapter 5 investigates the distribution of both GPAT1 and DGAT1 in skeletal 
muscle obtained from ageing non obese and obese women in an attempt to establish whether 
there is a change in the localisation of these enzymes in response to obesity. Regulation of 
lipid turnover is also influenced by IMTG hydrolysis, thus in Chapter 6, the specific 
distribution of ATGL and CGI-58 (an activator of ATGL) are investigated together for the 
first time in human skeletal muscle of lean, moderately active males.  
 
Chapter 7 investigates the distribution of SNAP23 in six healthy, moderately active males. 
The colocalisation of SNAP23 with mitochondria, lipid droplets and the plasma membrane is 
also investigated. Chapter 8 investigates whether there are differences in the distribution of 
SNAP23 between six non obese and six obese ageing women in skeletal muscle samples 
obtained during elective orthopaedic surgery.   
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In Chapter 9 (General Discussion) the findings of each of the experimental chapters is 
discussed and placed in the context of the general literature and proposals are made for future 
research in light of the findings of the studies within this thesis. Future studies should aim to 
generate further information from lean, obese and obese type 2 diabetic individuals using 
immunofluorescence microscopy and complementary techniques with a higher spatial 
resolution in order to identify differences in distribution and colocalisation and impairments 
in translocation/fusion in response to physiological stimuli (insulin, meal, exercise, 
adrenaline) that result from these conditions to deepen our current insight into the 
mechanisms that lead to glucose intolerance, insulin resistance, metabolic syndrome and type 
2 diabetes and identify target enzymes or translocation/fusion processes for development of 
new drugs.  
1.8.2 Aims of the Experimental Chapters 
In section 1.5.1.1 and 1.5.1.2 the recently published evidence is presented that a high content 
or activity of the lipid synthetic enzymes GPAT1 and DGAT1, which determine the major 
rate controlling steps of IMTG synthesis, can offer protection against lipid induced insulin 
resistance. The distribution of GPAT1 and DGAT1 has not been investigated in human 
skeletal muscle to date and so the aims of Chapters 3 and 4 are to establish a protocol to be 
used for immunofluorescence staining of the most important isoforms of these enzymes and 
also to investigate their fibre type and subcellular distribution to include potential 
colocalisation with lipid droplets and mitochondria. Chapter 5 aims to investigate whether 
there are differences in the distribution of these enzymes between non obese and obese 
women. 
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In section 1.5 the arguments and rationale are given to underpin the view that a detailed 
understanding of the mechanisms that control lipid turnover (TAG synthesis, lipolysis and FA 
oxidation) is required to understand mechanisms responsible for insulin resistance in skeletal 
muscle. An imbalance between the components of lipid turnover could lead to an 
accumulation of FA metabolites which have been proposed to lead to insulin resistance 
through the activation of PKC (LCFACoA and DAG) and inactivation of Akt (ceramides). 
Chapter 6 aims to investigate the hydrolytic part of the lipid turnover pathway through the 
investigation of novel aspects of the distribution of ATGL and CGI-58 in human skeletal 
muscle.  
 
The aim of Chapter 7 is to validate an antibody for immunohistochemical studies of sections 
of human skeletal muscle obtained from lean, active males in order to investigate the 
subcellular and fibre type specific distribution of SNAP23 and its potential colocalisation with 
the plasma membrane, lipid droplets and mitochondria. In section 1.5.3.1 it was reported that 
lipid droplets in obese individuals and type 2 diabetes patients have been proposed to hijack 
part of the limited SNAP23 stores from the plasma membrane to lipid droplets where they 
might be required for lipid droplet fusion. Chapter 8 aims to investigate the distribution of 
SNAP23 in six non obese and six obese women in order to investigate if SNAP23 hijacking 
occurs in the obese women. 
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CHAPTER 2 
 
 
 
 
 
 
 
 
 
 
GENERAL METHODS 
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2.1 Ethical Approval 
Written informed consent was obtained from all participants. Approval for execution of the 
studies was obtained from NHS Research Ethics Committees in the Birmingham and 
Warwick region. 
 
2.2 Muscle Samples 
Percutaneous muscle biopsies were obtained from the m. vastus lateralis under local 
anaesthesia (~ 5 ml 1 % lidocaine) using the needle biopsy technique (Bergstrom, 1975). 
Following local anaesthesia, a small (~ 1 cm) incision was made in the skin and the fascia 
covering the central portion of the m. vastus lateralis. The biopsy needle was then inserted 
and sequential cuts were made with the application of suction (~ 100 mg). In addition, 
samples were obtained during elective orthopaedic surgery (Chapters 5 and 8 only) under 
general anaesthesia at Russells Hall Hospital, Dudley Group of Hospitals NHS Trust by Mr 
Edward Davis, Consultant Orthopaedic Surgeon. Following the initial incisions for the total 
hip arthroplasty surgery, a muscle biopsy (~ 200 mg) was obtained from the m. gluteus 
maximus. Following removal, samples were blotted of excess blood and any visible fat and 
collagen was separated from the sample and discarded. Part of the biopsy sample (~ 30 mg) 
was embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe, Zoeterwoude, The 
Netherlands) on a cork board which was immediately frozen in liquid nitrogen-cooled 
isopentane (Sigma-Aldrich, Dorset, UK) and stored in pre-cooled cryotubes at - 80 ºC for 
histological analyses. The rest of the biopsy samples were snap frozen in liquid nitrogen and 
stored at – 80 ºC for subsequent Western blotting analyses. 
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2.2.1 Sample Preparation for Histology 
Cryosections (5 µm) were cut using a microtome (Bright Instrument Company Limited, 
Huntingdon, England) housed within a cryostat at – 25 ºC. The sections were collected onto 
uncoated, pre-cleaned glass slides (VWR International Ltd, Leicestershire, UK), stored at 
room temperature and left to air dry for a maximum of one hour before treatment.  
 
2.3 Immunofluorescence Method Development 
2.3.1 Antibodies 
2.3.1.1 Antibody Validation 
The success of immunofluorescence staining techniques is critically reliant on the selection of 
an appropriate primary antibody which solely detects the target protein. Failure to critically 
analyse the specificity of the selected antibodies using a variety of techniques can lead to the 
generation of incorrect data and therefore pollution of the literature with artefacts. 
Fundamentally, all antibodies used in any antibody technology application must be specific to 
the protein of interest.  
 
All of the antibodies targeting the key proteins of interest in this thesis were validated for use 
in immunofluorescence staining. This was primarily completed with the Basic Local 
Alignment Search Tool (BLAST), immunofluorescence staining and Western blotting. The 
BLAST was used in order to determine that the sequence against which the antibody was 
raised exists within the protein of interest only. The BLAST was completed using the online 
resource www.uniprot.org. The immunofluorescence staining was used in order to determine 
whether the images obtained were in line with the expected distribution as purported in the 
literature or the function of enzymes. Western blotting was used to check that a single band 
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was revealed at the correct molecular weight. Specific details of the Western blotting 
procedures can be found later in this chapter in section 2.6.   
 
2.3.1.2 Primary Antibodies 
Primary antibodies were obtained from a variety of sources, both commercial as well as kind 
donations from Astra Zeneca R&D. All antibodies were diluted to their predetermined 
optimal working concentration in phosphate buffered saline (PBS) (PBS, 137 mM sodium 
chloride, 3 mM potassium chloride, 8 mM disodium hydrogen phosphate and 3 mM 
potassium dihydrogen phosphate, pH 7.4) with the addition of 5 % normal goat serum (NGS) 
or normal donkey serum (NDS) as a blocking agent depending on the primary antibody. Cell 
borders were marked using wheat germ agglutinin (WGA) (Invitrogen, Paisley, UK) which 
binds to sialic acid and N-acetylglucosaminyl sugar residues which are located predominantly 
at the plasma membrane. 
 
2.3.1.3 Secondary Antibodies 
Appropriately targeted secondary antibodies were also obtained from a variety of sources 
(Invitrogen, Paisley, UK; Stratech Scientific, Suffolk, UK). All secondary antibodies were 
Alexa Fluor conjugated or DyLight conjugated and were selected to fluoresce either red 
(568/594 nm), green (488 nm) or blue (350 nm). All secondary antibodies were diluted (1:200 
unless otherwise stated) in PBS as described above. 
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2.3.1.4 Oil Red O 
Intramuscular triglycerides (IMTG) were stained using the neutral lipid dye oil red O in 
combination with immunofluorescence as developed by Koopman et al., (2001). Oil red O 
stock solution was made up of 100 mg oil red O in 20 ml of 60 % triethylphosphate. A 60 % 
stock solution (in dd H2O) was then filtered twice through 150 mm Whatman filter paper 
(VWR, Leicestershire, UK) to remove any residual oil red O crystals. Cryosections were 
incubated with oil red O working solution at room temperature for 30 minutes followed by 3, 
30 second rinses in dd H2O and a 10 minute rinse under slow running cold tap water. 
 
2.3.2 Immunofluorescence Methods 
For each of the antibodies used within this thesis, a series of method development steps were 
taken in order to ensure that the images obtained were of the best possible quality and clarity.  
 
2.3.2.1 Sample Fixation 
Cryosections (5 µm) were imaged both after 3.7 % formaldehyde fixation as well as after 
acetone : ethanol (3:1) fixation in order to determine the fixative that provided the highest 
quality images. Formaldehyde fixation was used in order to maintain the structural integrity 
and antigenicity of the tissue. In a diluted aqueous solution of formaldehyde such as that used 
in this protocol, the majority of the formaldehyde is present as methylene-glycol which is 
formed when a molecule of water is combined with a molecule of formaldehyde. This 
reaction is reversible but has a heavy bias to the right hence the large reservoir of methylene-
glycol which is required to form the methylene (-CH2-) bridges which form between the 
proteins of the tissue providing the additional structural integrity (Fox et al., 1985). Alcohol 
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fixatives, such as the acetone : ethanol used, coagulate proteins rather than forming bonds, 
changing the shape of the molecules but not their chemical properties.  
 
2.3.2.2 Permeabilisation 
General membrane permeabilisation procedures often help to allow the fluorescent probes to 
reach and reveal epitopes hidden in the plasma membrane and the membranes of organelles 
and vesicles. This can be achieved using treatment with detergents such as Triton X-100 
which is commonplace in immunofluorescence staining as it helps to partly solvate the 
cellular membranes without disruption of protein-protein interactions. Previous work from 
this laboratory (Shaw et al., 2008;Shaw et al., 2009) has used 0.5 % Triton-X as a means of 
permeabilisation and so, during method development, staining was attempted both with and 
without permeabilisation, as this process can affect the epitopes that are revealed for antibody 
binding. This could therefore influence the image obtained in immunofluorescence quite 
dramatically. 
 
2.3.2.3 Antibody Dilution 
The appropriate primary antibody dilution and incubation time and temperature were also 
determined. Antibodies were each tested at dilutions of 1:25, 1:50 and 1:100 with incubations 
both for 1 hour at room temperature as well as overnight at 4 °C.  
 
2.3.2.4 Immunofluorescence Controls 
For each antibody, negative control samples were run in which the immunofluorescence 
microscopy procedure was completed, however the primary antibody was omitted and PBS 
was applied in its place. This allowed for testing for any non specific staining that may occur. 
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Controls were also carried out to prevent the chance of data being confounded by 
bleedthrough of signal into different channels. For instance when using the DAPI filter 
following the application of Alexa Fluor 350 (as well as the full immunofluorescence staining 
procedure), these images were also acquired with the FITC and Texas red filters to ensure that 
no signal was detected in the other channels used to visualise other proteins. This procedure 
was also carried out for the other secondary antibodies used (Alexa Fluor 488 and 594) as 
well as for oil red O. Cryosections were tested for autofluorescence in the absence of any 
antibodies, simply applying PBS to the section following the fixing and permeabilisation 
steps required.  
 
2.4 General Immunofluorescence Staining Method 
Samples were fixed for either 1 hour in 3.7 % formaldehyde or for 5 minutes in acetone : 
ethanol (3:1). Following fixation (formaldehyde only), samples were either washed 3 times 
for 5 minutes in PBS (if no permeabilisation was required) or 3 times for 30 seconds in 
doubly distilled water (if permeabilisation was deemed necessary). In the studies in this 
thesis, samples that were incubated in 0.5 % Triton X-100 for 5 minutes were then washed 
three times, for 5 minutes each, in PBS. Following these initial preparation steps, regardless 
of the fixation method, appropriately targeted primary antibodies were then applied. The 
duration of this incubation depended on the optimal conditions determined for each individual 
antibody. Following three 5 minute washes in PBS, secondary antibodies appropriately 
targeted to the primary antibodies were then applied for 30 minutes. Samples were then 
washed again 3 times for 5 minutes in PBS before the coverslips were mounted onto the 
slides. The mounting medium was made from 6 g glycerol and 2.4 g mowiol 4-88 dissolved in 
18 ml 0.2 M Tris-buffer (pH 8.5) with the addition of 0.1 % (0.026 g) 1,4-diazobicyclo-
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[2,2,2]-octane (DABCO) antifade medium. The slides were then left to dry overnight in the 
dark room.  
 
2.5 Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA). In order to visualise the Alexa 
Fluor 350 fluorophores, the DAPI (387/11) excitation filter was used. To visualize the Alexa 
Fluor 488 fluorophores the FITC (494/20) excitation filter was used. Alexa Fluor 568/594 as 
well as IMTG stained using oil red O were observed using the Texas Red filter. Digital 
images showing cross sections and longitudinal sections of skeletal muscle fibres were 
obtained using the 40 x (0.75 NA) objective. The filters used in this microscope system were 
3 excitation filters and 1 dichroic and 1 emission filter (“Pinkel” Triple Set, Semrock, 
Kettering, UK) which allow for crude measures of colocalisation due to zero pixel shift. The 
slides were illuminated with a 170 W Xenon Light Source and the filters were controlled 
using a semi-automated filterwheel (10B 10 Position Filterwheel, Sutter, USA). Detailed 
digital images demonstrating the cellular distribution of target proteins were obtained using an 
inverted confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63 x (1.4 NA) oil 
immersion objective which allows for a greater amount of clarity to be viewed in the images. 
The confocal microscope also allows the investigation of colocalisation at a greater resolution. 
Alexa fluor 488 fluorophores were excited with a 488 nm line of the argon laser for excitation 
and 510 - 555 nm for emission. Alexa fluor 594 fluorophores were excited with 594 nm line 
of the helium-neon laser for excitation and 617 nm for emission. 
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2.5.1 Image Analysis 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). 
For the analysis of IMTGs, intensity thresholds were selected to represent minimum values 
for lipid droplets. These were kept consistent throughout all image analysis. For each image, 
the muscle fibre area and the area occupied by lipid droplets were measured and any 
comparisons were made with sections on the same slide. Lipid content was expressed as the 
area fraction by dividing the stained area in the fibre by the total area of that fibre. The 
fluorescence intensity of some stains was measured by selecting the whole of the fibre area of 
interest and using measures of optical density. Using this method in combination with a fibre 
type stain, it was possible to determine the fibre type differences of the proteins of interest. 
All images used for these analyses were oriented as cross-sections. Colocalisation analysis of 
confocal microscopy images was conducted in Image Pro Plus 5.1 using Pearson’s 
correlation. The significance of the colocalisation was determined by overlaying non matched 
images and running the same Pearson’s correlation analysis, a method proposed by 
Lachmanovich et al., (2003). If these non matched images showed significantly less 
colocalisation (using a paired samples t-test) than the matched image pairs, the colocalisation 
was deemed significant.  
 
2.5.2 Automated Image Capture and Analysis 
The routine analysis of IMTG and mitochondria in Chapters 4, 5, 7 and 8 was completed 
using automated image analysis. Measures of fibre type specific fluorescence intensity were 
also completed using this automated system in Chapters 5 and 7. Images were captured using 
a Metafer Slide Scanning platform (MetaSystems, Bicester, UK) which is based on a Zeiss 
Imager Z2 microscope with an automated slide feeder and slide stage. Image acquisition was 
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controlled via Metafer 4 software. The process of image capture was completed through the 
pre-scanning of each slide at 5 x objective (Zeiss plan neofluar 5x) and automated analysis 
completed to determine which regions of the cell contain tissue. Subsequently the tissue 
containing regions were then captured using a 40 x oil objective (Zeiss plan-neofluar 40 x oil 
1.3 NA). 
 
2.5.3 Automated Image Processing 
Images were then analysed in detail using Definiens Cellenger software (Munich, Germany). 
User defined thresholds were determined for the intensity and contrast of either mitochondria 
or lipid stained objects where contrast refers to the contrast between the object pixel 
intensities and the background pixel intensities in a greyscale image. The user value was 
determined on a scale from -10 – 0 and defined the minimum contrast between an object and 
its surroundings, where 0 means little or no contrast.  The contrast value was then used later 
in the analysis in the ruleset in conjunction with other parameters to define the object 
detection. 
 
If investigating fluorescence intensity, further thresholds were also determined for the 
intensity of myosin heavy chain type I staining to identify muscle fibre type and also a value 
for “muscle cell growth” which was required to adjust for the width of the WGA staining that 
can encroach into the cell area. In the rulesets, a number for muscle cell growth was 
determined. This value was always set to ‘5’ which refers to the number of pixels to dilate the 
muscle fibre once it has been identified from the WGA stain. This was required because the 
WGA stain did not form a narrow, well defined border around the fibre and in some fibres the 
fibre specific staining occurred overlapping or outside of the WGA stain. Therefore the 
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“muscle cell growth” parameter was required to increase the muscle cell size in order to 
correct for this.  
 
Once these settings were established, firstly, muscle cells were detected using a non-user 
defined threshold on the WGA staining. Subsequently, images were ‘quality controlled’ 
manually to ensure they only contained cells identified as muscle cells. The algorithm then 
assigned whether the cell was fast or slow type, then (depending on whether lipid or 
mitochondria analysis was required) the algorithm defined the fine detail objects using a 
watershed algorithm. This allowed the channel in which the objects of interest were identified 
to be considered a topographic surface, with gradients from the highest pixel intensities to the 
lowest intensities or local minima (background within a fibre). In the muscle, criteria were set 
that classified objects that were identified as the threshold decreased and emerging pixels that 
have common criteria and could be segmented. Therefore, as the threshold was decreased, 
each emerging object was analysed and its shape, relation to neighbouring pixels, intensity 
and contrast to neighbouring pixels was evaluated. 
 
2.6 Western Blotting 
Western blotting was used as a method to show specificity of the selected primary antibodies. 
 
2.6.1 Muscle Extraction Protocol 
Homogenisation buffer (50 mM Tris - HCl, 1 mM EDTA, 1 mM EGTA and 1 % Triton X-
100 in dd H2O) was used for dilution of lysis buffer (protease inhibitor cocktail, 10 mM β-
glycerophosphate, 50 mM sodium fluoride and 0.5 mM sodium orthovanadate) in which the 
total protein fraction was isolated. A bicinchoninic acid (BCA) assay was then used to 
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determine the protein concentration of the homogenate in order that samples could then be 
normalised to all contain 2 µg of protein/µl.   
 
2.6.2 Sample Preparation 
Samples were made up from protein, homogenising buffer and Laemmli SDS Buffer (3.78 g 
(30%) glycerol, 2.6 mL 0.625 M Tris buffer, 3 mL 20 % sodium dodecyl sulphate, 0.5 mL 0.5 
% bromophenol blue, 0.12 ml deionised water, 100 µl of β-mercaptoethanol per 900 µl of 
sample buffer). Finally samples were heated to 95 ºC for 4 minutes. 
 
2.6.3 Western Blotting 
Proteins were then loaded (35 µl) and separated in a Tris-HCl Polyacrylamide Gel (Biorad, 
Hertfordshire, UK) applying a 40 mA current for approximately 90 minutes. Proteins were 
then transferred for approximately 2 hours at a 350 mA current to a polyvinylidene fluoride 
(PVDF) membrane. The membrane was blocked in 5 % skimmed milk powder (Cell 
Signalling, New England Biolabs, Hertfordshire, UK) for 1 hour at room temperature and 
following three 10 minute washes in TBST (TBS in 1 % tween) the membrane was then 
incubated overnight at 4 °C in appropriately targeted primary antibodies at a dilution of 
1:1000 . Following three 10 minute washes in TBST, membranes were then incubated for 1 
hour with an appropriately targeted horseradish peroxidase linked secondary antibody. The 
membrane was then washed twice in TBST (each for 10 minutes) followed by one 10 minute 
wash in TBS. The signal was developed using Super signal West Dura chemiluminescent 
substrate (Pierce Scientific, Northumberland, UK) which was applied for 5 minutes. The 
membrane was dried and wrapped in cling film and then encased inside a developer with blue 
X-ray film and exposed for as long as necessary (usually 2 - 5 minutes). The X-ray film was 
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then developed in photographic developer (1:25), rinsed in water and then fixed (photographic 
fixer, 1:25) (Jessops, UK).     
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CHAPTER 3 
 
 
 
 
 
 
 
 
 
 
GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE EXHIBITS FIBRE 
TYPE SPECIFICITY IN HUMAN SKELETAL MUSCLE 
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3.1 Abstract 
Intramuscular triglycerides (IMTG) accumulate in skeletal muscle as discrete lipid droplets 
that are in close proximity to the mitochondria. The key enzymes in IMTG synthesis are 
glycerol-3-phosphate acyltransferase (GPAT) (which exists in a mitochondrial (GPAT1) and 
a microsomal (GPAT4) isoform) and diacylglycerol acyltransferase 1. These enzymes 
catalyse acylations that consume the fatty acid (FA) metabolites that may lead to insulin 
resistance. The aim of the present study was to develop methods that allow the investigation 
of the spatial and fibre type distribution of the enzymes involved in the first catalytic stage of 
IMTG synthesis, GPAT1 and GPAT4, in human skeletal muscle. Percutaneous biopsies were 
obtained from the m. vastus lateralis of six lean, healthy males. Cryosections (5 µm) were 
stained using either rabbit anti-GPAT1 or rabbit anti-GPAT4 antibodies, each in combination 
with mouse anti-myosin heavy chain type I. IMTG were stained using the neutral lipid dye oil 
red O and images were viewed using widefield and confocal fluorescence microscopy. A 
strong GPAT1 signal was present in type I fibres, while GPAT1 staining was almost absent in 
type II fibres (P < 0.001).  GPAT4 staining showed a diffuse signal throughout all fibres, 
however still with a stronger signal in type I compared to type II fibres (P < 0.002). These 
results demonstrate that type I fibres have a higher content of the enzymes involved in the 
first step of IMTG synthesis than type II fibres, which is in line with the observation that type 
I fibres contain more IMTG whilst being more insulin sensitive. The low content of GPAT1 
in type II fibres despite the presence of IMTG suggests that GPAT4 may be responsible for 
the first step of IMTG synthesis in type II fibres.  
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3.2 Introduction 
Lipid droplets are made up of a central core of neutral lipids (mainly triacylglycerols or 
cholesteryl esters) surrounded by a monolayer of phospholipids and associated proteins 
(Martin & Parton, 2006) and are present in numerous cell types. They are involved in many 
cellular processes including energy storage and lipid homeostasis. The accumulation and 
dysfunctional regulation of this lipid store in skeletal muscle is thought to play a role in the 
development of metabolic diseases such as type 2 diabetes (He et al., 2001;Taskinen, 2003). It 
has been proposed that the inflexibility of this intramuscular triglyceride (IMTG) pool 
(reduced rates of fatty acid (FA) incorporation into IMTG and reduced FA oxidation) in 
sedentary obese individuals results in the accumulation of FA metabolites such as long chain 
fatty acyl CoA (LCFACoA) (Ellis et al., 2000), diacylglycerol (DAG) and ceramides (Itani et 
al., 2000;Itani et al., 2001;Itani et al., 2002). These FA metabolites appear to induce insulin 
resistance through the activation of  protein kinase C-β and θ and serine phosphorylation of 
insulin receptor substrate-1 which leads to the inhibition of the insulin signalling cascade 
(Itani et al., 2002).  
 
IMTG are synthesised via a series of sequential acylation reactions. The first step of IMTG 
synthesis is the acylation of glycerol-3-phosphate with LCFACoA to form lysophosphatidic 
acid (LPA). This step is catalysed by mitochondrial glycerol-3-phosphate acyltransferase 
(mtGPAT) (Gonzalez-Baro et al., 2007).  To date, two mtGPAT isoforms have been 
identified, GPAT1 and GPAT2 (Lewin et al., 2004;Shin et al., 1991). There are also two 
microsomal isoforms of GPAT (micGPAT), GPAT3 and GPAT4 (Cao et al., 2006;Chen et 
al., 2008). In the majority of body tissues studied in animals, mtGPAT makes up less than 
10% of total GPAT activity and shows a preference for saturated acyl-CoAs (Coleman & Lee, 
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2004). However in rat skeletal muscle mtGPAT has been demonstrated to be responsible for 
the majority of GPAT activity (Park et al., 2002). The enzymes involved in the latter stages of 
triglyceride synthesis are present at the endoplasmic reticulum (ER) along with micGPAT, 
however it has been suggested, perhaps unexpectedly, that lipid formation is initially 
regulated by the mitochondrial isoform (Hammond et al., 2002;Coleman & Lee, 2004;Igal et 
al., 2001).  
 
There has been little previous research into micGPAT as its isoforms are yet to be identified 
and cloned, however it has been proposed that 6-acylglycerol 3-phosphate acyltransferase 
(AGPAT6) should be re-classified as a micGPAT isoform (GPAT4) as it was found that 
purified AGPAT6 demonstrated GPAT activity but surprisingly no AGPAT activity (Chen et 
al., 2008). It has also been identified that GPAT3 has 80 % gene sequence identity with the 
acyltransferase domain of AGPAT6 (Cao et al., 2006) and also is closely related to GPAT4 
(Gimeno & Cao, 2008). Overexpression of AGPAT6 increased LPA levels in HEK293 cells 
suggesting that AGPAT6 plays a role in the acylation of glycerol-3-phosphate (Chen et al., 
2008). Furthermore, COS-7 cells overexpressing AGPAT6 were found to have increased 
GPAT specific activity in the absence of an increase of AGPAT specific activity (Nagle et al., 
2008). This provides further support that AGPAT6 should be reclassified as an isoform of 
GPAT.  
 
It has recently been reported that an increase in IMTG synthesis resulting from an increased 
content of GPAT1 (and another IMTG synthetic enzyme, diacylglycerol acyltransferase) 
occurs one day following a single bout of endurance exercise in untrained women and 
prevents insulin resistance induced by a lipid and heparin infusion by reducing the content of 
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the FA metabolites which lead to insulin resistance (Schenk et al., 2005;Schenk & Horowitz, 
2007;Newsom et al., 2010). Thus it is possible that a high protein expression of GPAT1 and 
possibly GPAT4 plays a protective role in the development of insulin resistance. As there is 
currently little research (Schenk & Horowitz, 2007;Newsom et al., 2010) into these enzymes 
in human skeletal muscle, the aim of the present study was to investigate the subcellular and 
fibre type distribution of GPAT1 and GPAT4 in skeletal muscle of healthy, male individuals.  
72 
 
3.3 Methods 
Muscle Samples 
Percutaneous muscle biopsies were obtained from the m. vastus lateralis of six lean, healthy 
male subjects using the needle biopsy technique (Bergstrom, 1975) in the overnight fasted 
state. Subject characteristics can be seen in Table 3.1. Samples were prepared and stored as 
described previously in Chapter 2.2.  
 
Table 3.1 Subject Characteristics 
 Male Participants 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
6 
31 ± 2 
1.78 ± 0.03 
74.3 ± 2.9 
23.4 ± 0.4 
Data are presented as means ± SEM.  
 
Antibodies 
Fibre type was determined by incubating sections in mouse anti-myosin heavy chain type I 
(MHCI) (A4.840 DSHB, developed by Dr. Blau). This antibody was added in combination 
with rabbit anti-GPAT1 (kind donation of Professor Jan Oscarsson, Astra Zeneca, Mölndal, 
Sweden) or rabbit anti-AGPAT6 (GPAT4) (Atlas Antibodies, Stockholm, Sweden) which was 
used to identify micGPAT, as AGPAT6 has previously been shown to have GPAT activity 
(Nagle et al., 2008;Chen et al., 2008). Mitochondria were also visualised using mouse anti-
cytochrome c oxidase (COX) (Invitrogen, Paisley, UK). Subsequently, samples were 
incubated with appropriately targeted secondary Alexa Fluor conjugated antibodies for 30 
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minutes (goat anti-mouse IgM 350 and goat anti rabbit IgG 488, Invitrogen, UK). IMTGs 
were stained using the neutral lipid dye oil red O in combination with immunofluorescence 
originally developed by Koopman et al., (2001), as described previously in Chapter 2.3.1.4. 
 
Immunofluorescence Staining 
Cryosections were treated using fixation, permeabilisation and antibody application methods 
described in Chapter 2.4. For both GPAT1 and GPAT4, primary antibodies were used at a 
1:50 dilution and incubation time was 1 hour at room temperature and secondary antibody 
incubation time was 30 minutes at room temperature.  
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters described 
in Chapter 2.5 to visualise Alexa Fluor 350, 488 as well as oil red O. Digital images showing 
the distribution of GPAT1, GPAT4, and IMTG in longitudinally oriented and cross sections 
of muscle fibres were obtained. Detailed digital images demonstrating the subcellular 
distribution of GPAT1 were obtained using an inverted confocal microscope (Leica DMIRE2, 
Leica Microsystems) with a 63 x oil immersion objective. Alexa Fluor 488 fluorophore was 
excited with a 488 nm line of the argon laser for excitation and emits at 510-555 nm. Alexa 
Fluor 594 and oil red O was excited with the 594 nm line of the Helium–Neon laser for 
excitation. 
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Image Processing 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA) 
and intensity thresholds were selected to represent minimum values for lipid droplets. These 
were kept consistent throughout all image analysis. For each image, the muscle fibre area and 
the area occupied by lipid droplets was measured. Lipid content was expressed as the area 
fraction by dividing the stained area in the fibre by the total area of that fibre. Fibre type 
differences in GPAT1 and GPAT4 fluorescence intensity were quantified using measures of 
optical density.  
 
Antibody Validation 
Antibodies were validated using Western Blotting in order to check the molecular weight of 
the bands stained by the antibody against GPAT1. Proteins were extracted from the skeletal 
muscle sample as described in Chapter 2.6.1. Proteins were then loaded (70 µg) and separated 
in 10 % Tris - HCl Polyacrylamide Gel (Biorad, Hertfordshire, UK) and transferred to a 
PVDF membrane which was then blocked in 5 % milk powder (Cell Signaling, New England 
Biolabs, Hertfordshire, UK) for 1 hour at room temperature. Membranes were then incubated 
overnight at 4 °C in polyclonal rabbit anti-GPAT1 (Prof. Jan Oscarsson, Astra Zeneca R&D, 
Mölndal, Sweden) which was specifically targeted against the murine amino acid sequence 
312-326 (IFLEGTRSRSGKTSC). Following washing, membranes were then incubated for 1 
hour at room temperature with horseradish peroxidase linked goat anti-rabbit IgG and 
developed using Super signal West Dura chemiluminescent substrate (Pierce Scientific, 
Northumberland, UK).  
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The reported molecular weight of GPAT1 is 90 kDa (Shin et al., 1991), but initial analysis of 
GPAT1 extracted from human muscle homogenate and subjected to Western blot analysis 
revealed a band just below 50 kDa (Figure 3.1A). The basic local alignment search tool 
(BLAST) was used to analyse the amino acid sequence against which the GPAT1 antibody 
was raised. The result showed that no other human protein contained the sequence against 
which the antibody was raised suggesting that GPAT1 in the muscle homogenate had been 
broken down by proteolysis. Western blot analysis of a rat liver homogenate showed a band at 
the expected molecular weight for GPAT1 (Figure 3.1B). Therefore, a sample of rat liver 
homogenate was mixed with human muscle homogenate and incubated overnight at 4 °C 
before the protein extraction and Western blot analysis. On the resultant Western blot the 
band at 90 kDa had disappeared, again leaving only the band at ~50 kDa (Figure 3.1C). This 
experiment provided convincing evidence that GPAT1 was broken down by remaining 
proteolytic activity in the muscle homogenate from the intact 90 kDa protein to a 50 kDa 
fragment despite the presence of a protease inhibitor cocktail in the extraction buffer.  
 
In addition to the Western Blotting, a protein competition assay was also used to test the 
specificity of anti-GPAT1. Human GPAT1 protein was kindly donated by AstraZeneca R&D 
(Alderley Park, Macclesfield, UK) and following 5 minutes of boiling at 95 °C, was added in 
excess to the anti-GPAT1 and incubated together at 4 °C for 24 hours prior to 
experimentation. The mixed GPAT1-antibody solution was then added in place of the primary 
antibody during the immunohistochemical staining procedures and this resulted in total 
elimination of the staining (Figure 3.2) adding further evidence of the specificity of the 
GPAT1 antibody.  
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Anti-GPAT4 which targets a specific amino acid sequence of human AGPAT6 
(FAWATLRMERGAKEKNHQLYKPYTNGIIAKDPTSLEEEIKEIRRSGSSKALDNTPEFE
LSDIFYFCRKGMETIMDDEVTKRFSAEELESW) has previously been validated for 
immunohistochemistry in human skeletal muscle in the human protein atlas (HPA) (see 
Ponten et al., (2008) for more details of the HPA).  BLAST analysis showed that this 
sequence is present in GPAT4 and that GPAT4 is the only human skeletal muscle protein that 
contains this sequence. 
 
 
  
  
 
         
 
Figure 3.1. Western immunoblots demonstrating specificity
Results generated using samples of human skeletal muscle homogenate. B: Results 
generated using rat liver homogenates. C: Results generated using 
skeletal muscle and rat liver homogenate.
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Figure 3.2. Immunofluorescence competition assay using human GPAT1 protein. Representative staining of GPAT1 in human skeletal 
muscle (A). Competition assay following overnight incubation of anti
the competition assay suggesting specificity of anti
-GPAT1 with hGPAT1 protein (B). Note the reduction of signal in 
-GPAT1 to human GPAT1. Bar is 50 µm.  
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Statistical analyses 
A Student's paired samples t-test was used to investigate whether statistically significant 
differences existed between type I and type II fibres for the staining intensity of GPAT1 and 
GPAT4 and for the lipid droplet area fraction. Statistical significance was set at P < 0.05. All 
data are expressed as mean ± SEM unless otherwise stated. 
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3.4 Results 
Representative images of human skeletal muscle using widefield immunofluorescence 
microscopy following incubation with rabbit anti-GPAT1, mouse anti-MHCI and oil red O 
staining of IMTG can be seen in Figure 3.3A. The GPAT1 staining showed a strong positive 
signal in type I muscle fibres and very little staining in type II fibres. The type I muscle fibres 
also had a stronger oil red O signal (Figure 3.3). Longitudinally oriented cryosections viewed 
with confocal microscopy also showed a distinct fibre type specific distribution of GPAT1 
with a striated distribution pattern of GPAT1 running across the length of the muscle fibre 
(Figure 3.4).  
 
Figure 3.3B shows representative images of human skeletal muscle viewed using a widefield 
immunofluorescence microscope following incubation with anti-GPAT4 in combination with 
mouse anti-MHCI and oil red O staining of IMTG. The GPAT4 staining showed a diffuse but 
weak signal distributed throughout all muscle fibres with no obvious fibre type difference.  
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Figure 3.3. Widefield immunofluorescence microscopy 
Visualisation of GPAT4, MHCI and IMTG
GPAT1 and does not show an obvious fibre type difference. 
 
images to show visualisation of GPAT1, MHCI and IMTG
 is shown in section B.  The diffuse stain of GPAT4 gives a 
 Bar represents 50µm.  
 
 staining (section A). 
weaker signal than that of 
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Figure 3.4. Confocal immunofluorescence microscopy to show visualisation of GPAT1 distribution in human skeletal muscle fibres. 
Bar represents 20µm. Note the striated spatial distribution of the stain.  
GPAT1 
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Figure 3.5. Mean lipid droplet area fraction in human skeletal muscle. Values are mean ± 
SEM. * Denotes significant difference between fibre type (P < 0.05). 
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In Figures 3.5 and 3.6 mean values of staining intensities for six subjects are presented. An 
~two-fold greater IMTG content was seen in type I muscle fibres compared to type II muscle 
fibres (Figure 3.5) (mean lipid droplet area fraction 0.0365 ± 0.0155 vs. 0.0197 ± 0.0079, P < 
0.020). Figure 3.6A shows a significantly greater GPAT1 staining intensity in type I muscle 
fibres (mean fluorescence intensity 79 ± 10) than in type II muscle fibres (24 ± 5) (P < 0.001) 
which corresponded to the fibres with the greatest lipid content (P < 0.020). Figure 3.6B 
shows that the signal of GPAT4 was significantly more intense in type I muscle fibres than in 
type II muscle fibres (83 ± 7 vs. 74 ± 6) (P < 0.002).   
  
  
Figure 3.6. Mean fluorescence intensity measurements showing fibre type comparisons for 
GPAT1 (A) and GPAT4 (B) in human skeletal muscle fibres. Values are mean ± SEM. * 
Denotes significant difference
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 between fibre type (P< 0.05). 
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Figure 3.7 shows confocal images of the subcellular distribution of GPAT1 and IMTG. It can 
be seen that the IMTG are distributed between the striations of the GPAT1 protein. This 
GPAT1 staining demonstrates the muscle fibre type specific nature of GPAT1 as the type II 
muscle fibre at the top of the image contains IMTG but lacks GPAT1 staining. Figure 3.8 is a 
representative confocal image displaying the subcellular distribution of GPAT1 and the 
mitochondrial network (stained using anti-COX). The image demonstrates that there is little 
colocalisation between GPAT1 and COX. The mitochondrial network seems to fit into the 
space between the striations of GPAT1. 
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Figure 3.7. Confocal microscopy to demonstrate subcellular distribution of GPAT1 and IMTG. Bar represents 10 µm.
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Figure 3.8. Confocal microscopy to demonstrate subcellular distribution of GPAT1 and COX. Bar represents 10 µm. Note the 
positioning of the mitochondria between the striations of 
 
GPAT1.  
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3.5 Discussion 
GPAT isoforms are responsible for the initial committed step in IMTG synthesis; however, 
before completion of this study the subcellular distribution of these enzymes had yet to be 
identified in skeletal muscle. This study, therefore, aimed to visualise the subcellular and fibre 
type distribution of two GPAT isoforms namely GPAT1 and GPAT4. It was shown, using 
widefield immunofluorescence microscopy techniques, that GPAT1 and GPAT4 are each 
present in both type I and type II skeletal muscle fibres (to varying degrees) with both 
enzymes giving a greater signal in type I fibres compared to type II fibres (Figure 3.6). This is 
the first time that the distribution of these enzymes has been described in human skeletal 
muscle.  
 
The finding that GPAT1 is highly expressed in type I muscle fibres is in line with a previous 
study that has demonstrated a higher GPAT1 expression (measured with Western blots) and 
enzyme activity in oxidative (soleus) compared to glycolytic rat muscle (extensor digitorum 
longus) (Lewin et al., 2001). The high GPAT1 activity may also contribute to higher rates of 
IMTG synthesis in oxidative rat muscle (Budohoski et al., 1996). Numerous previous human 
studies have demonstrated that type I muscle fibres have a 2-3-fold greater IMTG content 
than type II fibres (Malenfant et al., 2001;van Loon et al., 2004;Shaw et al., 2008). The 
greater GPAT expression in type I muscle fibres is also likely to be part of the mechanism 
leading to a greater IMTG content in type I muscle fibres in basal conditions and higher 
IMTG resynthesis rates in the period following IMTG depleting exercise (van Loon et al., 
2003b). The most striking and perhaps unexpected finding of the present study was the 
distinctly weak GPAT1 signal in type II fibres (Figures 3.3A and 3.6A) despite the clear 
presence of IMTG in these fibres (Figure 3.3 and 3.5). The present study has also shown for 
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the first time that the GPAT4 protein is expressed in human skeletal muscle, with only a 
marginally lower protein content in type II than in type I muscle fibres. This seems to imply 
that GPAT4 is primarily responsible for the initial step of IMTG synthesis in type II fibres.  
 
At rest, the majority of FAs taken up by the muscle enter esterification pathways and are 
incorporated into IMTGs (Sacchetti et al., 2004), however during exercise the vast majority of 
FAs entering the muscle are oxidised and only ~ 10 % are incorporated into the IMTG pool 
(Sacchetti et al., 2002). The apparent differences in IMTG synthetic enzyme content between 
muscle fibre types found in the present study could have important implications for 
differences between type I and type II fibres in FA handling in the postprandial period, during 
exercise and in the period after exercise. 
 
In longitudinally oriented fibres stained for GPAT1, a striated pattern was seen (Figure 3.4). 
As it has been reported that GPAT1 is located at the outer mitochondrial membrane in rat 
liver mitochondria (Lewin et al., 2004), GPAT1 colocalisation was investigated with COX as 
a marker of the mitochondrial network (Shaw et al 2008). However, no colocalisation of 
GPAT1 was observed with the COX stain indicating that in human skeletal muscle, in the 
resting fasted state, GPAT1 (also named mitochondrial GPAT) is not present in the outer 
mitochondrial membrane. However, the distribution in a striated pattern suggests that GPAT1 
takes a regular place in the mitochondrial network and in some way is associated with the 
mitochondria (Figure 3.8). In rat liver it has been suggested that GPAT1 is present in part in 
the outer mitochondrial membrane and in part in mitochondria associated vesicles (MAVs) or 
membranes (MAMs) (Pellon-Maison et al., 2007). The fraction in the outer mitochondrial 
membrane had by far the highest activity and Pellon-Maison et al., (2007) therefore suggested 
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that a high activity in this fraction is crucial to direct LCFACoA away from carnitine 
palmitoyl transferase 1 (CPT1) and β-oxidation during lipid oversupply. The regular 
arrangement of GPAT1 in the spaces in which COX staining is absent may suggest that 
GPAT1 is present in ER membranes, as these have been suggested to play a role in lipid and 
phospholipid synthesis in several tissues (Lebiedzinska et al., 2009). As there is a small 
amount of colocalisation of GPAT1 with some of the lipid droplets (Figure 3.7), it is tempting 
to speculate that GPAT1 plays a role in lipid droplet formation in skeletal muscle, thus 
depositing the lipid droplets at these regular positions in the gaps between the mitochondria, 
ready for use as a fuel by the mitochondria. This may imply that GPAT1 exerts its controlling 
effect on the LCFACoA concentration seen by CPT1 (and thus reducing β-oxidation) from a 
larger distance in skeletal muscle, or that part of GPAT1 can translocate to a position closer to 
the mitochondria in the fed state and during recovery from exercise when IMTG resynthesis 
rates are high (Sacchetti et al., 2002;Sacchetti et al., 2004;Summermatter et al., 2010). This 
however is yet to be confirmed and should be addressed in future experiments. 
 
Little is currently known about the regulation of GPAT1 and GPAT4 activity but it is likely 
that the subcellular location and association with related proteins and/or organelles as 
observed in the current study (Figure 3.8) are important. As the content/activity of GPAT 
isoforms will influence the concentration of the FA metabolites LCFACoA and DAG, 
variation in the content/activity of these enzymes may play a role in the mechanisms leading 
to insulin resistance and determine diabetes risk. The accumulation of these FA metabolites 
leads to insulin resistance through the activation of PKCβ and serine phosphorylation and 
inactivation of IRS1 (Itani et al., 2002).  
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In summary, this study has revealed, for the first time, the subcellular and fibre type 
distribution of GPAT1 and GPAT4. Future studies comparing IMTG synthetic capacity and 
GPAT1 and DGAT1 distribution in lean, obese and obese type 2 diabetic subjects are 
warranted and may provide new information on the role of these enzymes in the control of FA 
metabolites that play a role in the development of insulin resistance in skeletal muscle.   
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CHAPTER 4 
 
 
 
 
 
 
 
 
 
SUBCELLULAR DISTRIBUTION AND FIBRE TYPE DIFFERENCES 
IN PROTEIN CONTENT OF DIACYLGLYCEROL 
ACYLTRANSFERASE-1 IN HUMAN SKELETAL MUSCLE 
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4.1 Abstract 
Intramuscular triglycerides (IMTG) accumulate in skeletal muscle as discrete lipid droplets 
that are in close proximity to the mitochondria. The key enzymes in IMTG synthesis are 
glycerol-3-phosphate acyltransferase (GPAT) and diacylglycerol acyltransferase 1 (DGAT1).  
DGAT1 catalyses an acylation reaction that consumes the fatty acid metabolites 
diacylglycerol and long-chain fatty acyl-CoA, which both lead to insulin resistance. The aim 
of the present study was to develop methods that allow the investigation of the spatial and 
fibre type distribution of DGAT1 in human skeletal muscle. Percutaneous biopsies were 
obtained from the m. vastus lateralis of six lean, moderately active males at rest and 
following an overnight fast. Cryosections (5 µm) were stained using goat anti-DGAT1 in 
combination with mouse anti-myosin heavy chain type I. Mitochondria were stained using 
mouse anti-cytochrome c oxidase and IMTGs were stained using the neutral lipid dye oil red 
O. The stained sections were viewed using widefield and confocal microscopy. DGAT1 
staining revealed a diffuse staining distribution within the fibres with some areas seemingly 
having more organised distribution. There were brighter spots visible throughout the diffuse 
staining in cross sections, and in longitudinally oriented sections striations were visible in the 
staining distribution. DGAT1 staining also showed a greater staining intensity in type I fibres 
(P < 0.05). IMTG staining revealed a greater IMTG content (expressed as area fraction 
stained) in type I compared to type II fibres (P < 0.05). Mitochondrial staining also showed a 
greater intensity in type I compared to type II fibres. The results of the present study show 
that DGAT1, the enzyme responsible for the final step of IMTG synthesis, has a higher 
protein content in type I than in type II fibres.   
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4.2 Introduction 
Intramuscular triglycerides (IMTG) are synthesised via a series of sequential acylation 
reactions. Diacylglycerol acyltransferase 1 (DGAT1) catalyses the final step of IMTG 
synthesis (Choi et al., 2007) which is the acylation of DAG with LCFACoA.  In this role, 
DGAT1 can increase IMTG synthesis and reduce DAG and LCFACoA (Bagnato & Igal, 
2003). Two DGAT isoforms are known to exist, DGAT1 and DGAT2 (Cases et al., 
1998;Cases et al., 2001). It has recently been reported that an increase in IMTG synthesis 
resulting from increased content of DGAT1 (and the enzyme responsible for the first step of 
IMTG synthesis, glycerol-3-phosphate acyltransferase 1, GPAT1) occurs the day following a 
single bout of endurance exercise and prevents insulin resistance induced by infusion of lipid 
and heparin in healthy untrained women by reducing the content of the FA metabolites which 
lead to insulin resistance (Schenk et al., 2005;Schenk & Horowitz, 2007;Newsom et al., 
2010). A 70% increase in muscle DGAT1 activity was also shown in a group of exercise 
trained mice (6 swimming sessions per day for one week) which coincided with an increased 
IMTG synthesis rate. Furthermore, overexpression of DGAT1 in skeletal muscle of a 
transgenic mouse model led to an acute protection against insulin resistance induced by 
switching to a high fat diet (Liu et al., 2007). More recently, it has been shown that mice 
overexpressing DGAT1 in skeletal muscle are protected against skeletal muscle lipotoxicity 
via a mechanism involving both increases in triacylglycerol synthesis and FA oxidation (Liu 
et al., 2009b) 
 
DGAT1, therefore, may play an important role in the control of the concentration of FA 
metabolites in skeletal muscle and thus offer protection against insulin resistance. As there is 
currently little research (Schenk & Horowitz, 2007;Newsom et al., 2010) into DGAT1 in 
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human skeletal muscle, the aim of the present study was to investigate the fibre type specific 
distribution of DGAT1 in human skeletal muscle obtained from lean, moderately active and 
healthy individuals.  
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4.3 Methods 
Measurement of VO2max 
Subjects performed a progressive exercise test to exhaustion on an electronically braked cycle 
ergometer (Lode BV, Groningen, The Netherlands) in order to determine maximal oxygen 
consumption (VO2max) using an online gas collection system (Oxycon Pro, Jaeger, 
Wuerzburg, Germany).  The test consisted of initially cycling at 95 W, followed by sequential 
increments of 35 W every 3 minutes until cadence was reduced to < 50 rpm, at which point 
the test was terminated.  VO2max was taken as the highest value obtained in the last 30-seconds 
of the test.  
 
Muscle Samples 
Percutaneous muscle biopsies were obtained from the m. vastus lateralis of six lean, 
moderately active male subjects using the needle biopsy technique (Bergstrom, 1975). Subject 
characteristics can be seen in Table 4.1. Samples were prepared and stored as described 
previously in Chapter 2.2.  
Table 4.1 Subject Characteristics 
 Lean Male Participants 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
VO2 max (ml/min/kg) 
Wmax (W) 
6 
20 ± 1 
1.79 ± 0.03 
72.0 ± 2.8 
22.4 ± 0.4 
55.8 ± 1.8 
282.0 ± 17.0 
Data are presented as means ± SEM.  
98 
 
Antibodies 
DGAT1 was identified using goat anti-DGAT1 (Abcam, UK). This was used in combination 
with mouse anti-myosin heavy chain type I (MHCI) (A4.840 DSHB, developed by Dr. Blau) 
to investigate fibre type distribution. The secondary antibodies used in this case were donkey 
anti goat IgG (targeting DGAT1) and donkey anti mouse IgM (targeting MHCI). Mouse anti-
cytochrome c oxidase (COX) (Invitrogen, Paisley, UK) was also used to visualise 
mitochondria. This stain was combined with MHCI. The secondary antibodies applied were 
goat anti mouse IgG2a (targeting COX) and goat anti mouse IgM (targeting MHCI).  Cell 
borders were marked using wheat germ agglutinin (WGA) (Invitrogen, Paisley, UK). IMTGs 
were stained using the neutral lipid dye oil red O in combination with immunofluorescence 
developed by Koopman et al., (2001) as described previously in Chapter 2.3.1.4. 
 
Immunofluorescence Staining 
Cryosections were treated using fixation, permeabilisation and antibody application methods 
described in Chapter 2.4. For immunofluorescence staining anti-DGAT1 was used at a 
dilution of 1:50.  
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters described 
in Chapter 2.5 to visualise Alexa Fluor 350, 488 as well as oil red O. Digital images showing 
the distribution of DGAT1 and IMTG in longitudinally oriented and cross sections of muscle 
fibres were obtained. Detailed digital images demonstrating the cellular distribution of 
DGAT1 were obtained using an inverted confocal microscope (Leica DMIRE2, Leica 
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Microsystems) with a 63 x oil immersion objective. The excitation and emission wavelengths 
of each Alexa Fluor dye can be found in Chapter 2.5. 
 
Image Processing 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). A 
mean of 200 type I fibres and 164 type II fibres were analysed per participant.  Fibre type 
differences in DGAT1 fluorescence intensity were quantified using measures of optical 
density using the WGA outline to mark the individual cells.  
 
Automated Image Capture and Analysis 
The routine analysis of IMTG and mitochondria was completed using automated image 
analysis as described in Chapter 2.5.2. In the widefield images obtained using automated 
analysis a mean of 684 type I fibres were analysed and a mean of 740 type II fibres were 
analysed per participant.  
 
Antibody Validation 
Antibodies were validated using Western Blotting in order to check the molecular weight of 
the bands stained by the antibody against DGAT1. The total protein fraction of the skeletal 
muscle sample was isolated as described in Chapter 2.6.1. Proteins were then loaded (50 µg) 
and separated in 10 % Tris - HCl Polyacrylamide Gel (Biorad, Hertfordshire, UK) and 
transferred to a PVDF membrane which was then blocked in 5 % bovine serum albumin 
(BSA) (Sigma Aldrich, UK) in TBST for 1 hour at room temperature. Membranes were then 
incubated for 2 hours at room temperature in polyclonal goat anti-DGAT1 (Abcam, 
Cambridge, UK) which is specifically targeted against amino acids 305-317 of human 
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DGAT1. Following washing, membranes were then incubated for 1 hour at room temperature 
with horseradish peroxidase linked donkey anti-goat IgG and developed using Super signal 
West Dura chemiluminescent substrate (Pierce Scientific, Northumberland, UK). 
 
Western blot analysis completed using anti-DGAT1 revealed a dense band at ~50 kDa (Figure 
4.1). The expected molecular weight of DGAT1 is 47 kDa.  BLAST analysis for anti-DGAT1 
returned a single 100 % sequence identity match to human DGAT1. 
  
                               
Figure 4.1. Western blot 
determine the specificity of anti
kDa. A dense band was seen at ~
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of an extract of a human skeletal muscle homogenate to 
-DGAT1. The expected molecular weight of DGAT1 is 47 
 50 kDa.   
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In addition to the Western Blotting, a protein competition assay was also used to test the 
specificity of anti-DGAT1. Human DGAT1 protein was kindly donated by AstraZeneca R&D 
(Alderley Park, Macclesfield, UK) and was added in excess of the anti-DGAT1 and incubated 
together at 4 °C for 24 hours prior to immunohistochemical staining. The mixed DGAT1-
antibody solution was then added in place of the primary antibody alone during the 
immunohistochemical staining procedures and this resulted in total elimination of the staining 
(Figure 4.2) adding further evidence of the specificity of the DGAT1 antibody. 
 
 
Statistical analyses 
In order to investigate fibre type differences in DGAT1 signal in type I and type II muscle  
fibres, a Student’s paired samples t-test was undertaken on the fluorescence intensity analysis. 
Furthermore the lipid droplet area fraction and mitochondria content for both type I and type 
II fibres was also compared using a Student’s paired samples t-test. Statistical significance 
was set at P < 0.05. All data are expressed as mean ± SEM. 
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Figure 4.2. Immunostaining competition assay to generate evidence of the specificity of anti--DGAT1. Panel A shows anti-DGAT1 
staining in human skeletal muscle. The image of Panel B was generated using exactly the same procedure except anti-DGAT1 was 
preincubated with human DGAT1 protein for 24 h prior to being used for immunostaining. Bar is 50 µm.  
 
DGAT1 DGAT1 + hDGAT1
A B
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4.4 Results 
DGAT1 staining revealed a diffuse staining distribution within the fibres with some areas 
showing a more specific distribution with brighter punctate staining within the diffuse 
intracellular staining. There was also intense staining in some peripheral areas of the cells 
(Figure 4.3A and 4.4A). There were brighter spots visible throughout the diffuse staining in 
cross sections (Figure 4.3A) and in longitudinally oriented sections striations were visible in 
the staining distribution (Figure 4.4A). When combined with a MHCI stain, it was found that 
the positively stained MHCI cells corresponded to the brighter DGAT1 stained fibres (Figure 
4.3 and 4.4).  Quantifying the images obtained from all the participants in this study, DGAT1 
staining was, on average, 17 % more intense in type I fibres (66 ± 4) than in type II fibres (56 
± 3) (P < 0.05) (Figure 4.5). 
 
  
105 
                             
                                             
Figure 4.3. Widefield fluorescence microscopy of cross sections of human skeletal muscle showing anti-DGAT1 staining (panel A), cell 
borders stained in blue using WGA (panel B), type I fibres positively stained in red with anti-MHCI (panel C), and the merged image 
(panel D). Bar represents 50 µm. 
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Figure 4.4. Widefield fluorescence microscopy of longitudinally oriented sections of human skeletal muscle showing anti-DGAT1 
staining (panel A), cell borders stained in blue using WGA (panel B), type I fibres positively stained in red with anti-MHCI (panel C), 
and the merged image (panel D). Bar represents 50 µm. 
DGAT1
MHCI Merged
WGA
A B
DC
107 
 
                                  
 
 
Figure 4.5. Fibre type specific distribution of DGAT1 in human skeletal muscle. Data are 
mean ± SEM. * Denotes significant difference between fibre types at P < 0.05.  
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Oil red O staining of IMTG showed the expected spotted distribution throughout the fibres 
(Figure 4.6A) and the automated analysis revealed that there was a significantly greater IMTG 
content (expressed as area fraction stained) in type I fibres (0.023 ± 0.002) compared to type 
II fibres (0.016 ± 0.002) (P = 0.004) (Figure 4.6B). These data are in line with data previously 
observed in our laboratory in a smaller number of cells using the traditional method of 
analysis (Shaw et al., 2008). 
 
The automated analysis of the mitochondrial staining using anti-COX also showed a 
distribution similar to that shown elsewhere in this thesis (Chapter 3, Chapter 7, Chapter 8) as 
well as in work previously published by our laboratory (Shaw et al., 2008). In cross sections, 
the mitochondrial distribution was spotted in appearance with a greater density in the number 
of these spots towards the peripheral areas of the cells (Figure 4.7A). In longitudinally 
oriented sections, the distribution of COX staining appeared to show a network like 
distribution as previously observed by Shaw et al., (2008), again with the greatest staining 
density in peripheral regions of the cell (Figure 4.7B). The staining intensity was greater in 
type I fibres (147 ± 7) compared to type II fibres (136 ± 7) (P = 0.035) (Figure 4.7C). 
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Figure 4.6. IMTG staining of human skeletal muscle using oil red O (A). Bar is 30 µm. Panel B shows graph of IMTG content (expressed as 
area fraction stained) in type I and type II fibres as obtained through the automated analysis. Data are mean ± SEM of 6 individuals. * 
Denotes significant difference between fibre types at P < 0.05. 
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Figure 4.7. Mitochondrial staining using anti-COX in cross sections (A) and longitudinally oriented sections (B) of human skeletal 
muscle using immunofluorescence microscopy. Bar is 30 µm. Panel C shows graph of mitochondrial staining intensity in type I and 
type II fibres obtained using the automated analysis. Data are mean ± SEM of six individuals. * Denotes significant difference between 
fibre types at P < 0.05.  
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4.5 Discussion 
DGAT1 is known to be responsible for the final step of IMTG synthesis; however the 
distribution of this enzyme had yet to be identified in human skeletal muscle at the start of 
this study. The results show that DGAT1 is present in both type I and type II skeletal muscle 
fibres with a 17 % greater signal in type I fibres compared to type II fibres (Figures 4.3, 4.4 
and 4.5). These findings suggest that the higher DGAT1 protein content may contribute to the 
greater IMTG content of type I fibres in humans (Figure 4.6B) (Malenfant et al., 2001;van 
Loon et al., 2004) and to the higher IMTG synthesis rates in type I than in type II fibres of 
rats (Budohoski et al., 1996). 
 
In summary, the findings of this study show for the first time the subcellular and fibre type 
distribution of  DGAT1. Future studies comparing IMTG synthetic capacity and GPAT1 and 
DGAT1 distribution in lean, obese and obese type 2 diabetic subjects are warranted and may 
provide new information on the role of these enzymes in the control of FA metabolites that 
play a role in the development of insulin resistance in skeletal muscle.   
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CHAPTER 5 
 
 
 
 
 
 
 
 
 
 
GPAT AND DGAT DISTRIBUTION IN AGEING NON OBESE AND 
OBESE FEMALES 
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5.1 Abstract 
The content and activity of the enzymes glycerol-3-phosphate acyltransferase 1 (GPAT1) and 
diacylglycerol acyltransferase 1 (DGAT1) could mediate the concentration of fatty acid (FA) 
metabolites and therefore muscle insulin sensitivity. The subcellular localisation of these 
enzymes could influence their activity, yet no studies in human skeletal muscle have 
investigated this. The aim of the present study was to investigate the distribution of GPAT1 
and DGAT1 in skeletal muscle of six non obese and six obese ageing women. Biopsies were 
taken from the m. gluteus maximus during elective orthopaedic surgery under general 
anaesthesia. Cryosections (5 µm) were immunolabelled with antibodies against GPAT1 and 
DGAT1. Fibre type was determined through the use of anti-myosin heavy chain type I and 
mitochondria were labelled using anti-cytochrome c oxidase. Intramuscular triglycerides 
(IMTG) were stained using the neutral lipid dye oil red O in combination with 
immunofluorescence. There was no difference in IMTG content, mitochondria area fraction 
or mitochondria intensity between the non obese and obese individuals for either muscle fibre 
type. GPAT1 did not colocalise with IMTG in either group (non obese: r = 0.09 ± 0.02; 
obese: r = 0.08 ± 0.02) and mitochondria showed only a weak colocalisation with GPAT1 in 
both groups (non obese: r = 0.12 ± 0.02; obese: r = 0.10 ± 0.02). This study visualised the 
subcellular distribution of GPAT1 and DGAT1 for the first time in human skeletal muscle of 
obese females and did not observe differences in the distribution of these enzymes between 
non obese and obese women. 
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5.2 Introduction 
Glycerol-3-phosphate acyltransferase 1 (GPAT1) catalyses the conversion of glycerol-3-
phosphate and long-chain fatty acyl-coenzyme A (LCFACoA) into lysophosphatidic acid. 
Diacylglycerol acyltransferase 1 (DGAT1) catalyses the conversion of LCFACoA and 
diacylglycerol (DAG) into TAG. Both reactions, therefore, consume fatty acid (FA) 
metabolites that have been proposed to lead to insulin resistance in skeletal muscle (Ellis et 
al., 2000;Itani et al., 2002). It can, therefore, be expected that a high content of these 
enzymes will protect against insulin resistance, while a low content might contribute to 
insulin resistance. To test this hypothesis a number of animal studies have investigated the 
effect of gain or loss of function of these enzymes on insulin action in skeletal muscle.  
 
Transgenic overexpression of DGAT1 in mouse skeletal muscle increased the IMTG content 
reduced the DAG content and protected the mice against high-fat diet-induced insulin 
resistance (Liu et al., 2007). Moreover, in isolated muscle, DGAT1 deficiency exacerbated 
insulin resistance caused by FA, whereas DGAT1 overexpression mitigated the detrimental 
effect of fatty acids (Liu et al., 2007). In a subsequent study (Liu et al., 2009b) transgenic 
overexpression of DGAT1 in mouse skeletal muscle was shown to simultaneously lead to 
increased IMTG synthesis and increased FA oxidation rates. Transgenic overexpression in 
the mouse heart (Liu et al., 2009a) simultaneously increased the TAG content, while 
substantially reducing FA, DAG and ceramide levels.  In rats, unilateral overexpression of 
DGAT1 resulted in higher IMTG in the treated tibialis anterior muscle compared to control 
leg (Roorda et al., 2005). Collectively, these animal studies strongly suggest that increasing 
the DGAT1 content in skeletal muscle can increase IMTG synthesis, reduce the concentration 
of FA metabolites and prevent insulin resistance.  
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Skeletal muscle DGAT1 activity was also found to be increased in mice in response to 
swimming exercise (six sessions a day (5-10 min each) for a week) (Liu et al., 2007) and 
again resulted in increased TAG synthesis and decreases in DAG and ceramide 
concentrations. In a human study elevations in GPAT1 and DGAT1 content have also been 
observed the day following a single 90 minute bout of endurance exercise (Schenk & 
Horowitz, 2007). This increase in GPAT1 and DGAT1 also led to a higher TAG content, and 
reductions in DAG and ceramides the day following exercise and protected the muscle 
against insulin resistance induced by a lipid-heparin infusion. In a continuation of this work, 
using a similar protocol, Newsom et al., (2010) found an increase in GPAT1 activity and a 
protection against lipid induced insulin resistance following the 90 minute bout of endurance 
exercise the day before an overnight lipid-heparin infusion. Taken together, these studies 
suggest that acute exercise and exercise training are natural means to increase the protein 
content and activity of GPAT1 and DGAT1 and increase IMTG content while offering 
protection against insulin resistance. 
 
Two studies have measured the GPAT1 protein content in lean and obese individuals with 
Western blots and did not observe a difference between these groups (Thrush et al., 2009;Li 
et al., 2011). Again, using Western blots one study observed a lower DGAT1 content in 
obese than in lean individuals (Li et al., 2011), while another study did not observe a 
difference (Thrush et al., 2009). However, Western blots do not reveal whether there are 
differences in the subcellular distribution of these enzymes between lean and obese 
individuals that might explain the difference in skeletal muscle insulin resistance between 
these groups. The recent observation that high DAG concentrations in the compartment 
directly under the plasma membrane might lead to insulin resistance (Bergman et al., 2012) 
makes it worthwhile to investigate this hypothesis. 
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Therefore, the present study aimed to investigate the total protein content and distribution of 
GPAT1 and DGAT1 using immunofluorescence microscopy in skeletal muscle obtained from 
non obese and obese women in order to investigate whether there are differences in the 
spatial distribution and protein content of these enzymes between these groups.   
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5.3 Methods  
Muscle Samples 
Muscle biopsies were obtained from the m. gluteus maximus of six non obese females and six 
obese females during elective orthopaedic surgery (total hip arthroplasty) under general 
anaesthesia. Subject characteristics can be seen in Table 5.1. All participants were 
undergoing surgery at Russells Hall Hospital (Dudley Group of Hospitals) and gave their 
informed consent for participation in this study. The study was approved by the local NHS 
Research Ethics Committee. A small sample of muscle (~ 200 mg) was taken by Consultant 
Surgeon Mr. Edward Davis immediately following the initial surgical incision.  
 
Table 5.1 Subject Characteristics 
 
Non Obese Females Obese Females 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
Fasting plasma Glucose (mmol/L) 
Fasting plasma Insulin (µU/ml) 
HOMA IR 
6 
62 ± 3 
1.59 ± 0.03 
57.36 ± 4.54 
22.63 ± 1.40 
6.98 ± 0.36 
11.91 ± 3.23 
3.92 ± 1.15 
6 
68 ± 3 
1.60 ± 0.03 
85.14 ± 4.73* 
33.3 ± 1.63* 
6.32 ± 0.36 
21.53 ± 4.04 
6.19 ± 1.25 
Data are presented as mean ± SEM. * P < 0.05 
 
The sample preparation and storage procedures were performed as described in Chapter 2.2. 
Immunofluorescence methods are described in Chapter 2.4.  
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Blood Analyses 
Following anaesthesia, blood was collected into two vacutainers, one containing EDTA (for 
plasma). Blood samples were centrifuged at 3,500 rpm for 15 minutes at 4 °C. Aliquots of 
serum and plasma were then frozen and stored at −80 °C until later analysis. Plasma glucose 
concentration was analysed using an ILAB automated analyser (Instrumentation Laboratory, 
Cheshire, UK). Serum insulin concentrations were measured using ELISA (Invitrogen, 
Paisley, UK). 
 
Antibodies 
All antibodies used in this chapter were identical to those used in Chapters 3 and 4. Anti-
GPAT1 was a kind gift from Professor Jan Oscarsson (AstraZeneca R&D, Mölndal, Sweden) 
and anti-DGAT1 was obtained from a commercial source (Abcam, Cambridge, UK). Anti-
myosin heavy chain type I (MHCI) was obtained from DSHB, Iowa, USA. Anti-cytochrome 
c oxidase (COX) (Invitrogen, Paisley, UK) was used to stain mitochondria using the 
procedure previously described by Shaw et al., (2008). IMTG were stained using the neutral 
lipid dye oil red O in combination with immunofluorescence as described by Koopman and 
colleagues (2001). 
  
Antibody Validation 
Details of antibody validation are described in Chapter 2.3.1.1 and also in the antibody 
validation sections of the methods of Chapters 3 and 4. 
 
Immunofluorescence Staining 
Cryosections were stained using methods described in Chapter 2.4. Specifically, following 
formaldehyde fixing, and permeabilisation, samples were incubated in appropriate antibodies 
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for 1 hour. Subsequently, samples were incubated with appropriate Alexa Fluor conjugated 
secondary antibodies for 30 minutes (donkey anti rabbit IgG-488, donkey anti mouse IgM-
594, goat anti rabbit IgG-488, goat anti mouse IgM 594). IMTG were stained as described in 
Chapter 2.3.1.4. 
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters 
described in Chapter 2.5 to visualise Alexa Fluor 350, 488, 594 as well as oil red O. To 
investigate fibre type specific contents, ORO, COX, GPAT1 and DGAT1 antibodies were 
each incubated with MHCI and WGA. To investigate GPAT1 colocalisation with lipid 
droplets and mitochondria, GPAT1 was co-incubated with ORO or COX, along with WGA.  
Digital images showing distribution in cross sections of muscle fibres were obtained. 
Detailed digital images were captured using an inverted confocal microscope (Leica 
DMIRE2, Leica Microsystems) using the excitation filters as described in Chapter 2.5.  
 
Image Processing 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA), a 
description of which can be found in Chapter 2.5.1. Analysis was completed for fibre type 
specific lipid content and mitochondrial intensity. Colocalisation was investigated in confocal 
images of cross sections using Pearson’s correlation analysis in the Image-Pro Plus 5.1 
software.  
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Automated Image Capture and Analysis 
For analysis of IMTG and mitochondria, and fibre type specific fluorescence of GPAT1 and 
DGAT1, automated image analysis was used. Details of automated image capture and 
analysis are described in Chapter 2.5.2. Images were captured using a 40 x oil objective.  
 
Automated Image Processing 
Details of automated image processing are described in Chapter 2.5.3. Images were analysed 
using Definiens Cellenger software (Munich, Germany) with the user defined algorithms 
which assigned whether the cell is fast or slow type, then (depending on the analysis 
required) the algorithm defined the fine detail objects using a watershed algorithm. 
 
Statistics 
Total mitochondria area fraction and intensity and total IMTG content (expressed as area 
fraction stained) of type I and type II fibres were compared using a paired samples t-test. 
Fibre type specific GPAT1 and DGAT1 distribution was investigated using a paired samples 
t-test. Between group differences in IMTG content, mitochondrial content and intensity and 
GPAT1 and DGAT1 fluorescence intensity were also investigated using an independent 
samples t-test. Colocalisation of GPAT1 with both lipid droplets and mitochondria was 
investigated using Pearson’s correlation coefficient. Statistical significance was set at P < 
0.05. All data are expressed as mean ± SEM.  
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5.4 Results 
The distribution of GPAT1 was visually similar in both non obese (Figure 5.1A) and obese 
individuals (Figure 5.1B). There was intense staining in some fibres and little staining in 
other fibres. In longitudinally oriented fibres, the GPAT1 staining showed a striated 
distribution with striations running across the fibre in both non obese (Figure 5.1A) and obese 
(Figure 5.1B) individuals. Combination with the fibre type stain MHCI revealed that the 
fibres intensely stained for GPAT1 were the type I fibres. Quantitative analysis showed that 
the GPAT1 staining was significantly greater in type I than in type II fibres in both non obese 
(80 ± 5 vs. 43 ± 4, P = 0.001) and obese individuals (81 ± 6 vs. 42 ± 2, P = 0.001) (Figure 
5.2). However, there was no difference between the non obese and obese individuals in either 
type I (non obese: 80 ± 5 vs. obese: 81 ± 6, P = 0.86) or type II (non obese: 43 ± 4 vs. obese: 
42 ± 2, P = 0.82) fibres (Figure 5.2). 
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Figure 5.1 GPAT1 distribution in human skeletal muscle. Panel A shows the distribution 
of GPAT1 in skeletal muscle of non obese women in both cross sections (left image) and 
longitudinally oriented sections (right image). Panel B shows the distribution of GPAT1 in 
skeletal muscle obtained from obese women in both cross sections (left image) and 
longitudinally oriented sections (right image). Bar = 50 µm. 
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Figure 5.2 Fibre type specific distributi
represent mean values of non obese participants and white bars represent mean values of 
obese participants. GPAT1 was greater in type I compared to type II fibres in both non 
obese and obese individuals. Val
between fibre types at P < 0.05.
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Given the role of GPAT1 in IMTG synthesis, co-staining of GPAT1 and IMTG, using oil red 
O, was completed in order to investigate their colocalisation. Visual inspection of GPAT1 and 
IMTG co-staining showed little colocalisation in both non obese (Figure 5.3A) and obese 
participants (Figure 5.3B) in the confocal microscopy images. The images were analysed 
using Pearson’s correlation. This also revealed limited colocalisation in both non obese (r = 
0.09 ± 0.02) and obese individuals (r = 0.08 ± 0.02) (Figure 5.3C). The observed values were 
significantly greater than the values of non matched, randomised images (P < 0.05) (Figure 
5.3C). 
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Figure 5.3. GPAT1 and IMTG (stained with oil red O) colocalisation in skeletal muscle of non obese (A) and obese (B) females. Bar is 50 
µm. Pearson’s correlation was used to investigate the colocalisation of GPAT1 and oil red O (C). Colocalisation was deemed significant 
compared to randomised non matched pairs of images. Values are mean ± SEM. * Denotes a significant difference between matched and non 
matched pairs of images at P < 0.05. 
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When examining fibre type differences in IMTG, there was no difference in lipid droplet area 
fraction in type I fibres (non obese: 0.034 ± 0.006 vs. obese: 0.034 ± 0.007, P = 0.977) or type 
II fibres (non obese: 0.020 ± 0.002 vs. obese: 0.020 ± 0.005, P = 0.991) between the non 
obese and obese individuals (Figure 5.4A). However, there was a fibre type difference in lipid 
droplet area fraction in both the non obese (type I fibres: 0.034 ± 0.006 vs. type II fibres: 
0.020 ± 0.002, P = 0.03) and obese individuals (type I fibres: 0.034 ± 0.007 vs. type II fibres: 
0.020 ± 0.005, P = 0.01) (Figure 5.4A). There was also no difference in lipid droplet size 
between the non obese and obese individuals (0.72 ± 0.04 µm2 vs. 0.82 ± 0.08 µm2, P = 0.29) 
(Figure 5.4B). 
 
 
 
 
      
 
Figure 5.4. Lipid parameters in non obese and obese individuals where black bars 
represent mean values for non obese participants and white bars represent mean values for 
obese participants. Lipid droplet area fraction (
type II fibres in both non obese and obese individuals. Lipid droplet size (
different between non obese
significant difference between fibre types
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GPAT1 is also known as mitochondrial GPAT and as such the GPAT1 stain was combined 
with the mitochondrial stain, COX, in order to investigate their colocalisation. Co-staining of 
GPAT1 and COX revealed little colocalisation in both non obese (Figure 5.5A) and obese 
(Figure 5.5B) individuals in the confocal microscopy images. This was confirmed by 
Pearson’s correlation analysis (r = 0.12 ± 0.02 and r = 0.10 ± 0.02 for non obese and obese 
individuals respectively, P = 0.581) (Figure 5.5C). This Pearson’s correlation coefficient for 
matched images was significantly higher for matched than for non matched pairs of images (P 
< 0.05) (Figure 5.5C). 
 129 
 
 
Figure 5.5. GPAT1 and mitochondria (stained using COX) colocalisation in skeletal muscle of non obese (A) and obese (B) females. Bar is 
50 µm. Pearson’s correlation was used to investigate the colocalisation of GPAT1 and COX (C). Colocalisation was significant in both 
groups compared to randomised non matched pairs of images. Values are mean ± SEM. *Denotes a significant difference between 
overlapping and random images at P < 0.05. 
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In the non obese individuals, mitochondria intensity was significantly greater in type I fibres 
than in type II fibres (type I: 98 ± 13 vs. type II: 80 ± 10, P = 0.01) (Figure 5.6A). 
Mitochondrial area fraction was also greater in type I fibres than in type II fibres (type I: 
0.127 ± 0.03 vs. type II: 0.090 ± 0.02, P = 0.02) (Figure 5.6B). In obese individuals, both 
mitochondrial intensity (type I: 87 ± 11 vs. type II: 75 ± 9, P = 0.02) (Figure 5.6A) and 
mitochondrial area fraction (type I: 0.109 ± 0.02 vs. type II: 0.069 ± 0.01, P = 0.02) (Figure 
5.6B) were significantly greater in type I than in type II fibres. However, there were no 
differences between non obese and obese individuals in either type I or type II fibres in 
mitochondria intensity or mitochondria area fraction (P > 0.05).   
 
 
 
 
  
Figure 5.6. Mitochondrial 
represent mean values for non obese participants and white bars represent mean values for 
obese participants. Mitochondria intensity (A) was greater in type I fibres in both non 
obese and obese individuals. Mitochondria area fraction (B) was greater in type I fibres 
than in type II fibres in both non obese and obese individuals. Values are mean ± SE
Denotes a significant difference between fibre types
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The distribution of DGAT1 was similar in the non obese (Figure 5.7A) and obese individuals 
(Figure 5.7B). The staining was diffuse throughout the fibres with some areas of intense 
staining towards the cell borders. The DGAT1 stain also was stronger in some fibres than 
others but not to the same extent as GPAT1. There was also some brighter, intense punctate 
staining throughout the diffuse signal. Combining the DGAT1 staining with anti-MHCI 
revealed that DGAT1 staining was significantly greater in type I fibres than in type II fibres 
in both non obese (type I: 91 ± 5 vs. type II: 74 ± 5, P = 0.001) and obese individuals (type I: 
85 ± 5 vs. type II: 70 ± 4, P = 0.002) (Figure 5.7C). There was also no difference between the 
groups in DGAT1 intensity in type I fibres (non obese: 91 ± 5 vs. obese: 85 ± 5, P = 0.203) 
and type II fibres (non obese: 74 ± 5 vs. obese: 70 ± 4, P = 0.240) (Figure 5.7C). In 
longitudinally oriented sections, there was no difference in the distribution between the non 
obese and obese individuals. Both groups showed areas of intense signal at the borders of the 
cells and clear striations running across the fibres (Figure 5.8). 
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Figure 5.7 Visualisation of DGAT1 in human skeletal muscle of non obese (A) and obese 
individuals (B). DGAT1 was stained in combination with MHCI to identify type I fibres 
(red). Cell borders were stained using WGA (blue). Bar = 50 µm. DGAT1 had a greater 
intensity in type I compared to type II fibres in both non obese and obese individuals. All 
values are mean ± SEM. * denotes significant difference between fibre types at P < 0.05. 
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Figure 5.8 DGAT1 distribution in longitudinally oriented sections of skeletal muscle obtained from non obese and obese women. Bar = 
50 µm. 
Non Obese Obese
DGAT1 DGAT1
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5.5 Discussion 
The present study is the first to show the distribution of GPAT1 and DGAT1 in human 
skeletal muscle. The data also show that there is no difference in the content and distribution 
of these enzymes between skeletal muscle obtained from non obese and obese women. In this 
study, it has also been observed that there appears to be a difference in the morphology of the 
cross sections compared to those in biopsies taken from lean men (see Figure 3.3 for 
example). Decreases in fibre number and fibre size have previously been reported in ageing, 
resulting in sarcopenia (Deschenes, 2004) which may explain why we see this different 
morphology in samples from ageing individuals.  
 
This study showed a weak colocalisation of GPAT1 with the mitochondria and this 
observation is in agreement with the findings in lean, healthy men reported in Chapter 3 of 
this thesis. As described in Chapter 3, this is somewhat surprising given that the enzyme is 
named mitochondrial GPAT. GPAT1 was localised in close proximity to (but only weakly 
colocalised with) the mitochondria in both this study and in Chapter 3 of this thesis. The 
mitochondrial marker, COX, is an inner mitochondrial membrane enzyme involved in the 
electron transport chain which has been used previously to stain the mitochondrial network 
(Shaw et al., 2008). This may therefore explain the lack of colocalisation of GPAT1 with the 
COX stain as GPAT1 was initially proposed to reside at the outer mitochondrial membrane. 
However, the resolving power of the microscope in this case is 0.2 µm and would therefore be 
unlikely to distinguish between the inner and outer mitochondrial membranes. In rat liver 
fractions the highest GPAT1 protein content has been observed in the mitochondrial 
associated vesicles (MAV), while the greatest GPAT1 activity was found in the outer 
mitochondrial membrane (OMM) fraction (Pellon-Maison et al., 2007). It may be that in rat 
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liver, GPAT1 translocates from MAV to OMM when its activity is required for the reciprocal 
inhibition of carnitine palmitoyl transferase 1 (CPT1), thus directing LCFACoA towards 
IMTG storage. The data of the present study and that of Chapter 3 does suggest that GPAT1 
in human skeletal muscle is in fact not directly tethered to the mitochondria in the overnight, 
fasted state in both non obese and obese individuals. It cannot be excluded that in response to 
feeding, GPAT1 translocates to the OMM in order to direct LCFACoA towards storage 
pathways, however this requires future verification.    
 
DGAT1 is proposed to reside at the endoplasmic reticulum, shown to be the site of lipid 
droplet synthesis in chicken liver (Weiss et al., 1960). This is likely to also be the case in rat 
skeletal muscle as immunofluoresence images showed that the distribution of DGAT1 
observed in the present study was similar to that of the sarcoplasmic reticulum protein 
calsequestrin (Jorgensen et al., 1979). The images in our human study clearly show striations 
running across the fibre in longitudinally oriented sections, which could well be in line with 
their presence in the ER. Definitive confirmation of this spatial location should be obtained 
using either DGAT1 colocalisation with markers of the ER or immunogold labelling of 
DGAT1 and transmission electron microscopy. 
 
The results of the present study did not show a difference in the distribution or content of 
GPAT1 and DGAT1 between non obese and obese women. As has been mentioned 
previously in Chapter 1.3.1 of this thesis, accumulation of FA metabolites in the muscle of 
obese individuals has been suggested to play a key role in the development of insulin 
resistance (Chalkley et al., 1998;Griffin et al., 1999;Yu et al., 2002;Itani et al., 2002). As 
GPAT1 and DGAT1 are enzymes that catalyse reactions consuming FA metabolites, 
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differences in subcellular distribution and concentration between these groups could have 
explained the increased insulin resistance in the obese women. The absence of such a 
difference must imply that other aspects of lipid metabolism, such as a higher arterial 
exposure and uptake rate of FA in skeletal muscle, higher rates of IMTG lipolysis or reduced 
mitochondrial oxidation must lead to higher levels of muscle FA metabolites in the obese 
women. The absence of a difference in GPAT1 is in line with two earlier studies which did 
not show a difference in total GPAT1 protein expression measured with Western Blots 
between lean and obese individuals (Thrush et al 2009, Li et al 2011). The absence of a 
difference in DGAT1 is in line with one Western blot study (Thrush et al., 2009), while 
another study found a lower content in obese than in non obese women (Li et al., 2011).  
 
The present study did not show differences in lipid droplet content between non obese and 
obese women. This is perhaps surprising given that a number of previous studies have shown 
that the IMTG content is greater in sedentary obese than in lean individuals (Goodpaster et 
al., 2001;He et al., 2001;Li et al., 2011). The difference between this study and the previous 
study may be that the subjects of the present study were older (> 60 years) and were sedentary 
women. The women were awaiting orthopaedic surgery and had very limited mobility. The 
majority were able to move around using crutches or a frame however some were restricted to 
a wheelchair. In previous studies younger and potentially more active men and women were 
investigated (Goodpaster et al., 2001;He et al., 2001;Li et al., 2011). Ageing shows a positive 
correlation with the accumulation of intramuscular lipid (Kim et al., 2004a) and the 
development of muscle insulin resistance and a sedentary lifestyle also correlates with a 
decline in insulin sensitivity (Stuart et al., 1988;Lipman et al., 1972;Mikines et al., 1991;Kim 
et al., 2004a). A larger lipid droplet area fraction was observed in type I compared to type II 
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fibres in both non obese and obese women, a finding which is in line with previous reports on 
lean (Malenfant et al., 2001;van Loon et al., 2003a) and obese individuals (He et al., 2001). 
There was no difference in mitochondrial content between the non obese and obese group 
neither in type I nor in type II fibres. This may indicate that both groups had very low activity 
levels. Mitochondrial content in both groups was greater in type I compared to type II fibres, 
confirming data previously reported in trained young men (Shaw et al., 2008).  
 
In conclusion, this study shows the first immunofluorescence staining images of GPAT1 and 
DGAT1 in human skeletal muscle obtained from obese females and demonstrates that both 
enzymes have a greater expression in type I compared to type II fibres. There was no 
difference in the protein content and distribution of GPAT1 and DGAT1 between non obese 
and obese sedentary elderly women. 
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CHAPTER 6 
 
 
 
 
 
 
 
 
 
 
VISUALISATION OF ADIPOSE TRIGLYCERIDE LIPASE AND ITS 
ACTIVATOR COMPARATIVE GENE IDENTIFICATION-58 IN 
HUMAN SKELETAL MUSCLE 
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6.1 Abstract 
Lipid droplets are present in skeletal muscle and the fatty acids (FA) liberated through 
lipolysis are utilised as a readily available fuel source, during exercise in lean trained 
individuals. Adipose triglyceride lipase (ATGL) is responsible for the first step of lipolysis in 
human skeletal muscle; the removal of a FA from triacylglycerol (TAG) to form 
diacylglycerol (DAG). Comparative gene identification-58 (CGI-58) is required for full 
activation of ATGL in a kidney cell line. The aims of the present study were to develop 
immunofluorescence methodology to visualise ATGL and, for the first time, its activator 
CGI-58 and potential colocalisation with ATGL in sections of human skeletal muscle. The 
acquired images showed that ATGL fluorescence was greater in type I compared to type II 
fibres (P < 0.001), while the fluorescence intensity of CGI-58 did not differ between the fibre 
types. The images also revealed that ATGL and CGI-58 only partially colocalised with lipid 
droplets in human skeletal muscle in the overnight fasted and resting state. IMTG content was 
greater in type I compared to type II fibres (P < 0.001). ATGL staining revealed a strong stain 
in peripheral regions of the cell and a weak diffuse intracellular stain. CGI-58 showed diffuse 
intracellular staining with more intense spots in peripheral regions, which colocalised with the 
nuclei. ATGL and CGI-58 partially colocalised, particularly in peripheral and nuclear regions 
of the cell. The intense staining of CGI-58 in the myonuclei suggests that the protein may 
play a role in the local DAG and/or FA generation at this site.  
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6.2 Introduction 
In humans, excess caloric intake is stored as triacylglycerol (TAG) in lipid droplets, primarily 
in adipose tissue and to a lesser extent in skeletal muscle and liver. Lipid droplets are stores of 
neutral lipid in the cytosol surrounded by a phospholipid monolayer. The most abundantly 
stored lipid molecules are TAG followed by cholesteryl esters (Bostrom et al., 2009). Data 
obtained in adipocytes have shown that lipid droplets are coated by a number of proteins 
including the so called PAT proteins (perilipin 1, adipocyte differentiation related protein 
(ADRP) and tail interacting protein (TIP-47)). The PAT proteins have been suggested to 
regulate the access of the lipolytic enzymes to the stored TAG, to thus liberate FA that can 
then be released (adipose tissue) or oxidised to generate energy (muscle) (Prats et al., 
2006;Listenberger et al., 2007;Bell et al., 2008).  
 
The first lipase discovered in skeletal muscle was hormone sensitive lipase (HSL) which for 
some time was believed to be the only lipase in skeletal muscle. Observations in HSL 
knockout mice showed that they do not accumulate TAG but instead accumulate 
diacylglycerol (DAG), suggesting that an additional lipase may be responsible for the removal 
of the first FA from TAG to form DAG (Haemmerle et al., 2002;Schweiger et al., 2006). This 
data initiated a search for an additional lipase generating DAG and led to the discovery of 
ATGL (Zimmermann et al., 2004) also known as desnutrin or calcium-independent 
phospholipase A2ζ (Jenkins et al., 2004;Villena et al., 2004). ATGL plays a role in basal 
lipolysis in adipocytes (Ryden et al., 2007;Langin et al., 2005) and it has been shown in a 
kidney cell line that it requires an activator protein, comparative gene identification - 58 
(CGI-58), to reach maximum activity (~ 20 fold increase) (Lass et al., 2006). 
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ATGL has been suggested to play a crucial role in skeletal muscle TAG lipolysis; animals 
with a general ATGL knockout show significant TAG accumulation in all tissues (Haemmerle 
et al., 2006). ATGL has been shown to be present in rat skeletal muscle (Zimmermann et al., 
2004) and more recently in human skeletal muscle (Jocken et al., 2008;Alsted et al., 2009) 
where it was demonstrated to be predominantly present in type I fibres (Jocken et al., 2008).  
 
Incomplete lipolysis, resulting from an imbalance between the activity of ATGL and HSL, 
may lead to the accumulation of DAG and generation of long-chain fatty acyl-coenzyme A 
(LCFACoA), which are both known to inhibit insulin signalling in obese (Itani et al., 2000) 
and type 2 diabetic humans (Itani et al., 2001). This imbalance has been seen in HSL 
knockout mice, which accumulate DAG in skeletal muscle and have reduced insulin 
sensitivity (Osuga et al., 2000;Mulder et al., 2003). ATGL deficiency on the other hand 
results in an accumulation of TAG (including ~ 20 fold increase in IMTG), but perhaps 
surprisingly improved insulin sensitivity (Haemmerle et al., 2006). This finding seems to 
confirm that increases in FA metabolites in skeletal muscle, rather than increases in the total 
size of the IMTG pool play a key role in the mechanism that leads to insulin resistance in 
skeletal muscle. Further, DAG concentrations in skeletal muscle of ATGL knockout mice 
have been found to be normal despite an increased body weight resulting from excess fat 
accumulation (Hoy et al., 2011). Conversely, HSL knockout mice have reduced fat mass and 
severe DAG accumulation in skeletal muscle (Haemmerle et al., 2002;Zechner et al., 2009). 
Therefore HSL is considered to be the rate limiting step for DAG hydrolysis whereas ATGL 
is responsible for cleavage of the first ester bond, liberating DAG from the stored TAG.   
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CGI-58 is ubiquitously expressed and has been shown to be present in skeletal muscle 
(Brown, 2001). CGI-58 is a 39 kDa protein and plays a role in facilitating the hydrolysis of 
TAG in almost all cell types (Lass et al., 2006;Yamaguchi et al., 2007), however it lacks 
intrinsic lipase activity due to the lack of a serine residue in its catalytic domain (Lass et al., 
2006;Yamaguchi et al., 2007). In adipocytes, under basal conditions, CGI-58 interacts with 
the PAT protein, perilipin 1, at the surface of the lipid droplet. Upon catecholamine 
stimulation, PKA activity is increased which phosphorylates both HSL (Yamaguchi et al., 
2004;Subramanian et al., 2004) and perilipin 1 (Yamaguchi et al., 2007;Lass et al., 2006). 
CGI-58 dissociates from perilipin 1, activating ATGL, and causing an increase in lipolysis. 
Lass et al., (2006) demonstrated in a kidney cell line that CGI-58 acts as a coactivator of 
ATGL but not HSL. The mechanism of activation of ATGL by CGI-58 and its role in 
lipolytic regulation in skeletal muscle has currently not been investigated. In both kidney and 
adipocyte cell lines it has however been shown that CGI-58 coactivation of ATGL requires 
direct protein-protein interaction (Lass et al., 2006;Granneman et al., 2007). Further, in 
kidney cells, CGI-58 must bind to the lipid droplet (Gruber et al., 2010) to bring about 
activation of ATGL. Given the importance of skeletal muscle lipolysis in fuel selection 
mechanisms and in the pathogenesis of insulin resistance and type 2 diabetes, the aim of this 
study was to develop a method that allows investigation of the spatial distribution of ATGL 
and its coactivator CGI-58 and their colocalisation with each other and with lipid droplets in 
human skeletal muscle. This method will be applied to the muscle of six lean, healthy 
individuals studied in the overnight fasted state to generate the first data on the spatial 
distribution of CGI-58 and its colocalisation with ATGL in man.  
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6.3 Methods 
Measurement of VO2max 
Subjects performed a progressive exercise test to exhaustion on an electronically braked cycle 
ergometer (Lode BV, Groningen, The Netherlands) in order to determine maximal oxygen 
consumption (VO2max) using an online gas collection system (Oxycon Pro, Jaeger, 
Wuerzburg, Germany).  The test consisted of initially cycling at 95 W, followed by sequential 
increments of 35 W every 3 minutes until cadence was reduced to < 50 rpm, at which point 
the test was terminated.  VO2max was taken as the highest value obtained in the last 30 seconds 
of the test. 
 
Muscle Samples 
Percutaneous muscle biopsies were obtained from the vastus lateralis muscle of six healthy, 
lean and active male subjects using the needle biopsy technique (Bergstrom, 1975) as 
described in detail in Chapter 2.2. Subject characteristics are shown in Table 6.1. 
 
Table 6.1 Subject Characteristics 
 Male Participants 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
VO2max (ml/min/kg) 
6 
26 ± 1 
1.81 ± 0.02 
72.0 ± 2.7 
22.0 ± 0.3 
60 ± 2 
Data are presented as means ± SEM.  
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Antibodies 
ATGL staining was carried out using rabbit anti-ATGL (10006409, Cayman Chemical 
Michigan, USA) targeting amino acids 382-400 (KRKLGRHLPSRLPEQVELR) which, using 
BLAST (www.uniprot.org) showed 100% sequence identity to human ATGL (504 amino 
acids in length) as well as a shorter isoform (180 amino acids in length). This antibody has 
been validated in Western blotting (Figure 6.1) (unpublished data kindly shared by Dr Johan 
Jocken, Maastricht University, NL) and has been used in previously published research 
(Jocken et al., 2008). CGI-58 staining was completed using rabbit anti-CGI-58 (NB110-
41576, Novus Biologicals, Littleton, CO) produced from a synthetic peptide corresponding to 
residues 200-300 of the human protein  
(ALGAALTPFNPLAGLRIAGPFGLSLVQRLRPDFKRKYSSMFEDDTVTEYIYHCNVQT
PSGETAFKNMTIPYGWAKRPMLQRIGKMHPDIPVSVIFGARSCI).  
  
  
 
 
 
 
Figure 6.1 Validation of 
molecular weight (54 kDa) in skeletal muscle of lean and obese individuals. 
with a blocking peptide as well as the primary antibody removes all visible bands.
kindly provided courtesy of Dr Johan Jocken, Maastricht University, The Netherlands. 
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BLAST (www.uniprot.org) showed 100 % sequence identity to human CGI-58 as well as 
58% sequence identity to ABHD4, a protein that is not present in skeletal muscle. Therefore 
the antibody is selective as it can detect only one protein in muscle. This antibody has also 
been validated for use in Western blotting (Figure 6.2), detecting a single band at the correct 
molecular weight in mesenchymal stem cells (kindly shared unpublished data, Dr. Johan 
Jocken, Maastricht University, NL). This antibody has been used in human skeletal muscle to 
assess CGI-58 protein content (Jocken et al., 2010). Fibre type was determined by incubating 
sections in mouse anti-myosin heavy chain type I (MHCI) (A4.840 DSHB, developed by Dr. 
Blau). Nuclei were stained using the DNA stain 4',6-diamidino-2-phenylindole (DAPI). PBS 
was used for dilution of all antibodies and for use in the washing steps of the procedure. 
IMTGs were stained using the neutral lipid dye oil red O in combination with 
immunofluorescence as developed by Koopman et al., (2001) and described in Chapter 
2.3.1.4. 
  
  
 
Figure 6.2 Validation of 
molecular weight (39 kDa) in 
Johan Jocken, Maastricht University, The Netherlands.
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CGI-58 antibody. Western blot shows band at the correct 
mesenchymal stem cells. Data kindly provided courtesy of Dr 
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Immunofluorescence Staining 
Details of the immunofluorescence staining are described in Chapter 2.4. In staining 
procedures for CGI-58, samples were blocked for 30 minutes in 5 % normal goat serum 
(NGS) before the application of anti-CGI-58 (1:100) overnight at 4 °C. When identifying 
ATGL, anti-ATGL was applied at a dilution of 1:50 for 1 hour at room temperature. 
Following washing steps, all samples were then treated with the appropriate Alexa Fluor 
conjugated secondary antibody. Sections were then incubated in oil red O for 30 minutes at 
room temperature.  
 
Sequential Staining of ATGL and CGI-58 
Double staining of ATGL and CGI-58 was performed using a method which allows for 
application of two primary antibodies from the same host species (rabbit) (Granneman et al., 
2009b). Samples were incubated as follows. Anti-ATGL was applied for 1 hour at room 
temperature followed by an excess of Dylight 594 conjugated goat anti rabbit Fab (Stratech 
Scientific, Suffolk, UK) for one hour at room temperature. The Fab fragment covers the 
surface of the first primary antibody applied so that in the application of the whole IgG 
secondary antibody, the only available binding sites are those of the second primary antibody. 
Cryosections were then incubated in anti-CGI-58 before Alexa Fluor 488 conjugated 
secondary antibody (Invitrogen, Paisley, UK) was applied for 30 minutes at room 
temperature. Samples were washed thoroughly between antibody incubations as well as 
blocking for 30 minutes in 10 % NGS. Using this protocol, we aimed to eliminate cross-
reactivity between the two sets of primary and secondary antibodies. Control experiments that 
omitted each primary antibody resulted in complete elimination of the fluorescent signal in 
the corresponding channel.  
 150 
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters described 
in Chapter 2.5 to visualise Alexa Fluor 350, DAPI, Alexa Fluor 488, Dylight 594 and oil red 
O. Digital images showing the distribution of ATGL, CGI-58 and IMTG in cross sections and 
longitudinally oriented muscle fibres were obtained.  
 
Image Processing 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA) 
and intensity thresholds were selected to represent minimum values for lipid droplets. These 
were kept consistent throughout all image analysis. For each image, the muscle fibre area and 
the area occupied by lipid droplets was measured. Lipid content was expressed as area 
fraction stained by dividing the stained area in the fibre by the total area of that fibre. Fibre 
type differences in ATGL and CGI-58 fluorescence intensity were quantified using measures 
of optical density.  
 
Statistical analyses 
In order to compare fibre type differences in ATGL and CGI-58 signal and IMTG area 
fraction, a Student’s paired samples t-test was undertaken on the fluorescence intensity 
analysis. Statistical significance was set at P < 0.05. All data are expressed as mean ± SEM 
unless otherwise stated. 
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6.4 Results 
In order to investigate the distribution of ATGL and CGI-58 in human skeletal muscle, 
cryosections were stained with appropriately targeted antibodies. Representative images of 
immunofluorescence staining with anti-CGI-58 can be seen in Figure 6.3A. A weak, diffuse 
fluorescence signal was seen throughout all fibres with some spots of greater intensity in 
peripheral areas of the cells. When the CGI-58 stain was combined with anti-MHCI to denote 
fibre type, no differences in fibre type distribution of CGI-58 were seen (Figure 6.4) with a 
mean fluorescence of 67 ± 2 in type I fibres and a mean fluorescence of 62 ± 3 in type II 
fibres (P = 0.292) (Figure 6.3D). There was also greater intensity in large structures around 
the cell periphery which colocalised with nuclei stained using the DNA stain DAPI, showing 
that CGI-58 was present in the nuclei (Figure 6.5). There was also a more intense signal in 
some extranuclear areas of the cell periphery (Figure 6.3A). Oil red O staining revealed a 
relatively large number of small distinct spots demonstrating the presence of lipid droplets 
(Figure 6.3C). In line with previous observations ((Chapters 3, 4 and 5; (Malenfant et al., 
2001;van Loon et al., 2003a;Shaw et al., 2008)), there was a greater content of lipid in type I 
(0.027 ± 0.006) when compared to type II fibres (0.015 ± 0.005) (P < 0.001) (Figure 6.3B, 
6.3C, 6.3E and 6.6). Combination of the CGI-58 stain with the oil red O staining revealed that 
lipid droplets only partially colocalised with CGI-58 (Figure 6.3E). 
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Figure 6.3. Widefield immunofluorescence microscopy to show visualisation of CGI-58 (A), MHC type I (B) and IMTG (C). 
Combinations of the merged images are also shown: CGI-58 merged with MHC type I (D), CGI-58 merged with IMTG (E) and the 
merging of all three images (F).  Bar represents 50µm. 
CGI-58 MHC IMTG
CGI-58, MHC and IMTG
A B C
CGI-58 and IMTG
E
CGI-58 and MHC
D F
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Figure 6.4. Fibre type specific CGI-58 fluorescence intensity. Data are mean ± SEM.   
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Figure 6.5. Representative images showing (A) distribution of CGI-58 in cross sections of human skeletal muscle, (B) nuclei stained 
with DAPI (B), and (C) merged images showing the colocalisation of CGI-58 with the nuclei. Bar is 50 µm. 
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Figure 6.6. Fibre type specific lipid area fraction. ** Significant difference between fibre 
types (P < 0.001). Data are mean ± SEM.   
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Anti-ATGL staining showed a strong stain at peripheral regions of the cell (Figure 6.7A) and 
there was also a more diffuse and weaker fluorescence signal present in the interior of the cell. 
There did appear to be some spatial structure in the staining in the interior of the cell, 
however, this was not consistent across all subjects. ATGL staining was more intense in type 
I fibres compared to type II fibres (95 ± 4 vs. 57 ± 5, P < 0.001) (Figure 6.6 and 6.8). This 
was also true for lipid droplet distribution with a greater lipid content in type I compared to 
type II fibres (P < 0.001) (Figure 6.3 and 6.6), however there was also no obvious 
colocalisation between lipid droplets and ATGL (Figure 6.7). ATGL and CGI-58 co-staining 
is shown in Figure 6.9. ATGL and CGI-58 colocalise particularly at the cell periphery in 
subsarcolemmal and nuclear regions with little colocalisation within the cell interior. It seems 
that in longitudinally oriented sections ATGL is distributed in a striated network (Figure 
6.9A). The distribution of CGI-58 also shows a regular distribution when viewed 
longitudinally (Figure 6.9B). 
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Figure 6.7. Cross sections showing (A) distribution of ATGL, (B) type I fibres using the MHCI stain, (C) IMTG stained with oil red O. 
Merged images of these stains are shown in panel D-F. Bar is 50 µm. 
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Figure 6.8. Fibre type specific ATGL fluorescence intensity. ** Significant difference 
between fibre types (P < 0.001). Data are mean ± SEM of 6 individuals. 
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Figure 6.9. Representative images of costaining of ATGL (A) and CGI-58 (B) in human skeletal muscle. Merged images are shown in 
C. The area highlighted in white is shown at a larger magnification in images D, E and F. Bar is 50 µm. 
160 
 
6.5 Discussion 
This study is the first to show spatial distribution of ATGL and CGI-58 in human skeletal 
muscle. Protein content of ATGL was higher in type I fibres and its staining intensity was 
greater in peripheral regions of the cells. Partial colocalisation of ATGL and CGI-58 was 
demonstrated within the cytosolic regions of the cell and a greater amount of colocalisation 
was seen at the cell periphery. 
 
 The observation that ATGL distribution is fibre type specific (Figure 6.8) is in line with 
earlier work of Jocken et al., (2008) and was to be expected as lipid droplet content is greater 
in type I compared to type II fibres ((Figure 6.6; Chapters 3 and 4, and as shown in earlier 
work of others (Malenfant et al., 2001;van Loon et al., 2004;Shaw et al., 2008)). There were 
no fibre type differences in the CGI-58 protein content. This may be related to the fact that 
CGI-58 has multiple roles, and apart from activating ATGL, is also involved in the acylation 
of lysophosphatidic acid (LPA) (Ghosh et al., 2008;Montero-Moran et al., 2009).  For the 
distribution of ATGL, there did appear to be a difference in signal within the interior of the 
cells whether they were cross sections or longitudinally oriented. This, for the time being, 
remains unexplained. It may be that there were some problems with the penetration of the 
antibodies which could explain the weak signal in the cell interior in longitudinally oriented 
sections.    
 
Colocalisation of CGI-58 with lipid droplets has been observed in adipocytes via a direct 
protein-protein interaction with perilipin 1 (Liu et al., 2004). This colocalisation has also been 
observed in non lipid droplet compartments in adipocytes (Yamaguchi et al., 
2004;Subramanian et al., 2004) and Chinese hamster ovary cells (Yamaguchi et al., 2004). 
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Further, colocalisation of CGI-58 with the endoplasmic reticulum (ER) and golgi apparatus 
has been observed in hepatocytes (Brown et al., 2007). However, very little colocalisation of 
CGI-58 and lipid droplets was observed in this study in human skeletal muscle (Figure 6.3). 
The staining of CGI-58 in the present study was diffuse throughout the muscle fibres on 
cross-sections (Figure 6.3) and a pattern with striations was observed in longitudinal sections 
(Figure 6.9E). This could potentially point at its presence at the ER in skeletal muscle. 
However, this would need confirmation in future studies through co-staining of an ER marker 
and CGI-58. There are still many gaps in our knowledge of lipolysis of lipid droplets in 
skeletal muscle, however, extrapolation of in vitro data (Murphy & Vance, 1999;Robenek et 
al., 2006) suggests that the ER may be both the site of growth and lipolysis of small lipid 
droplets with the lipolytic enzymes ATGL, HSL and the activator CGI-58 potentially being 
located close to/at the ER for ease of access to the lipid droplets when lipolysis is required for 
FA generation during times of increased energy demand.   
 
The absence of perilipin 1 in lipid droplets in skeletal muscle (Sztalryd et al., 2003;Greenberg 
et al., 1993;Londos et al., 1995;Servetnick et al., 1995) may explain why CGI-58 does not 
colocalise with lipid droplets in human skeletal muscle, as it has been shown in adipocytes 
that this interaction is dependent upon the presence of perilipin 1. In cardiomyocytes, CGI-58 
binds specifically to lipid droplets containing perilipin 5 (MLDP/ OXPAT) (Granneman et al., 
2009a). It has been shown that ADRP (perilipin 2) regulates the access of ATGL to lipid 
droplets in vitro in human kidney cells and in mouse liver cells (Listenberger et al., 2007;Bell 
et al., 2008), however it is yet to be shown whether CGI-58 is also involved in this process.  
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The fact that CGI-58 was present in locations other than the lipid droplets was not unexpected 
as it has recently been suggested that CGI-58 may be involved in the regulation of other 
metabolic processes such as mediating the acylation of LPA (Ghosh et al., 2008;Montero-
Moran et al., 2009). This would likely require localisation to the ER membrane which is the 
site where TAG synthesis occurs, as the acylation of LPA is one of the steps involved in this 
process (Takeuchi & Reue, 2009). The protein itself recently has also been shown to have 
enzymatic activity catalysing the CoA-dependent acylation of LPA (Montero-Moran et al., 
2010). The proposed function is that it channels FA released from hydrolysis of TAG into 
phospholipids (Montero-Moran et al., 2010). This may explain its apparent homogenous 
distribution in the cytosol, presumably close to the ER where there may be small growing 
lipid droplets, as LPA (the substrate for CGI-58) is produced during phospholipid synthesis. 
Further, overexpression of CGI-58 leads to increased phospholipid content (Yamaguchi, 
2010). Therefore it is possible that CGI-58 could be involved in both TAG hydrolysis 
(activating ATGL) and phospholipid synthesis dependent on the metabolic status of the cell 
(Lass et al., 2010). The colocalisation of CGI-58 with myonuclei may be related to the 
observation that separate metabolically active pools of DAG (the product of the action of 
ATGL and CGI-58) exist in nuclei and are important in regulation of gene expression 
(D'Santos et al., 1999).   
 
The overall conclusion of this study is that ATGL content is higher in type I than in type II 
fibres, while a similar content was seen for CGI-58 in both fibre types. The merged images 
suggest that there is partial colocalisation of CGI-58 with lipid droplets however this requires 
further substantiation in future studies with the use of confocal microscopy which is the only 
valid method to quantitate colocalisation. ATGL however, did not appear to colocalise with 
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lipid droplets. These data suggest that, in the overnight fasted resting state, when lipolytic 
rates are low, ATGL and CGI-58 are not present in a high concentration in the lipid droplets 
in human skeletal muscle. 
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CHAPTER 7 
 
 
 
 
 
 
 
 
VISUALISATION AND DISTRIBUTION OF SYNAPTOSOMAL-
ASSOCIATED PROTEIN 23 IN SKELETAL MUSCLE OF LEAN, 
HEALTHY MALES 
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7.1 Abstract 
Lipid droplets are present in skeletal muscle and provide a cellular store of lipid and a readily 
available fuel source during exercise in trained humans. SNARE proteins such as 
synaptosomal associated protein 23 (SNAP23) are also present in skeletal muscle and play a 
crucial role in docking and fusion processes including GLUT4 docking with the plasma 
membrane and fusion of lipid droplets. Recently, on the basis of in vitro observations in lipid 
loaded cardiomyocytes, suggestions have been made that in obesity, the lipid droplets may 
hijack SNAP23 from the plasma membrane and thus impair GLUT4 fusion and docking. The 
aim of this research was to develop methodology in order to visualise SNAP23 and 
investigate its subcellular distribution in human skeletal muscle using immunofluorescence 
microscopy. Percutaneous biopsies were obtained from the m. vastus lateralis of six lean, 
moderately active males in the rested, overnight fasted state. Cryosections (5µm) were then 
stained with antibodies targeting SNAP23, the mitochondrial marker, cytochrome c oxidase, 
and the plasma membrane marker, dystrophin. Intramuscular lipid droplets were stained using 
the neutral lipid dye oil red O in combination with immunofluorescence. Immunofluorescence 
staining of SNAP23 showed a diffuse stain throughout the fibres with additional areas of 
intense punctate staining within the cells. There was also intense staining at the peripheral 
regions of the cell. SNAP23 staining intensity was similar throughout both type I and type II 
fibres (P = 0.422). Confocal microscopy images showed colocalisation of SNAP23 with the 
plasma membrane (Pearson’s correlation coefficient (r) = 0.499 ± 0.012) as well as diffuse 
and more intense punctate intracellular staining. The latter colocalised primarily with 
mitochondria (r = 0.504 ± 0.017) and to a lesser extent with lipid droplets (r = 0.208 ± 0.014). 
The distribution data are in line with the previously suggested main metabolic roles of 
166 
 
SNAP23, which are GLUT4 docking in the plasma membrane and shuttling of FAs generated 
by lipolysis of IMTG in lipid droplets into the mitochondria for subsequent β-oxidation. 
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7.2 Introduction 
In humans, the SNAREs (Soluble N-Ethylmaleimide-Sensitive Factor  (NSF) Attachment 
Protein Receptors) form a family of 36 proteins (Jahn & Scheller, 2006). Most SNARE 
proteins share a similar structure with a characteristic SNARE ‘motif’ which is a conserved 
sequence of 60 - 70 amino acids arranged in heptad repeats. The SNARE motif is connected 
by a short linker to the C-terminal end, which contains transmembrane domains. It is the 
SNARE motifs that mediate SNARE complex formation, forming helical core complexes 
which are extraordinarily stable. SNAREs are categorised according to the role they play in 
membrane fusion; vesicle-SNAREs (v-SNAREs) are found on the transport vesicles and 
target-SNAREs (t-SNAREs) are found at the plasma membrane. SNARE proteins play a 
crucial role in many intracellular docking and fusion processes, such as GLUT4 docking with 
the plasma membrane (Foster et al., 1999;Kawanishi et al., 2000b) and fusion of lipid 
droplets (Bostrom et al., 2007).  
 
Synaptosomal Associated Protein 23 (SNAP23) is a SNARE protein, which has been 
identified in non neural tissues and has been found to be an analogue of SNAP25 sharing high 
sequence homology (Ravichandran et al., 1996). In its role as a SNARE protein, SNAP23 is 
able to bind with VAMP1 and 2 and also Syntaxin1, 2, 3 and 4 playing a role in targeted 
exocytosis. SNAP23 is a t-SNARE (for a review see (Bryant et al., 2002) and it would 
therefore be expected to reside at the plasma membrane.  
 
SNAP23 has also been proposed to play a role in lipid droplet-mitochondria interactions 
(Jagerstrom et al., 2009) aiding the efficient delivery of fatty acids (FA) generated by 
lipolysis of intramuscular triglycerides (IMTG) of lipid droplets into the mitochondria for 
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subsequent β-oxidation. Therefore in both lean and trained individuals, it would also be 
expected that SNAP23 would reside within the cells specifically at the mitochondria and lipid 
droplets.  
 
Lipid droplets are present in multiple cell types including skeletal muscle and provide a 
cellular store of lipid and a readily available fuel source during exercise in trained humans. It 
has been reported that one of the many adaptations to endurance training is a dispersal of 
larger lipid droplets into a larger number of smaller droplets (He et al., 2004). This would 
increase the surface area making the IMTG more accessible to lipases and their activators and 
thus facilitate the utilisation of intramuscular lipids as a fuel during exercise. Electron 
microscopy has been used to demonstrate that in skeletal muscle, lipid droplets appear to be 
localised in close proximity to the mitochondria, presumably in order for efficient lipid 
oxidation during times of increased demand (Hoppeler, 1999). Further, using electron 
microscopy, an increased spatial contact between mitochondria and lipid droplets has been 
demonstrated following a seven week endurance training protocol in previously untrained 
individuals (Tarnopolsky et al., 2007). In addition to this data, lipid droplets have been shown 
to be situated in close proximity to the mitochondrial network using confocal microscopy in 
skeletal muscle of lean, highly trained cyclists (Shaw et al., 2008). This adaptation has been 
suggested to aid in the efficient oxidation of FAs liberated from lipid droplets upon lipolysis 
during exercise as it reduces the diffusion distance of the released FAs to the site of β-
oxidation. In a recent study in fibroblasts, ablation of SNAP23 resulted in a decreased spatial 
complex formation between mitochondria and lipid droplets and decreased mitochondrial β-
oxidation (Jagerstrom et al., 2009). This has led to the suggestion that SNAP23 is implicated 
in the formation of functional lipid droplet-mitochondria complexes.  
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The purpose of the present study was to investigate whether the subcellular distribution of 
SNAP23 in human skeletal muscle is in agreement with the functional roles proposed above 
in the plasma membrane, mitochondria and lipid droplets. The developed staining 
methodologies are important as they generate the first detailed images of the distribution of 
SNAP23 in human skeletal muscle. The study was conducted using percutaneous muscle 
biopsies obtained in the resting, overnight fasted state from six lean, moderately active males 
and analysed using widefield and confocal fluorescence microscopy.  
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7.3 Methods  
Measurement of VO2max 
Subjects performed a progressive exercise test to exhaustion on an electronically braked cycle 
ergometer to determine VO2max as described in Chapter 4.3.   
 
Muscle Samples 
Percutaneous biopsies were obtained from the m. vastus lateralis of 6 lean, healthy, 
moderately active male subjects using the needle biopsy technique (Bergstrom, 1975). Subject 
characteristics can be seen in Table 7.1. Samples were prepared and stored as described 
previously in Chapter 2.2.  
 
Table 7.1 Subject Characteristics 
 
Lean Male Participants 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
VO2 max (ml/min/kg) 
Wmax (W) 
6 
20.2 ± 0.7 
1.79 ± 0.03 
72.0 ± 2.8 
22.4 ± 0.4 
55.8 ± 1.8 
282.0 ± 17.0 
Data are presented as means ± SEM.  
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Antibody Validation Overview 
Validation of the selected antibody was completed using the methods described in Chapter 
2.3.1.1. Western blotting revealed a single band at the correct molecular weight (23 kDa) as 
well as an additional band at ~ 75 kDa (Figure 7.1). This additional band may relate to an 
extracellular protein as extracellular staining was visible in Figure 7.5. Also, the BLAST 
analysis indicated a single match in human skeletal muscle of the target sequence to SNAP23 
and its shorter isoform SNAP23B.  
 
SNAP23 Green Fluorescent Protein – Transfection 
In addition to the aforementioned techniques, a green fluorescent protein (GFP) transfection 
study was also completed. A human cancer cell line (HeLa cells) were transfected with human 
GFP-tagged SNAP23 cDNA (Amsbio, Abingdon UK). Cells were incubated with 100 µg 
SNAP23-GFP construct for 48 hours before fixing in 4 % paraformaldehyde for 20 minutes 
before washing 3 times, for 5 minutes each in PBS. The plate was then washed using PBS and 
0.2 % triton X-100. The cells were then stained using anti-SNAP23 (Synaptic Systems, 
Germany) (1 hour incubation at room temperature). The primary antibody was applied in the 
dilution series 1:100, 1:200, 1:500 as well as a control with no primary antibody. This allowed 
for 4 repeats on the 96 well plate. The secondary antibody (donkey anti-rabbit IgG 647) 
(Invitrogen, Paisley, UK) was applied for 30 minutes at room temperature. The cells were also 
counterstained with the nuclear stain Hoechst. The plate was then imaged using ImageXpress 
software (California, USA).  
 
The HeLa cells displayed a heterogenous expression of the plasmid. The antibody did 
successfully colocalise with the transfected GFP-tagged SNAP23 (Figure 7.2). The antibody 
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was also able to detect variations in SNAP23 (Figure 7.3) as quantification of the cytoplasmic 
intensities of SNAP23-GFP and of the immunostaining with anti-SNAP23 showed a linear 
relationship.  
 
On the basis of these antibody validation tests this antibody (anti-SNAP23, Synaptic Systems) 
was selected for use in this study.  
  
  
                       
Figure 7.1. Immunoblot using 
of human skeletal muscle from a lean individual.
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anti-SNAP23 (Synaptic Systems, Germany) of a 
 
 
homogenate 
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Figure 7.2. HeLa cells transfected with 100 µg SNAP23-GFP plasmid incubated for 48h. 
The cells displayed a heterogenous expression of the plasmid and show colocalisation of 
SNAP23-GFP and immunostaining for SNAP23 with anti-SNAP 23 (1:100 dilution). In the 
merged image (D) the SNAP23-GFP plasmid is visualised in green, SNAP23 stained with 
anti-SNAP23 in red, nuclei in blue, and colocalisation of SNAP23-GFP with anti-SNAP23 
in yellow. 
 
  
  
Figure 7.3. Quantification of the 
immunostaining with anti-
wells and show a linear relationship.
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cytoplasmic fluorescence intensities of 
SNAP23. Data points are obtained from 337 cells 
 
 
SNAP23-GFP and 
in 3 replicate 
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Antibodies 
Images of the spatial distribution of SNAP23 were obtained with anti-SNAP23 (Synaptic 
Systems, Goettingen, Germany). This antibody was used in combination with others in order 
to further investigate the specific subcellular distribution of SNAP23. Mitochondria were 
visualised using anti-cytochrome c oxidase (COX) (Invitrogen, Paisley, UK). The secondary 
Alexa Fluor conjugated antibodies applied were goat anti rabbit IgG (targeting SNAP23) and 
goat anti mouse IgG2a (targeting COX). The plasma membrane of the cells was visualised 
using anti-dystrophin (Sigma Aldrich, UK). The secondary Alexa Fluor conjugated antibodies 
applied were goat anti rabbit IgG (targeting SNAP23) and goat anti mouse IgG2b (targeting 
dystrophin). Fibre type was determined using anti-myosin heavy chain type I (MHCI) 
(developed by Dr. Blau, DSHB, Iowa, USA). The secondary Alexa Fluor conjugated 
antibodies applied were goat anti rabbit IgG (targeting SNAP23) and goat anti mouse IgM
 
(targeting MHCI). IMTGs were stained using the neutral lipid dye oil red O in combination 
with immunofluorescence using the method developed by Koopman et al., (2001) as 
described previously in Chapter 2.3.1.4. 
 
Immunofluorescence Staining 
Cryosections were treated using fixation, permeabilisation and antibody application methods 
described in Chapter 2.4. For immunofluorescence staining, anti-SNAP23 was used at a 
dilution of 1:50.  
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters described 
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in Chapter 2.5 to visualise Alexa Fluor 350, 488, 594 as well as oil red O. Widefield images 
were obtained in order to examine the fibre type specificity of SNAP23 using MHCI. Digital 
images showing the distribution of SNAP23 and IMTG in longitudinally oriented and cross 
sections of muscle fibres were obtained. Detailed digital images demonstrating the cellular 
distribution of SNAP23, COX, IMTG and dystrophin were obtained using an inverted 
confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63 x oil immersion 
objective using the excitation wavelengths described in Chapter 2.5.  
 
Image Processing 
Images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). 
Lipid and mitochondria content was expressed as the area fraction stained by dividing the 
stained area in the fibre by the total area of that fibre. Colocalisation was investigated in the 
confocal microscopy images using Pearson’s correlation analysis using Image-Pro Plus 5.1 
software. An average of 14 images were investigated per participant. Each image contained 
approximately seven fibres leading to a total of 98 fibres analysed for colocalisation. The 
significance of this colocalisation was also investigated by overlaying staining of non-
matched sections and analysing these images using the same method as matched images as 
described previously by Lachmanovich et al., (2003). This enabled us to investigate whether 
the colocalisation was significantly higher in matched than non matched images.   
 
Automated Image Capture and Analysis 
The routine analysis of IMTG and mitochondria was completed using automated image 
analysis as described in detail in Chapter 2.5.2. In the widefield images obtained using 
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automated analysis a mean of 684 type I fibres were analysed and a mean of 740 type II fibres 
were analysed per participant.  
 
Automated Image Processing 
Images were analysed in detail using Definiens Cellenger software (Munich, Germany) as 
described in Chapter 2.5.3.  
 
Statistics 
Total mitochondria and total IMTG content of type I and type II fibres were compared using a 
paired samples t-test. Comparisons of both mitochondria and IMTG content was also 
compared using a paired samples t-test. The fibre type specific SNAP23 distribution was 
investigated using a paired samples t-test. Colocalisation was investigated using Pearson’s 
correlation coefficient. Statistical significance was set at P < 0.05. All data are expressed as 
mean ± SEM.  
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7.4 Results  
SNAP23 Distribution.  
Immunofluorescence staining of human skeletal muscle obtained from 6 lean individuals 
showed diffuse staining throughout the individual fibres with some more intense puncta 
stained within the cells (Figure 7.4A). Some parts of the cell border regions were also stained 
with a greater intensity than other regions of the cell (Figure 7.4A). In longitudinally oriented 
sections, SNAP23 appeared to show a regular distribution with a network like structure 
(Figure 7.4B), similar to that shown previously for mitochondria in skeletal muscle (Shaw et 
al., 2008). The staining was of similar intensity throughout both type I and type II fibres 
(Figure 7.4C) with no significant difference (type I: 57 ± 2 vs. type II: 56 ± 2, P = 0.422) in 
SNAP23 fibres positively stained as type I fibres and MHCI negative fibres. 
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Figure 7.4. SNAP23 distribution in cross sections (A) and longitudinally oriented sections (B) of human skeletal muscle. Images were 
obtained using a 63 x oil immersion objective of a confocal microscope. Bar is 30µm. There was no difference in the fluorescence intensity of 
SNAP23 between type I and type II fibres (C) where type I fibres were positively labelled with anti-MHCI.  
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SNAP23 and Dystrophin 
Immunofluorescence staining in cross sections of human skeletal muscle revealed an intense 
stain in peripheral regions of the cell. Combined staining of SNAP23 with the plasma 
membrane marker dystrophin revealed partial colocalisation (r = 0.499 ± 0.012) (Figure 
7.5A). When comparing non-matched image overlays, to determine whether the 
colocalisation was significant, an r of 0.007 ± 0.003 was obtained, implying that the 
colocalisation in the matched overlays was significant (P < 0.001) (Figure 7.6A).  
 
SNAP23 and COX 
Immunofluorescence staining of SNAP23 in cross sections of human skeletal muscle also 
showed a diffuse intracellular stain interspersed with some intense punctate staining. When 
stained in combination with the mitochondrial marker COX, it was shown that the punctate 
staining partially colocalised with mitochondria (r = 0.504 ± 0.017) (Figure 7.5B). For the 
SNAP23 and COX non matched images an r of 0.006 ± 0.005 was obtained, implying that the 
colocalisation in the matched overlays was significant (P < 0.001) (Figure 7.6B). It was also 
found that the staining intensity of the COX stain was greater in type I fibres (147 ± 7) 
compared to type II fibres (136 ± 7) (P = 0.035) (Figure 7.7A).  
182 
 
                                                    
 
Figure 7.5 Representative images showing SNAP23 colocalisation with the plasma 
membrane marker dystrophin (A), mitochondrial marker COX (B) and IMTG staining 
using oil red O (C). All images were obtained using a 63x oil objective of a confocal 
microscope. Bar = 30 µm. Mean Pearson’s correlation values are shown on the merged 
images. 
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Figure 7.6. SNAP23 colocalisation with the plasma membrane labelled with anti-
dystrophin (A), the mitochondria labelled with COX (B) and lipid droplets labelled with oil 
red O (C). Random bar represents the mean colocalisation of non matched pairs of images. 
Data are mean ± SEM. * Denotes a significant difference between matched and non 
matched images at P < 0.05. 
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Figure 7.7. Fibre type specific mitochondria intensity (A) and 
mean ± SEM. * Denotes a significant difference between fibre types (P < 0.05).
lipid droplet area fraction (B) (expressed as area fraction stained)
 
 
. Data are 
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SNAP23 and Oil Red O 
SNAP23 was also stained in combination with the neutral lipid dye oil red O in order to 
investigate its colocalisation with the intramuscular lipid droplets. SNAP23 showed a weak, 
partial colocalisation with oil red O (r = 0.201 ± 0.014) (Figure 7.5C). For the non matched 
images the mean colocalisation was r = 0.000 ± 0.003, implying that the colocalisation in the 
matched images was significant (P = 0.0001) (Figure 7.6C).   
 
Quantitative analysis of the lipid droplets revealed no difference in lipid droplet size between 
the type I (15.17 ± 0.63) and type II (16.09 ± 0.79) fibres (P = 0.086). It was however shown 
that type I lipid droplet area fraction (0.023 ± 0.002) was significantly greater than type II 
lipid droplet area fraction (0.016 ± 0.002) (P = 0.004) (Figure 7.7B).  
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7.5 Discussion 
As SNAP23 is a t-SNARE and has been proposed to play a role in the docking and fusion of 
GLUT4 vesicles into the plasma membrane (Foster et al., 1999;Kawanishi et al., 2000b), a 
high degree of colocalisation with the plasma membrane would be expected. This indeed was 
confirmed in the images (Figure 7.5), which show a partial colocalisation with the plasma 
membrane marker dystrophin. Our data are in line with results recently obtained in human 
skeletal muscle from lean individuals using widefield immunofluorescence microscopy 
(Bostrom et al., 2010). A high SNAP23 content has also been observed in the plasma 
membrane of cardiomyocytes (Bostrom et al., 2007) and in plasma membrane fractions of rat 
adipocytes (St-Denis et al., 1999). Collectively these data suggest that SNAP23 resides at the 
plasma membrane ready to enable GLUT4 docking with the membrane in the basal fasted 
state before meal ingestion or exercise both of which enhance GLUT4 docking and fusion. 
 
The hypothesis that SNAP23 is involved in the formation of lipid droplet-mitochondria 
complexes is based on recent observations in fibroblasts (Jagerstrom et al., 2009). It has been 
proposed that these complexes play a functional role in the channelling of FA liberated by 
lipolysis into the mitochondria for subsequent β-oxidation. The partial colocalisation between 
SNAP23 and the mitochondrial stain COX observed in this study has a higher Pearson’s 
correlation coefficient than the colocalisation with lipid droplets and is the first evidence in 
humans that SNAP23 may also exert this FA channelling role in human skeletal muscle in 
vivo (Figure 7.5).  
 
In conclusion, this study reveals that in the muscle of lean, healthy, moderately active men, 
SNAP23 primarily resides at the plasma membrane and in close proximity to the 
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mitochondria. A weak colocalisation was observed with the lipid droplets. These distribution 
data are in line with the previously suggested main metabolic roles of SNAP23; GLUT4 
docking in the plasma membrane and shuttling of FAs generated by lipolysis of IMTG of 
lipid droplets into the mitochondria for subsequent β-oxidation.  
 
7.6 Acknowledgements  
I would like to thank Dr Ed Ainscow (AstraZeneca, UK) for expertise and guidance in the 
running the GFP-Transfection experiment. 
I would also like to thank James Pilling (AstraZeneca, UK) for the expertise in the automated 
image acquisition and analysis using algorithms written for the Definiens software. 
 
188 
 
CHAPTER 8 
 
 
 
 
 
 
 
 
 
 
SYNAPTOSOMAL-ASSOCIATED PROTEIN 23 DISTRIBUTION IN 
AGEING NON OBESE AND OBESE FEMALES 
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8.1 Abstract 
The aim of this study was to investigate the distribution of SNAP23 in skeletal muscle of non 
obese and obese women using immunofluorescence microscopy to generate evidence for the 
hijacking hypothesis and to investigate the potential role of SNAP23 in mitochondrial FA 
oxidation. Participants were six non obese (age: 62 ± 3 years, BMI: 22.6 ± 1.4, HOMA-IR 3.9 
± 1.2) and six obese women (age: 68 ± 3 years, BMI: 33.3 ± 1.6, HOMA-IR: 6.2 ± 1.3) 
undergoing elective orthopaedic surgery. Biopsies were obtained from the m. gluteus maximus 
during hip arthroplasty. Cryosections (5µm) were stained with antibodies targeting SNAP23, 
mitochondria and the plasma membrane. Lipid droplets were visualised using oil red O. There 
was no difference in lipid droplet or mitochondria content between non obese and obese 
individuals in either type I or type II fibres. In both groups SNAP23 showed partial 
colocalisation with the plasma membrane (Pearson’s correlation non obese: r = 0.39 ± 0.01, 
obese: r = 0.37 ± 0.03, P = 0.640) and with the mitochondria with significantly more 
colocalisation with the mitochondria in the non obese women (non obese: r = 0.34 ± 0.03, 
obese: r = 0.27 ± 0.03, P=0.037). SNAP23 showed a more weak colocalisation with lipid 
droplets with no difference between groups (non obese: r = 0.12 ± 0.02, obese: r = 0.07 ± 
0.02, P = 0.277).  This study does not confirm the hypothesis that more SNAP23 hijacking 
would occur in obese than non obese elderly women as there was no difference in the 
colocalisation of SNAP23 with the lipid droplets or the plasma membrane between the 
groups. The reduced colocalisation of SNAP23 with the mitochondria in the obese women 
may suggest a target for investigation of the reduced IMTG oxidation in obesity, and for 
larger increases in the concentration of FA metabolites that have been proposed to lead to 
insulin resistance of skeletal muscle.  
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8.2 Introduction 
SNAP23 has also been proposed to play a role in lipid droplet fusion as addition of short 
interfering RNA inhibiting SNAP23, syntaxin 5 and VAMP4 led to a decrease in the rate of 
lipid droplet fusion in cardiomyocytes (Bostrom et al., 2007). Furthermore, incubation of 
cardiomyocytes with oleic acid resulted in an increase in lipid droplet fusion, the growth of 
lipid droplets and a decrease in insulin sensitivity. It was proposed that the process of lipid 
droplet fusion reduces the SNAP23 content in the plasma membrane and subsequently limits 
GLUT4 docking and inhibits insulin-mediated glucose uptake. This impairment in glucose 
uptake was overcome with SNAP23 transfection and subsequent replenishment of the plasma 
membrane SNAP23 pool (Bostrom et al., 2007). These in vitro findings led to the proposal of 
the hypothesis that fusing lipid droplets in the muscle of obese sedentary individuals and 
patients with type 2 diabetes might be able to hijack SNAP23 and thus reduce its content in 
the plasma membrane and impair GLUT4 fusion and docking (Sollner, 2007). Bostrom et al., 
(2010) generated evidence in support of the hijacking hypothesis in patients with type 2 
diabetes as, using immunofluorescence microscopy they observed a redistribution of SNAP23 
away from the plasma membrane to the cell interior (specifically, to the microsomal/cytosolic 
compartment) in comparison with results obtained in healthy, lean, insulin sensitive 
individuals.   
 
It has been known for a long time that there is close spatial contact between the phospholipid 
monolayer of the lipid droplets and the mitochondrial outer membrane (Hoppeler, 1999;Shaw 
et al., 2008) and the total contact area is known to increase following a period of exercise 
training (Tarnopolsky et al., 2007). SNAP23 has been proposed to play a role in increasing 
the efficiency of mitochondrial β-oxidation of FA by forming complexes between lipid 
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droplets and mitochondria which channel the FA derived from IMTG lipolysis into the 
mitochondria for oxidation. This suggestion is based on observations by Jagerstrom et al., 
(2009) in fibroblasts. Ablation of SNAP23 using siRNA reduced complex formation and β-
oxidation, which suggested that these lipid droplet-mitochondria complexes are functional in 
living cells (Jagerstrom et al., 2009). It may be that exercise training leads to a more efficient 
SNAP23 mediated fusion process between lipid droplets and mitochondria then it could also 
be part of the mechanism that allows trained individuals to utilise IMTG at much higher rates 
than sedentary and obese individuals (Schrauwen-Hinderling et al., 2003;Van Proeyen et al., 
2011), while simultaneously keeping the intramuscular concentration of FA metabolites low 
and therefore insulin sensitivity high. The high colocalisation between SNAP23 and 
mitochondria observed in Chapter 7 in lean, healthy, moderately trained men would be in line 
with the proposed role of SNAP23 in establishing these functional lipid droplet-mitochondria 
complexes. 
 
This study had two main aims. The first aim was to investigate the hypothesis that SNAP23 
hijacking by lipid droplets is more pronounced in obese ageing women than in age-matched 
non obese controls and leads to a larger reduction in the colocalisation of SNAP23 with the 
plasma membrane. The second aim was to investigate the hypothesis that SNAP23 
colocalisation with the mitochondria is lower in the obese ageing women than in age-matched 
non obese controls. Both of these mechanisms might lead to larger impairments in glucose 
tolerance and insulin sensitivity in the obese women. In order to investigate these hypotheses 
the methods described in Chapter 7 will be applied to percutaneous muscle biopsies of obese 
and non obese women to measure colocalisation of SNAP23 with lipid droplets, the plasma 
membrane and mitochondria. 
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8.3 Methods 
Muscle Samples 
Percutaneous muscle biopsies were obtained from the m. gluteus maximus of six non obese 
women and six obese women during elective orthopaedic surgery. Subject characteristics can 
be seen in Table 8.1. All participants were undergoing total hip arthroplasty at Russells Hall 
Hospital (Dudley Group of Hospitals) and gave their informed consent for participation in this 
study. The study was approved by the local NHS Research Ethics Committee. An ~ 300mg 
muscle biopsy was taken by Consultant Surgeon, Mr. Edward Davis immediately following 
the initial incision.  
 
Table 8.1 Subject Characteristics 
 
Non Obese Females Obese Females 
n 
Age (y) 
Height (m) 
Body Mass (kg) 
Body Mass Index (BMI) (kg/m2) 
Fasting plasma glucose (mmol/L) 
Fasting serum insulin (µU/ml) 
HOMA IR 
6 
62 ± 3 
1.59 ± 0.03 
57.4 ± 4.5 
22.6 ± 1.4 
6.98 ± 0.36 
11.91 ± 3.23 
3.92 ± 1.15 
6 
68 ± 3 
1.60 ± 0.03 
85.1 ± 4.7* 
33.3 ± 1.6* 
6.32 ± 0.36 
21.53 ± 4.04 
6.19 ± 1.25 
Data are presented as means ± SEM. * P < 0.05 
 
Samples were prepared and stored at -80 °C as described previously in Chapter 2.2. For 
immunofluorescence analysis, cryosections (5 µm) were cut using a microtome (Bright 
Instrument Company Limited, Huntingdon, England).  
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Blood Analyses 
Following anaesthesia, blood was collected into two vacutainers, one containing EDTA (for 
plasma). Blood samples were centrifuged at 3,500 rpm for 15 min at 4°C. Aliquots of serum 
and plasma were then frozen and stored at −80°C until later analysis. Plasma glucose 
concentration was analyzed using an ILAB automated analyzer (Instrumentation Laboratory, 
Cheshire, UK). Serum insulin concentrations were measured using ELISA (Invitrogen, 
Paisley, UK). 
 
Antibodies 
The antibodies used in this study are the same as those used in Chapter 7. Each antibody used 
is detailed in Chapter 7.3. Details of SNAP23 antibody validation procedures can also be 
found in Chapter 7.3. 
 
Immunofluorescence Staining 
Cryosections were stained using methods described in Chapter 2.4. Identical methods to those 
used in this chapter can be found in Chapter 7.3.  
 
Fluorescence Microscopy 
Images were captured using a Nikon E600 microscope coupled to a SPOT RT KE colour 3 
shot CCD camera (Diagnostic instruments Inc, MI, USA) using the excitation filters described 
in Chapter 2.5 and 7.3. For colocalisation analyses, detailed digital images were captured 
using an inverted confocal microscope (Leica DMIRE2, Leica Microsystems) as described in 
Chapter 2.5 and 7.3.  
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Image Processing 
Image processing was completed in this Chapter using methods identical to Chapter 7. For 
details of lipid and mitochondrial image processing and colocalisation analyses see Chapter 
7.3.  
 
Automated Image Capture and Analysis 
Details of automated image capture and analysis can be found in Chapter 2.5.2 and 7.3. 
Automated image analysis was used for fluorescence intensity, lipid and mitochondria 
analysis.  Images were captured with widefield microscopy using a 40 x oil objective.  
 
Automated Image Processing 
Details of automated image processing using Definiens Cellenger software (Munich, 
Germany) can be found in Chapter 2.5.3 and 7.3.  
 
Statistics 
The total IMTG content (expressed as area fraction stained) and the total mitochondria area 
fraction and intensity of type I and type II fibres were compared using an independent 
samples t-test. Between group differences in IMTG content and mitochondrial content and 
intensity were also investigated using an independent samples t-test. Colocalisation of 
SNAP23 with lipid droplets, plasma membrane and mitochondria was investigated using 
Pearson’s correlation coefficient. Statistical significance was set at P < 0.05. All data are 
expressed as mean ± SEM.  
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8.4 Results 
Non obese and obese women were recruited with significantly different body mass and BMI 
(48 % and 47 % higher respectively in the obese group) (Table 8.1). However, the groups 
were not significantly different in their fasting plasma glucose and serum insulin 
concentrations nor insulin resistance as assessed by HOMA-IR (Table 8.1). 
 
The overall staining patterns of SNAP23 appeared to be similar in both the non obese and 
obese individuals. The distribution of SNAP23 showed a diffuse stain throughout the fibres, 
some of which were speckled with some more intense punctate signal. Interestingly in some 
fibres, there appeared to be a strong, diffuse stain of SNAP23, far stronger than that observed 
in the ‘speckled’ fibres however this particular distribution was not present in every section 
examined. There was no difference between the groups in the detection of these bright fibres 
(P > 0.05). Of the fibres examined, the intense staining was detected in 17 ± 7 % of fibres 
investigated in non obese individuals whereas in obese individuals the intense staining was 
detected in 25 ± 4 % of fibres examined. There was also an intense stain in peripheral regions 
of the cell.  
 
Cell area was greater in type I fibres compared to type II fibres in non obese individuals (type 
I: 12580.16 ± 804.77 µm2 vs. type II: 11135.17 ± 643.35 µm2, P = 0.05) however this 
relationship only tended towards significance in the obese individuals (type I: 12569.44 
±756.15 µm2 vs. type II: 11354.95 ± 758.56 µm2, P = 0.07). There was no difference in cell 
area between the groups in either type I or type II fibres (P > 0.05).  
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SNAP23 and Dystrophin 
In both non obese and obese individuals, SNAP23 showed a strong stain in some regions at 
the cell borders (Figure 8.1A and 8.1B). SNAP23 was stained in combination with anti-
dystrophin to determine its colocalisation with the plasma membrane. In skeletal muscle of 
non obese women, SNAP23 partially colocalised with the plasma membrane marker 
dystrophin (r = 0.387 ± 0.014) (Figure 8.1A and 8.1C). A similar degree of colocalisation was 
seen in skeletal muscle obtained from obese women (r = 0.368 ± 0.029) (P = 0.643) (Figure 
8.1B and 8.1C). Both of these values were significantly higher (P = 0.001) than the 
colocalisation seen in non matched pairs of images (non obese r = 0.004 ± 0.004 and obese r = 
0.003 ± 0.004) (Figure 8.1C). 
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Figure 8.1. Representative images showing colocalisation of SNAP23 with the plasma 
membrane (stained using anti-dystrophin) in skeletal muscle of non obese women (A) and 
obese women (B). Bar is 30 µm. Pearson’s correlation coefficients are shown in panel C.   
* Denotes a significant difference between matched and non matched images at P < 0.05. 
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SNAP23 and COX 
In both the non obese and obese women, immunofluorescence staining of SNAP23 showed a 
diffuse intracellular stain interspersed with more intense punctate staining. When stained in 
combination with the mitochondrial marker COX, it was shown that the punctate staining 
partially colocalised with mitochondria. Mitochondrial staining showed similar images to 
those shown in an earlier publication from our laboratory (Shaw et al., 2008), with a punctate 
appearance that was more dense in the peripheral regions of the cell (Figure 8.2A and 8.2B). 
In skeletal muscle obtained from non obese women, SNAP23 partially colocalised with 
mitochondria (r = 0.344 ± 0.030) (Figure 8.2A and 8.2C). This value was significantly greater 
than the colocalisation occurring in non-matched images (r = 0.015 ± 0.002, P = 0.0001) 
(Figure 8.2C). In the skeletal muscle obtained from obese women, SNAP23 also partially 
colocalised with mitochondria (r = 0.265 ± 0.027) (Figure 8.2B and 8.2C) which was again 
significantly greater than the colocalisation of non matched images (r = 0.006 ± 0.005, P = 
0.0002) (Figure 8.2C). The degree of colocalisation between SNAP23 and mitochondria in 
the skeletal muscle of the non obese women was significantly greater than of the obese 
women (non obese: r = 0.344 ± 0.030 vs. obese: r = 0.265 ± 0.027, P = 0.037).  
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Figure 8.2. Representative images showing colocalisation of SNAP23 with mitochondria 
(stained with anti-COX) in skeletal muscle of non obese women (A) and obese women (B). 
Bar is 30 µm. Pearson’s correlation coefficients are shown in panel C. * Denotes a 
significant difference between matched and non matched images at P < 0.05. # Denotes a 
significant difference between obese and non obese individuals at P < 0.05.  
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When examining fibre type differences in mitochondrial intensity, it was found that there was 
no difference between non obese and obese individuals in mitochondrial intensity in type I 
fibres (non obese: 98 ± 13 vs. obese: 87 ± 11, P = 0.545) or type II fibres (non obese: 80 ± 10 
vs. obese: 75 ± 9, P = 0.698) (Figure 8.3A). However there was a fibre type difference in 
mitochondrial intensity in both the non obese (P = 0.01) and obese (P = 0.02) individuals 
with a greater intensity measured in type I fibres compared to type II fibres (Figure 8.3A). 
These findings were also similar for mitochondrial area fraction, with no difference between 
groups in either type I (non obese: 0.127 ± 0.03 vs. obese: 0.109 ± 0.02, P = 0.633) or type II 
fibres (non obese: 0.090 ± 0.02 vs. obese: 0.069 ± 0.01, P = 0.428) (Figure 8.3B). However 
both groups did show a greater mitochondrial content (expressed as mitochondria area 
fraction) in type I fibres compared to type II fibres (non obese: P = 0.02; obese: P = 0.02) 
(Figure 8.3B). 
  
  
 
Figure 8.3. Mitochondrial 
represent mean values for non obese participants and white bars represent mean values for 
obese participants. Mitochondria intensity (A) 
greater in type I than in type II 
mean ± SEM. * Denotes a significan
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and mitochondria area fraction (B) were
fibres in both non obese and obese individuals. Values are 
t difference compared to type II fibres
 
 
. Black bars 
 
 (P < 0.05).   
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SNAP23 and IMTG 
In both the non obese and obese individuals, the IMTG were stained using the neutral lipid 
dye oil red O and the distribution showed a number of small droplets distributed through the 
fibres. There was more intense staining in some fibres compared to others and in both the non 
obese and obese individuals, there were some larger lipid droplets present in addition to the 
smaller droplets (Figure 8.4A and 8.4B). In skeletal muscle obtained from non obese women, 
SNAP23 showed a weak colocalisation with lipid droplets (r = 0.105 ± 0.019) (Figure 8.4A 
and 8.4C). This value was significantly greater than the colocalisation in non matched pairs 
of images (r = 0.001 ± 0.004, P = 0.003) (Figure 8.4C). In the skeletal muscle obtained from 
obese women, SNAP23 also showed a weak colocalisation with lipid droplets (r = 0.073 ± 
0.021) (Figure 8.4 B and 8.4C) which was again significantly greater than the colocalisation 
of non matched images (r = -0.001 ± 0.002, P = 0.012) (Figure 8.4C). There was no 
difference in the degree of colocalisation in the skeletal muscle of the non obese women 
compared to the obese women (non obese: r = 0.105 ± 0.019 vs. obese: r = 0.073 ± 0.021, P = 
0.645). 
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Figure 8.4. Representative images showing colocalisation of SNAP23 with IMTG (stained 
with oil red O) in skeletal muscle of non obese women (A) and obese women (B). Bar is 30 
µm. Pearson’s correlation coefficients are shown in panel C.* Denotes a significant 
difference between matched and non matched images at P < 0.05.  
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When examining fibre type differences in IMTG, there was also no difference reported in 
lipid droplet area fraction in type I fibres (non obese: 0.034 ± 0.006 vs. obese: 0.034 ± 0.007, 
P = 0.977) or type II fibres (non obese: 0.020 ± 0.002 vs. obese: 0.020 ± 0.005, P = 0.991) 
between the non obese and obese individuals (Figure 8.5A). However, there was a fibre type 
difference in lipid droplet area fraction in both the non obese (type I fibres: 0.034 ± 0.006 vs. 
type II fibres: 0.020 ± 0.002, P = 0.03) and obese individuals (type I fibres: 0.034 ± 0.007 vs. 
type II fibres: 0.020 ± 0.005, P = 0.01) (Figure 8.5A).  It was also found that there was no 
difference in lipid droplet size between the non obese and obese individuals (0.72 ±  0.04 µm2 
vs. 0.82 ± 0.08 µm2, P = 0.29) (Figure 8.5B). 
 
                                                            
 Figure 8.5. Lipid parameters in non 
represent mean values for non obese participants and white bars represent mean values for 
obese participants. Lipid droplet area fraction (
type II fibres in both non o
different between non obese and obese individuals.
significant difference compared to 
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A) was greater in type I fibres compared to 
bese and obese individuals. Lipid droplet size (
 Values are mean ± SEM. * 
type II fibres at P < 0.05.   
 
 
B) was not 
Denotes a 
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8.5 Discussion 
The results of this study did not confirm the hypothesis that SNAP23 hijacking by lipid 
droplets would be more pronounced in obese, ageing women than in age-matched non obese 
controls and would lead to a larger reduction in the colocalisation of SNAP23 with the plasma 
membrane. In fact, there was no difference in the colocalisation of SNAP23 with either the 
plasma membrane or with lipid droplets between the non obese and obese women. The 
results, on the other hand, did confirm the hypothesis that SNAP23 colocalisation with the 
mitochondria would be lower in the obese, ageing women than in age-matched non obese 
controls. 
 
The main limitation of the present study was that the individuals in both groups were inactive 
as they were awaiting orthopaedic surgery. It is possible that this inactivity may therefore 
negate any changes which may otherwise have been seen due to obesity. Perhaps the most 
surprising finding of this study was that there was no difference between the non obese and 
obese elderly women in the lipid droplet area fraction and size of the lipid droplets. Many 
previous studies, primarily in younger individuals, have shown that there are increased 
concentrations of plasma FA and TAG in obese individuals and a higher FA flux from the 
enlarged adipose tissue stores to skeletal muscle (Opie & Walfish, 1963;Frayn, 
2002;Mittendorfer et al., 2009). This would predict that more and potentially larger lipid 
droplets would accumulate in the muscle of obese individuals. More of the lipid droplets 
could also be expected to be in the active fusing stage, which requires the presence of 
SNAP23. Larger lipid droplets have indeed been observed in obese and obese type 2 diabetes 
patients compared to lean individuals in previous studies (He et al., 2004). There, however, 
also are a number of other studies that fail to observe an elevated IMTG content in obese 
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and/or type 2 diabetic compared to age-matched controls (Goodpaster et al., 2001;van Loon et 
al., 2004;Meex et al., 2010;Bostrom et al., 2010).  
 
As has been discussed previously in Chapter 5.5 of this thesis, the difference between the 
earlier studies and our study is that most of these studies involved younger men and women, 
who most likely were more active, and that in several cases a comparison was made between 
obese and truely lean individuals. The women recruited to our study were older (mean age 65) 
and as the women in both groups were scheduled for orthopaedic surgery they were very 
inactive with many only able to walk using crutches or a frame. A small number were even 
restricted to a wheelchair whilst they awaited the surgery. It is well known that normal ageing 
in non obese individuals is also associated with muscle lipid accumulation (Nakagawa et al., 
2007;Crane et al., 2010). The non obese elderly women in our study are representative for an 
elderly sedentary UK population and despite the BMI of 22.6 they cannot be qualified as lean 
and are likely to combine a significant fat mass with a low muscle mass. This may well be the 
reason that the two groups had a similar lipid droplet area fraction, lipid droplet size and also 
similar mitochondrial area fraction and intensity, despite a massive difference in body mass. 
This is probably also the reason that both groups had reduced insulin sensitivity and that there 
was no significant difference between the two groups in plasma glucose, serum insulin and 
the HOMA-IR score (Table 8.1). The latter is in part due to the fact that the non obese group 
does not have an optimal insulin sensitivity and in part due to the fact that the study is 
underpowered. A retrospective power calculation has shown that at least 10 subjects per 
group would be required to obtain a significant difference in the HOMA-IR score (calculation 
conducted using G Power (Erdfelder et al., 1996)).  
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The data in this study did not confirm the hypothesis that SNAP23 hijacking by lipid droplets 
occurs in obese and inactive ageing women however in a direct comparison between the 
obese group and an age-matched lean but physically active group the conclusion might well 
be different. This in fact may also be the reason that Bostrom et al., (2010) found evidence of 
a redistribution of SNAP23 from the plasma membrane to the microsomal/cytosolic 
compartment in a comparison between patients with type diabetes and lean (potentially more 
physically active) controls. Unfortunately Bostrom et al., (2010) did not present the results 
from a BMI-matched control group.   
 
SNAP23 primarily resides at the plasma membrane and at the mitochondria, while a weaker 
colocalisation was observed with the lipid droplets (also seen in Chapter 7). This implies that 
the results of Bostrom et al., (2010) of an increased SNAP23 content in the 
microsomal/cytosolic compartment need to be reevaluated and split into the amount present in 
lipid droplets and in the mitochondria before it can be concluded that it is the lipid droplets 
that hijack SNAP23. 
 
The results of this study show that there is a significant reduction in colocalisation of 
SNAP23 with the mitochondria in the obese individuals in comparison with the non obese 
individuals. This observation is important given the role that has been proposed for SNAP23 
associated with the mitochondria discussed in Chapter 7.5. Reduced colocalisation of 
SNAP23 with the mitochondria of the obese women would imply that more FA would escape 
from mitochondrial β-oxidation and this would then lead to higher cytosolic concentrations of 
long-chain fatty acyl CoA, diacylglycerol and ceramides in the muscle of the obese than the 
non obese women. These fatty acid metabolites have been proposed to lead to insulin 
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resistance in skeletal muscle (see Introduction section 1.3) via a mechanism that involves 
activation of PKC and IRS-1 serine phosphorylation. Impairment of the formation of these 
lipid droplet-mitochondria complexes most likely also reduces lipolysis of the IMTG and may 
provide a mechanism for the very low IMTG oxidation rates that have been observed during 
bouts of endurance exercise in obese, sedentary individuals and patients with type 2 diabetes 
(Blaak et al., 2000;Borghouts et al., 2002;van Loon et al., 2005).  
 
In summary, there was no difference in this study in the colocalisation of SNAP23 with either 
the plasma membrane or lipid droplets between obese and non obese elderly women. 
Therefore, the data generated do not support the hypothesis that obesity in elderly women 
leads to impaired glucose tolerance and insulin sensitivity via a mechanism that involves 
hijacking of SNAP23 by lipid droplets. However, there was a significant reduction in the 
colocalisation of SNAP23 with the mitochondria in the obese women in comparison to non 
obese controls. This may lead to an increased escape of FA generated by IMTG lipolysis from 
mitochondrial β-oxidation, cytosolic accumulation of FA metabolites, skeletal muscle insulin 
resistance and a decreased capacity to oxidise IMTG during endurance exercise. 
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CHAPTER 9 
 
 
 
 
 
 
 
 
 
 
GENERAL DISCUSSION 
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9.1 Introduction 
Impairments in intramuscular triglyceride (IMTG) turnover in skeletal muscle have been 
proposed to be important for the development of insulin resistance. A reduced ability to use 
IMTG during exercise and low IMTG resynthesis rates following exercise are seen in 
sedentary and obese individuals and patients with type 2 diabetes, and may be the cause of the 
accumulation of fatty acid (FA) metabolites that lead to insulin resistance. Acute bouts of 
exercise and long-term training interventions have lead to increased protein expression of 
lipogenic and lipolytic enzymes in skeletal muscle of humans (Schenk et al., 2005;Schenk & 
Horowitz, 2007;Thrush et al., 2009;Newsom et al., 2010;Bergman et al., 2010;Jocken et al., 
2010;Li et al., 2011). Exercise also leads to increased IMTG resynthesis and turnover rates 
and offers protection against skeletal muscle insulin resistance induced by acute lipid-heparin 
infusions. As the understanding of the underlying mechanisms was incomplete at the start of 
this PhD work, the aim of this thesis was to further current knowledge via the development of 
novel immunofluorescence microscopy methods, which are able to reveal the spatial 
distribution of these enzymes in skeletal muscle fibres, their colocalisation with lipid droplets, 
mitochondria and membranes and differences between fibre types. After development of these 
methods in biopsies of lean trained or moderately active men, this thesis specifically aimed to 
investigate if there were differences between non obese and obese elderly women that might 
explain the increased insulin resistance of the skeletal muscle of the obese women. A further 
aim was to investigate whether the recently proposed SNAP23 hijacking hypothesis (Sollner, 
2007) observed in cultured cardiomyocytes also operates in human skeletal muscle of obese 
women in vivo. Immunofluorescence microscopy has been used to investigate whether 
hijacking of SNAP23 by fusing lipid droplets would reduce the content of SNAP23 in the 
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plasma membrane and whether this leads to a lower SNAP23 plasma membrane content in the 
muscle of obese than of non obese elderly women.  
 
9.2 Summary of the novel findings of this thesis 
9.2.1 IMTG Synthesis 
In Chapter 3, GPAT1, the enzyme responsible for the first committed step of IMTG synthesis, 
was visualised in skeletal muscle and was shown to have a fibre type specific distribution 
with higher concentrations in type I compared to type II fibres. As GPAT1, on the basis of its 
presence in rat liver mitochondria, has been given the name mitochondrial GPAT it came as a 
surprise that it did not colocalise with the mitochondria in human skeletal muscle taken in the 
overnight fasted state. Instead GPAT1 appeared to reside at regular locations in the 
mitochondrial network in close proximity to, but not colocalising with, the mitochondria. In 
Chapter 4, DGAT1 distribution was investigated. DGAT1 is the enzyme responsible for the 
final step in triglyceride synthesis, which is the conversion of diacylglycerol (DAG) and long 
chain fatty acyl CoA (LCFACoA) to IMTG. DGAT1 showed a diffuse cytoplasmic staining 
in cross sections and a striated distribution in longitudinally oriented sections. There were also 
some intense spots of staining in the cells. DGAT1 also showed a greater content in oxidative 
type I fibres, which are the muscle fibres with the greatest lipid content (Malenfant et al., 
2001;van Loon et al., 2001). Chapter 5 showed that the distribution of GPAT1 and DGAT1 
did not differ between non obese and obese elderly women. GPAT1 also did not colocalise 
with mitochondria and lipid droplets in these groups.   
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9.2.2 IMTG hydrolysis 
In Chapter 6 of this thesis the distribution of ATGL and CGI-58 was investigated using 
immunofluorescence microscopy in healthy, lean, moderately active males. It was found that 
neither ATGL nor CGI-58 colocalised with lipid droplets in muscle biopsies taken in the 
fasted, resting state. ATGL was distributed in a fibre type specific manner with higher 
concentrations in type I fibres, however, CGI-58 was not.  
 
9.2.3 SNARE Proteins 
Chapter 7 details the distribution of SNAP23 in the muscle of healthy, lean, moderately active 
men. A diffuse distribution was observed which was speckled with more intense staining. 
This speckled staining colocalised with the mitochondrial stain anti-cytochrome c oxidase. 
This is the first time that colocalisation of SNAP23 and mitochondria has been observed in 
images of human skeletal muscle. Intense staining of SNAP23 was also observed at the 
plasma membrane with a high degree of colocalisation with the plasma membrane marker 
dystrophin in lean, moderately active males. This again is the first visualisation of this 
colocalisation in human muscle. A low colocalisation was observed for SNAP23 with lipid 
droplets stained with oil red O.  
 
As a continuation of this work, thesubcellular distribution of SNAP23 in skeletal muscle 
samples obtained from non obese and obese elderly women was compared in Chapter 8. The 
images showed that there was a reduced colocalisation of SNAP23 with the mitochondria in 
the obese compared to the non obese women, whereas the degree of SNAP23 colocalisation 
with both the plasma membrane and the lipid droplets was the same between the two groups. 
The data also showed that in both groups the highest Pearson correlation coefficient was 
214 
 
observed for SNAP23 and the plasma membrane marker dystrophin, followed by SNAP23 
colocalisation with the mitochondria and relatively low Pearson’s correlation coefficients for 
SNAP23 and lipid droplets stained with oil red O.  
 
9.3 Findings in the context of existing literature 
9.3.1 IMTG Synthesis 
Chapters 3 and 4 of this thesis provide a description of robust methods by which to investigate 
the distribution of the lipogenic enzymes GPAT1 and DGAT1 in human skeletal muscle. The 
data presented in Chapters 3 and 5 provide new evidence that GPAT1 is not localised at the 
mitochondrial outer membrane in human skeletal muscle in the overnight fasted state, but is 
instead localised in close proximity to the mitochondria, probably at sites in the endoplasmic 
reticulum (ER) with small growing lipid droplets. Earlier work in rat liver mitochondria 
(Lewin et al., 2004) suggested that GPAT1 is present in the outer mitochondrial membrane 
and therefore the enzyme was named mitochondrial GPAT. The present observations on the 
localisation of GPAT1 in human skeletal muscle are in line with a more recent study by 
Pellon-Maison and colleagues (2007) which found that the majority of the GPAT1 protein in 
rat liver mitochondria was found in mitochondria associated vesicles, which are assumed to 
be part of the ER (Lebiedzinska et al., 2009), rather than in the mitochondrial outer 
membrane. Future studies should investigate whether GPAT1 translocates to the mitochondria 
outer membrane in human skeletal muscle in conditions that lead to activation of IMTG 
synthesis, such as in the period after endurance exercise and ingestion of lipid containing 
mixed meals.  
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The data presented in Chapter 5 shows that there is no difference in the content of GPAT1 and 
DGAT1 in non obese and obese elderly women. This is in agreement with previous human 
studies using Western blots to measure the whole muscle protein content of these enzymes 
(Thrush et al., 2009;Li et al., 2011). The aim of the study in Chapter 5 also was to investigate 
if there were differences in the spatial distribution of GPAT1 and DGAT1 between the two 
groups. A recent study has provided evidence that higher DAG concentrations occur in the 
plasma membrane fraction of obese men with and without type 2 diabetes than in athletes, and 
that this explained the increased insulin resistance in the obese group (Bergman et al., 2012). 
On the basis of this observation, it was hypothesised that a lower content of GPAT1 and 
DGAT1 in subsarcolemmal areas in the obese women might lead to higher FA metabolites, 
but this hypothesis was not confirmed as there was no difference between the two groups both 
in total protein content and subcellular distribution.  
 
9.3.2 IMTG Hydrolysis 
Chapter 6 of this thesis developed methods by which to investigate the total protein content 
and spatial distribution of ATGL and CGI-58 in skeletal muscle of lean humans and the 
potential difference between fibre types. This study showed that ATGL was distributed in a 
fibre type specific manner with higher concentrations in type I fibres, however the CGI-58 
protein content did not differ between fibre types. A potential reason for the absence of a 
difference in CGI-58 content between fibre types is that there is substantial evidence that 
CGI-58 is also involved in alternative metabolic  processes such as the acylation of LPA 
(Ghosh et al., 2008;Montero-Moran et al., 2010) and the channelling of FA into 
phospholipids (Montero-Moran et al., 2010). Such processes may well have similar metabolic 
capacity requirements in type I and type II fibres.  
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9.3.3 SNARE Proteins 
Pearson’s correlation coefficients are a recognised quantitative measure of colocalisation of 
matched immunofluorescence images. The highest Pearson’s correlation coefficients (r = 0.50 
± 0.01 in lean active males, r = 0.39 ± 0.01 in non obese women and r = 0.37 ± 0.03 in obese 
elderly women) were observed for colocalisation between SNAP23 and dystrophin (as a 
marker of the plasma membrane). This observation is in line with the proposed role of 
SNAP23 in the docking and fusion of GLUT4 with the plasma membrane (Foster et al., 
1999;Kawanishi et al., 2000a).  
 
Relatively high Pearson’s correlation coefficients were also found for colocalisation of 
SNAP23 and the mitochondrial marker COX (r = 0.50 ± 0.02 in lean active males, r = 0.34 ± 
0.03 in non obese women and r = 0.27 ± 0.03 in obese women). This observation is in line 
with the recent work of Jagerstrom and colleagues (2009) who observed colocalisation of 
SNAP23 and mitochondria in fibroblasts. This observation has led to the hypothesis that 
SNAP23 is involved in the formation of lipid droplet-mitochondria complexes. It has been 
proposed that these complexes play a functional role in the channelling of FA liberated by 
lipolysis of IMTG present in lipid droplets into the mitochondria for subsequent β-oxidation. 
The partial colocalisation between SNAP23 and the mitochondrial stain COX observed in 
Chapters 7 and 8 provides the first evidence in humans that SNAP23 may also exert this FA 
channelling role in human skeletal muscle in vivo. Further, the findings of Chapter 8 show 
that this colocalisation of SNAP23 with the mitochondria is lower in the obese than in the non 
obese elderly women, potentially leading to less efficient channelling of FA into the 
mitochondria for oxidation and higher levels of FA metabolites in skeletal muscle. This 
therefore may explain the greater insulin resistance in the obese than in the non obese women.  
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The lowest Pearson’s correlation coefficients were actually observed for SNAP23 and lipid 
droplets stained with oil red O (r = 0.20 ± 0.01 in lean active males, r = 0.11 ± 0.02 in non 
obese women and r = 0.07 ± 0.02 in obese elderly women). This observation was unexpected 
as the aim of the study was to investigate whether the lipid droplets were a main location of 
SNAP23, especially in the obese women, and whether hijacking of SNAP23 by the lipid 
droplets in fact reduced the SNAP23 content of the plasma membrane, thus preventing 
GLUT4 docking and fusion. This expectation was based on the observation of Bostrom et al., 
(2010) which showed a redistribution of SNAP23 from the plasma membrane regions to the 
microsomal/cytosolic regions of the muscle fibres in type 2 diabetic patients. However, the 
data in Chapter 8 convincingly show that there was no difference in the colocalisation of 
SNAP23 with either the plasma membrane or the lipid droplets between the obese and non 
obese group. These data, therefore, do not support that the hijacking hypothesis (Sollner, 
2007), which was based on research in cultured cardiomyocytes (Bostrom et al., 2007), 
operates and contributes more to muscle insulin resistance in obese than non obese elderly 
women with low habitual physical activity levels.  
 
9.4 Suggestions for future studies 
9.4.1 Gaps in current knowledge about IMTG metabolism 
Most of the studies that have investigated the role of IMTG content and use as a fuel during 
exercise have been executed in male individuals. However, the few studies that have been 
executed in women have shown large gender differences (Kiens, 2006;Haugaard et al., 
2009;Moro et al., 2009;Perreault et al., 2010). Therefore a systematic evaluation of IMTG 
content, IMTG use during exercise, mitochondrial density, as well as all of the assays 
described in this thesis are needed in five groups of both male and female participants; 1) lean 
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sedentary, 2) obese sedentary, 3) obese type 2 diabetes patients, 4) lean habitually active 
individuals, and 5) highly trained individuals. As age, BMI and habitual physical activity are 
main determinants of IMTG turnover and insulin sensitivity, the use of properly matched 
control groups is of crucial importance. To be optimally informative the results in these group 
comparisons should be related to total skeletal muscle levels of FA metabolites, levels of 
subspecies of FA metabolites and the subcellular distribution of these FA metabolites as the 
FA metabolites are the strongest predictors of  insulin resistance in human skeletal muscle 
(Bergman et al., 2012).  
 
Differences in the total protein content of GPAT1 and DGAT1 and in the gradients in the 
protein concentration of these enzymes between the indicated groups could generate novel 
information on the mechanisms by which FA metabolites accumulate in the muscle and lead 
to the large range in insulin sensitivity between these groups. In situ measurements of the 
activity of GPAT1 and DGAT1 would be the ultimate aim of this type of research, but are not 
yet possible. As the work in Chapter 5 revealed no difference in the spatial distribution of 
GPAT1 and DGAT1 between non obese and obese women and also in the COX content as a 
marker of mitochondrial density, it may be that the increased FA uptake that has previously 
been observed in obesity (Bonen et al., 2004), cannot be matched by IMTG synthesis and 
mitochondrial β-oxidation rates. It may be this mismatch that leads to accumulation of FA 
metabolites. Future studies comparing lipid metabolism in different groups in muscle biopsies 
should, therefore, also be complemented by measurements of whole body lipolysis rates using 
stable isotope methodologies and the arterial extraction of FA and glycerol using limb 
arteriovenous difference measurements. 
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In studies investigating the SNAP23 hijacking hypothesis it would be important to also 
measure total SNAP23 content in skeletal muscle. It should be noted that in the non obese and 
obese elderly women the Pearson’s correlation was lower than in the lean, moderately active 
younger men at all three sites (plasma membrane, mitochondria and lipid droplets). This could 
imply that the total amount of SNAP23 is reduced and that the risk of a shortage of SNAP23 
at the plasma membrane is lower in young, moderately active men than in obese and non 
obese elderly women. Again, such information would be required in gender-matched groups 
as well, as there also may be a difference between genders and between young and old as 
suggested above. A very important unanswered question is the amount of SNAP23, or the 
degree of colocalisation with the plasma membrane, that is required to allow maximal rates of 
GLUT4 docking and fusion in response to meal induced increases in insulin and contraction 
induced GLUT4 translocation. Without such knowledge it will be difficult to determine 
whether a redistribution of SNAP23 to sites other than the plasma membrane might lead to a 
functional shortage of SNAP23 in the plasma membrane. In the first instance, this of course 
also would require the development of an immunofluorescence method to visualise GLUT4 in 
human skeletal muscle, which is further reflected upon in section 9.4.2. 
 
The lipid droplet-mitochondria interactions reported by Jagerstrom et al., (2009) may be an 
essential part of the mechanism that allows trained athletes to oxidise IMTG at high rates 
without developing high levels of FA in their muscles, and therefore may be part of the 
metabolic adaptation in highly trained athletes behind the 'athletes paradox' (Goodpaster et al., 
2001;van Loon et al., 2004). Following a discussion regarding the potential molecular 
mechanism behind this interaction with the late Professor Sven Olof Olofsson, it was 
hypothesised that the mechanism may involve the fusion of the lipid monolayer of the lipid 
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droplets with the outer layer of the lipid bilayer of the mitochondrial outer membrane. Such a 
functional fusion would channel FA released by the lipid droplets directly to LCFACoA 
synthase and, via the carnitine shuttle system of the mitochondria, into the mitochondrial 
matrix and β-oxidation. This functional interaction would prevent FA generated by IMTG 
lipolysis and LCFACoA from entering the cytosol and thus reduce the cytosolic levels of FA 
metabolites (LCFACoA, DAG and ceramides), which have been implicated in the 
mechanisms that lead to IRS-1 serine phosphorylation and insulin resistance in skeletal 
muscle (Ellis et al., 2000;Itani et al., 2002). 
 
9.4.2 The need for a GLUT-4 translocation assay in humans skeletal  
Surprisingly little research has been performed in humans to investigate the spatial 
distribution and translocation of GLUT4, the ultimate target and endpoint of the insulin 
signalling cascade, with immunofluorescence microscopy methods. The distribution of 
GLUT4 has been examined in skeletal muscle of animal models (Wang et al., 1996;Ploug et 
al., 1998;Hansen et al., 1998;Lauritzen et al., 2006;Lauritzen et al., 2008b;Lauritzen & 
Schertzer, 2010;Lauritzen et al., 2010) and in cultured adipocytes (Bai et al., 2007). However 
research in human skeletal muscle is, to the best of our knowledge, limited to published 
abstracts. The t-tubules, in mice at least, appear to be the most important target of GLUT4 
fusion and docking (Lauritzen et al., 2006). Upon insulin stimulation of mouse muscles in 
vivo, it has been shown that there is a delay of approximately 10 minutes in the appearance of 
GLUT4 in the t-tubules compared to the sarcolemma (Lauritzen et al., 2006). It is very 
important that this research is extended to man to thus generate a better understanding of the 
mechanisms behind the glucose uptake kinetics in human skeletal muscle after oral glucose or 
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mixed meal ingestion and after the start of a hyperinsulinaemic euglycaemic clamp and of the 
differences in glucose uptake kinetics between the groups mentioned in 9.4.1.  
 
It has also been suggested that high fat feeding leads to a further delay in GLUT4 
translocation to the t-tubules and contributes to the reduced insulin action and insulin 
signalling (Lauritzen et al., 2008a). Experiments in obese individuals and patients with type 2 
diabetes should determine if a delay in GLUT4 translocation to plasma and t-tubular 
membranes contributes to the process known as metabolic inflexibility (Storlien et al., 2004), 
which is the slower switching from fat as the main fuel in the fasted state to glucose as the 
main fuel after ingestion of a carbohydrate containing meal and vice versa. Metabolic 
inflexibility is seen as an early indicator of the development of the metabolic syndrome and 
again impairments in lipid metabolism play an important role in it, but the underlying 
mechanisms in the muscle are poorly understood. Ideally, in such studies GLUT4 
colocalisation with SNAP23 (due to its role in GLUT4 docking in the plasma membrane) 
should be investigated and related to insulin signalling intermediates such as IRS-1 tyrosine 
and serine phosphorylation, Akt phosphorylation and AS160 (TBC1D4) phosphorylation. In 
fact, co-staining of SNAP23 with GLUT4 would be ideal in order to corroborate the 
suggestion that SNAP23 hijacking by lipid droplets in obese individuals and patients with 
type 2 diabetes actually limits GLUT4 docking with the plasma membrane and thus would 
allow for a more thorough investigation of the hijacking hypothesis (Sollner, 2007). It would 
be of interest to investigate whether the appearance of GLUT4 in the t-tubules is paralleled by 
the appearance of SNAP23 in the t-tubules, given its role in GLUT4 docking. In addition to 
this, further fluorescence microscopy investigation of the SNARE complex (SNAP23, 
syntaxin 4 and VAMP2) proposed to be involved in GLUT4 docking at the plasma membrane 
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in skeletal muscle would also be important in terms of investigating exactly how this process 
occurs and the defects that occur with the development of insulin resistance. This would 
require the development of new immunofluorescence assays of a number of additional 
SNARE proteins.  
 
9.4.3 Enzymes that may play a role in reduced lipolysis and fatty acid 
oxidation in obesity and type 2 diabetes 
The isolation of lipid droplets from skeletal muscle homogenates requires drastic 
homogenisation and isolation procedures. This carries a high risk of artifactual protein loss or 
protein associations and therefore, colocalisation with immunohistochemical methods for the 
time being remains to be the preferred analytical method to identify the proteins that are 
naturally present in and play functional roles in lipid droplets.  
 
Future studies measuring lipases in skeletal muscle should also measure HSL protein content 
as well as subcellular and fibre type distribution, as suggestions have been made that 
accumulation of DAG may in fact result from incomplete lipolysis resulting from an 
imbalance between the activity of ATGL and HSL. The largest possible imbalance has been 
observed in HSL knockout mice, which as expected, accumulate a high DAG concentration in 
skeletal muscle and have reduced insulin sensitivity (Osuga et al., 2000;Mulder et al., 2003). 
Studies investigating HSL protein content and distribution should also include potential 
regulator or facilitator proteins, which in skeletal muscle, among others, include the PAT 
proteins perilipin 2 (ADRP) (Prats et al., 2006;Shaw et al., 2009). Another PAT protein, 
perilipin 5, has recently been proposed to play a role in the formation of functional lipid-
droplet mitochondria complexes and helps to determine whether FA are either used for IMTG 
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synthesis or for mitochondrial β-oxidation (Wang et al., 2011). Cardiomyocytes 
overexpressing perilipin 5 in basal conditions showed decreased lipid droplet lipolysis, 
decreased palmitate β-oxidation and increased palmitate incorporation into TAG. Whereas in 
stimulated conditions, lipid droplet hydrolysis inhibition was lifted and the released FA were 
channelled into the mitochondria for β-oxidation.  
 
Future studies using the methods developed in this thesis and complementary methods should 
not only make measurements in the fasted unstimulated state, but especially under conditions 
that are known to increase IMTG lipolysis, such as exercise and adrenaline infusion. The 
observation made by Prats et al., (2006) that in vitro electrical stimulation of rat soleus 
muscles and incubation with adrenaline (stimulating PKA) both led to HSL translocation from 
a cytosolic/microsomal site to the lipid droplets and to increased colocalisation of HSL with 
perilipin 2 still needs confirmation during dynamic exercise and adrenaline infusion in 
humans. A recent observation of my colleagues in Birmingham that lipid droplets containing 
perilipin 2 are preferentially used (oxidised) during one hour of endurance-type exercise in 
trained men (Shepherd et al., 2012) confirms that the PAT proteins present in the protein coat 
surrounding the lipid droplets probably should be regarded as lipid droplet scaffolding 
proteins that need to recruit the right environment (either neighbouring mitochondria or 
neighbouring ER binding sites containing GPAT1 and DGAT1) to determine if lipolysis or 
lipid synthesis prevails and whether IMTG can be oxidised during exercise (trained athletes) 
or not (obese sedentary and type 2 diabetes).  
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9.5 Final Conclusions 
The work contained within this thesis has demonstrated that a variety of immunofluorescence 
microscopy methods can be successfully developed and applied to sections of human skeletal 
muscle to thus generate novel information. These methods have also been used to make the 
first comparisons between obese and non obese elderly women. In future research these 
methods will be used to address some of the important unanswered questions on the 
mechanisms behind the impairments in lipid metabolism which prevent IMTG use in 
sedentary, obese and type 2 diabetic individuals and the mechanistic link between the inability 
to use IMTG during exercise, accumulation of FA metabolites in skeletal muscle and the 
development of insulin resistance. The added value of these immunofluorescence methods to 
traditional methods which focus on fuel use and insulin sensitivity, is that they provide a tool 
to investigate whether hypotheses generated in cultured cells and/or animal models (in which 
the expression and function of single proteins can be experimentally increased or decreased) 
also operate in skeletal muscle of human beings in vivo. In combination with the traditional 
methodologies to investigate regulation of metabolism in man (mentioned in earlier sections 
of this Chapter), these novel complementary immunohistochemical staining methods will help 
to identify novel drug targets and allow for more relevant metabolic evaluations of the effect 
and efficiency of life style interventions. Therefore these methods are expected to help and 
support medicine based evidence for the effectiveness of clinical trials and lifestyle 
interventions and to thus make a significant contribution to get improved control on the 
worldwide health threat of obesity and type 2 diabetes. 
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